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Abstract: 
The aims of this research were to develop novel surface modification strategies that can be 
used on a range of solid supports including polymeric and metallic matrices, as these could 
have a significant impact on the performance of bio/sensors employing these surfaces. These 
approaches were used to develop methods for immobilizing biomolecular recognition 
elements, such as antibodies, on modified matrices, and to exploit these approaches for the 
generation of high sensitivity bio-assays. Human fetuin A, mouse immunoglobulin G, and 
horseradish peroxidase were employed as model analytes. 
A silane-based surface modification strategy was designed and optimized for planar or flat 
surfaces such as polymeric sheets, chips or microtitre plates. These polymeric surfaces were 
activated prior to silane-functionalization using potassium hydroxide (aq.)-mediated mild 
oxidation (wet method) and oxygen-plasma etching. This novel surface activation strategy 
was further optimized in combination with surface functionalization and covalent 
immobilization of antibodies, for enhancing immunoassay sensitivities. Sensitivities 
obtained for immunoassays using antibodies immobilized with the developed and 
adsorption-based conventional strategies were 39 and 625 pg/mL, respectively, for human 
fetuin A. The strategy was demonstrated to be generic in nature and could be employed to 
activate a wide range of polymeric and metallic surfaces. In addition, highly sensitive 
detection of human fetuin A was achieved with antibodies captured in an oriented manner 
on covalently immobilized protein A (EC50 3.7 ng/mL) in comparison to randomly captured 
antibodies (EC50 5.8 ng/mL).  
High-brightness NIR664 dye-doped silica nanoparticles were employed to probe various 
activation states of platelets. These NPs were functionalized with silanes (viz. amine and 
carboxy-terminal) followed by conjugation to a platelet surface biomarker-specific antibody 
(anti-CD41) and successfully employed for probing platelet activation. The antibody-NP 
conjugates were found to be highly sensitive (>95%) and specific (≈100%). In addition, 
aggregation of NPs was minimized by controlling their surrounding chemical environment 
and their stability after antibody conjugation. 
Table of contents  
 
Chapter Section  Page Number 
    
  Abbreviations  i
  Analytical units  v
  Patents, IDFs, Publications and Conference 
presentations and posters 
 vi
       
1 Introduction: Strategies for immobilizing antibody molecules  1
    
 1.1 Introduction  2
 1.2 Overview of the available immobilization strategies and their  
implications for conformation-associated functionality 
 3
 1.2.1 Adsorption of antibody on chemically active surfaces  3
 1.2.2 Covalent immobilization of antibody on functionalized 
surfaces
 16
 1.2.2.1 Direct chemistries for antibody capture  16
 1.2.2.2 Linker-mediated strategies to capture antibody  23
 1.2.3 Site-specific immobilization of antibody  27
 1.2.3.1 Affinity tag-based site directed antibody capture  27
 1.2.3.2 Enzyme-substrate reaction-based site-directed antibody 
capture 
 33
 1.2.4 Site-specific orientation-based antibody capture  38
 1.3 Conclusions and Perspectives  39
 1.4 References  48
 1.5 Aims and Approach  71
    
2 Development of a modified high sensitivity rapid sandwich 
ELISA procedure with picogram sensitivity 
 72
     
 2.1 Abstract  73
 2.2 Introduction  74
 2.3 Materials  75
 2.4 Experimental Section  77
 2.4.1 Microtitre plate functionalization with amine silane and 
anti-human fetuin A antibody immobilization 
 77
 2.4.2 ELIA on anti-human fetuin A antibody-immobilized 
microtitre plates 
 78
 2.5 Results and Discussion  79
 2.5.1 Developed ELIA and conventional ELISA formats for 
human fetuin A detection 
 79
 2.5.2 Generic nature of the developed sandwich ELISA 
procedure on different substrates 
 83
 2.6 Conclusions  85
 2.7 References  85
    
3 Evaluation of apparent non-specific protein loss due to 
adsorption on sample tube surfaces and/ or altered 
immunogenicity  
 88
    
 3.1 Abstract  89
 3.2 Introduction  90
 3.3 Materials  91
 3.4 Experimental  92
 3.4.1 Tube blocking  92
 3.4.2 Sampling  93
 3.4.3 Analytical techniques   93
 3.4.4 Theory and analysis  94
 3.5 Results  97
 3.5.1 Evaluation of protein loss in unblocked polypropylene 
tubes 
 97
 3.5.2 Effect of tube blocking on protein analyte loss  102
 3.5.3 Evaluation of the contribution of human fetuin A 
fraction with conformation-related impaired 
immunogenicity 
 103
 3.5.4 Evaluation of the signal loss due to the nature of the tube 
material 
 106
 3.6 Conclusion  108
 3.7 References 
 
 108
4 Effect of antibody immobilization strategies on the analytical 
performance of a surface plasmon resonance-based immunoassay
 114
    
 4.1 Abstract  115
 4.2 Introduction  116
 4.3 Materials  118
 4.4 Methods  120
 4.4.1 Surface cleaning of SIA Au chip and APTES 
functionalization 
 120
 4.4.2 EDC activation of anti-HFA antibody   121
 4.4.3 Immobilization of anti-HFA antibody  121
 4.4.4 Covalent-CM5-dextran immobilization strategy  122
 4.4.5 HFA-detection  123
 4.4.6 Complete regeneration of the APTES-functionalized 
gold surface 
 123
 4.4.6.1 Siloxane bond lysis by acid treatment and O2-plasma  123
 4.4.6.2 SPR-based HFA immunoassay procedure  124
 4.4.6.3 SPR-based reproducibility analysis of antibody 
immobilization on the regenerated Au chips 
 125
 4.5 Results  125
 4.5.1 Comparison of antibody immobilization strategies as a 
function of antibody immobilization density 
 125
 4.5.2 Comparison of antibody immobilization strategies as a 
function of HFA capture densities 
 131
 4.5.3 Regeneration studies of the APTES-functionalized Au 
surface 
 133
 4.6 Conclusion  138
 4.7 References  139
    
5 Development of conjugates of dye-doped silica nanoparticles and 
anti-CD41 antibody for efficient platelet probing 
 145
    
 5.1 Abstract  146
 5.2 Introduction  147
 5.3 Materials  148
 5.4 Methods  149
 5.4.1 Synthesis of dye-doped nanoparticles   149
 5.4.2 Amine-silanization of the nanoparticles  150
 5.4.3 Bioassay performance to determine the efficiency of the 
antibody- nanoparticle conjugation 
 150
 5.4.4 Characterization of the aminated nanoparticles  151
 5.4.4.1 Zeta potential measurement  151
 5.4.4.2 Fourier Transform Infra Red spectroscopic studies  151
 5.4.4.3 Miscellaneous physical characterization approaches  152
 5.4.5 Antibody conjugation to nanoparticles and characterization  152
 5.5 Results  153
 5.5.1 Zeta potential measurement to measure surface charge  153
 5.5.2 Confirmation of the amine-functionalization of silica 
nanoparticles by Fourier Transform Infra Red spectroscopic 
measurement 
 154
 5.5.3 Antibody conjugation and bioassay performance  158
 5.6 Conclusion  160
 5.7 References  161
    
6 Analysis and reduction of process-induced aggregation of NIR-
664 dye-doped silica nanoparticles 
 165
    
 6.1 Abstract  166
 6.2 Introduction  167
 6.3 Materials  169
 6.4 Methods  169
 6.4.1 Defining aggregation tendency in terms of zeta potential  169
 6.4.2 Nanoparticle functionalization  170
 6.4.2.1 Functionalization with amino-silane  170
 6.4.2.2 Functionalization with carboxy-silane  170
 6.4.3 Storage stability  171
 6.4.3.1 Effect of solvent  171
 6.4.3.2 Effect of nanoparticle incubation at different pHs  171
 6.4.3.3 Effect of antibody cross-linking strategy and surface 
blocking methods 
 171
 6.4.3.3.1 Amine surface blocking strategy for antibody-cross-
linked-amine-functionalized anoparticle adducts 
 171
 6.4.3.3.2 Carboxy surface blocking strategy for antibody-cross-
linked-carboxy-functionalized nanoparticle adducts 
 172
 6.4.4 Characterization of nanoparticle stability using Surface 
charge (zeta potential) measurement 
 173
 6.5 Results and Discussion  174
 6.5.1 Effect of solvent  174
 6.5.2 Effect of pH  177
 6.5.3 Effect of antibody crosslinking  179
 6.6 Conclusion  182
 6.7 References  184
    
7 Conclusions and future work  188
    
 7.1 Conclusions  189
 7.1 Sorting nanoparticles as a function of their charge using 
a self-developed sorter 
 191
 7.2 Replacing ethylenediamine (EDA) with ethanolamine 
(EA) 
 192
 7.3 Gradual centrifugation as an aggregate sorting procedure  192
8 Appendix I – Publication list  193
 
i 
 
Abbreviations 
Ab  Antibody 
AFM  Atomic force microscopy 
Ag  Antigen 
APTES  Aminopropyltriethoxysilane 
AU  Arbitrary unit 
Au  Gold 
Au NP  Gold nanoparticle 
BMS  Bristol Myers Squibb  
BSA  Bovine serum albumin 
CA  Cellulose acetate 
CBD  Chitin-binding domain 
CD  Cluster of differentiation 
CHOP  Chinese hamster ovary protein 
CM  Carboxy methyl 
CV  Coefficient of variation 
Cy5  Cyanine 5 fluorescent dye 
DIW  Deionized water (18 mega ohms) 
DLVO  Derjaguin, Landau, Verwey and Overbeek (in DLVO 
theory) 
 
DRP  Domain recognition protein 
DTT  Dithiothreitol 
EC50  Half-maximal effective concentration 
ii 
 
EDA  Ethylenediamine  
EDC  1-ethyl-3-[3-dimethylaminopropyl]carbodiimide 
EDTA  Ethylenediamine tetra-acetic acid 
ELIA  Enzyme-linked immunoassay 
ELISA  Enzyme-linked immunosorbent assay 
ELP  Elastin-like polypeptide 
Fc  Fragment constant region (of antibody) 
FIA  Fluorescence immunoassay 
FCS  Fluorescence correlation spectroscopy 
FLCS  Fluorescence lifetime correlation spectroscopy 
FT-IR  Fourier transform infrared spectroscopy 
hAGT  Human O6-alkylguanine transferase 
H2O2  Hydrogen peroxide 
H2SO4  Sulfuric acid 
HBS  HEPES-buffered saline 
HCl   Hydrochloric acid 
HEPES  2-[4-(2-hydroxyethyl)-1-piperazinyl]ethanesulfonic acid 
HFA  Human fetuin A 
HRP  Horseradish peroxidase 
Ig  Immunoglobulin 
IgG  Immunoglobulin G 
IR  Infrared 
kL  Kappa-light 
iii 
 
KOH  Potassium hydroxide 
KPR  KOH to polymer ratio 
LOB  Limit of blank 
LOD  Limit of detection 
MES  2-(N-morpholino)ethanesulfonic acid 
N  Avogadro’s number (6.02 X 1023 mol-1) 
NaCl  Sodium chloride 
NHS  N-hydroxysuccinimide 
N/S  Noise to signal ratio 
NTA  Nitriloacetic acid 
PBS  Phosphate buffered saline 
PC  Polycarbonate 
PEG  Polyethylene glycol 
PHA  Polyhydroxyalkanoate  
PLL  Poly-L-lysine 
PMMA  Polymethylmethacrylate 
PNA  Peptide nucleic acid 
PrA  Protein A 
PS  Polystyrene 
PSA  Pressure sensitive adhesive 
PSBD  Polyhydroxyalkanoate depolymerase substrate-binding 
domain 
QCM  Quartz crystal microbalance 
r2  Correlation coefficient 
iv 
 
RBS  Rutherford back scattering 
RT  Room temperature 
ρ  Immobilization density 
RU  Response unit (SPR studies) 
SA  Streptavidin 
scFv  Short chain fragment variable (of antibody) 
SAM  Self-assembled monolayer 
SD  Standard deviation 
Si  Silica 
SIA  Surface interaction analysis 
Si NP  Silica nanoparticle 
S/N  Signal to noise ratio 
SNHS  Sulfo-N-hydroxysuccinimide 
SPR  Surface plasmon resonance 
TCEP  Tris(2-carboxyethyl)phosphine 
TGase  Transglutaminase 
TMB  3,3´,5,5´-tetramethyl benzidine 
UPW  Ultra pure water 
UV  Ultra violet 
Vis  Visible 
ZnX  Zeonex 
v 
 
Analytical Units 
 Abbreviation 
s 
 Full detail 
Second (time) 
min  Minute (time) 
h  Hour (time) 
psi  Pounds per square inch (pressure) 
J  Joule (energy) 
mJ  milli-Joule (energy) 
M  Molarity (concentration) 
N  Normality (concentration) 
μg/mL   Microgrammes per millilitre (concentration) 
ng/mL  Nanogrammes per millilitre (concentration) 
mm2  Millimetre square (area) 
cm  Centimetre 
Ω  Ohms (resistance)  
  
vi 
 
 
Patents 
1. Modified ELISA plate technology (Published patent number: WO2010/044083 
A2; DCU Ref: 2008/07/DCU/BT/CBAS): ‘Product and method relating to the multi-
well plate for biological assays, in particular, the invention relates to a multiwall 
plate for enzyme linked immunosorbent assays and a method for preparing such 
plates’. DCU Ref: 2008/07, European Application No. 08394037.9 filing date 14 
Oct, 2008. 
Contributors: Sandeep K. Vashist, Stephen O’Sullivan, Feidhlim O’Neill, Chandra 
K. Dixit, Brian O’Reilly, Harry Holthofer. 
PUBLICATIONS 
Published: 
1. Chandra Kumar Dixit, Sandeep Kumar Vashist, Feidhlim O’Neill, Brian O’Reilly, 
Brian MacCraith, and Richard O’Kennedy. Development of a high sensitivity rapid 
sandwich ELISA procedure and its comparison with the conventional approach 
Analytical Chemistry 2010, 82, 7049–7052. (IF: 5.84) 
2. Shibshekhar Roy, Chandra Kumar Dixit, Robert Wolley, Brian MacCraith, Richard 
O’Kennedy, and Colette McDonagh. Novel multiparametric approach to elucidate the 
surface amine-silanization reaction profile on fluorescent silica nanoparticles 
Langmuir 2010, 26(23), 18125-18134. (IF: 4.26) 
3. Chandra Kumar Dixit, Sandeep Kumar Vashist, Brian MacCraith, and Richard 
O’Kennedy. Evaluation of apparent non-specific protein loss due to adsorption on 
vii 
 
sample tube surfaces and/ or altered immunogenicity Analyst 2011, 136(7), 1406-
1411. (IF: 3.91) 
4. Chandra Kumar Dixit, Sandeep Kumar Vashist, Brian MacCraith and Richard 
O’Kennedy. Multi-substrate compatible ELISA procedures for rapid and high 
sensitivity immunoassays Nature Protocol 2011, 6, 439-445. (IF: 8.36) 
5. Ram Prasad Gandhiraman, Nam Le, Chandra Kumar Dixit, Cedric Volcke, Colin 
Doyle, Vladimir Gubala, Suresh Uppal, Richard O'Kennedy, Stephen Daniels, and 
David E Williams. Multi-layered plasma polymerized chips for SPR-based detection. 
Applied Material Interfaces. 2011. DOI: 10.1021/am201061k (IF: 2.92) 
6. Sandeep Kumar Vashist, Chandra Kumar Dixit, Brian McCraith, and Richard 
O’Kennedy. Effect of antibody immobilization strategies on the analytical 
performance of a surface plasmon resonance immunoassay. Analyst 2011, 136(21), 
4431-4436. (IF: 3.91) 
7. Shibshekhar Roy, Chandra Kumar Dixit, Robert Wolley, Richard O’Kennedy, and 
Colette McDonagh. Label-free optical characterization methods for detecting amine 
silanization-driven gold nanoparticle self-assembly. Langmuir 2011, 27(17), 10421-
10428. (IF: 4.26) 
PRESENTATIONS (*) AND POSTERS 
1. *Sandeep Kumar Vashist, Feidhlim O’Neill, Chandra Kumar Dixit, Brian O’Reilly, 
Barry Byrne, Gerard O’Donohoe, Richard O’Kennedy, and Brian MacCraith. Novel 
approaches for advanced bioanalytical platforms; International Conference on Trends 
in Bioanalytical Sciences and Biosensors (ICTBSB) 2009, Dublin, Ireland, January 26-
27. 
viii 
 
2. Chandra Kumar Dixit, Sandeep Kumar Vashist, Brian MacCraith, and Richard 
O’Kennedy. Development of novel strategies for antibody immobilization on agarose 
beads; NCSR 10th Anniversary symposium 2009 NCSR, Dublin City University, 
Dublin, Ireland, October 22.  
3. Chandra Kumar Dixit, Sandeep Kumar Vashist, Brian O’Reilly, Brian MacCraith, 
and Richard O’Kennedy. Development of highly sensitive antibody-coated microarray 
platforms for diagnostics and bioanalytical applications; International conference on 
sensors and related networks (SENNET) 2009, VIT Univ. Vellore, India, December 8-
10. 
4. Chandra Kumar Dixit, Sandeep Kumar Vashist, Brian MacCraith, and Richard 
O’Kennedy. Novel gold (Au)-chip modification strategy to immobilize antibody for 
surface plasmon resonance (SPR)-based platforms; EUROPT(R)ODE X - A conference 
on optical chemical sensors and biosensors 2010, Prague, Czech Republic, March 28-
31. 
5. Chandra Kumar Dixit, Shibsekhar Roy, Robert Woolley, Una Prendergast, Richard 
O’Kennedy, Colette McDonagh, Dye-doped silica nanoparticles as high-brightness 
probes: A study with Platelet-CD41 as model antigen system; 3rd Bangalore Nano 
2010, JNCASR, Bangalore, India, December  8-9. 
 
 
1 
 
 
 
  
 
 
 
Chapter 1  
Introduction 
Strategies for immobilizing antibody 
molecules 
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1.1 Introduction 
Antibodies are glycoproteins that belong to the immunoglobulin super family [1].  An 
antibody is a homo-dimer molecule composed of two heavy and two light chains with a 
molecular weight of approximately 150 kD. The heavy chains are attached together by 
disulfide bonds and a disulfide bond also links them to their corresponding light chains.  
Each antibody contains a constant domain (Fc) and an antigen-binding domain (Fab). 
The amino terminal region of the Fab domain is hyper-variable and responsible for 
antigen recognition and specificity. A typical antibody (IgG2) with all the available 
functional groups is depicted in Figure 1.1.  
The antibody and its isotypes are important components of the immune system; they are 
present either in soluble form or as membrane-bound surface receptors on B-cells. These 
antibody molecules occur naturally in the plasma. However, with advances in molecular 
biology they can be also developed as recombinant antibodies in bacterial and expression 
systems.  
A monoclonal antibody is highly specific and binds to a single defined region or epitope 
on an antigen; whereas, polyclonal antibody preparations consist of a mixture of 
antibodies and can recognize a wide range of antigens or multiple epitopes on a single 
antigen.  
There are variants of antibody structure (other than IgG) such as Fab (fragment antigen-
binding unit) and scFv (short chain fragment variable) which may be generated by 
chemical or genetic approaches [2-4]. A range of different ‘antibody-like’ entities, also 
known as nanobodies or single-domain antibodies, exist [5]. These single-domain 
antibodies are generally obtained from camels and fish, particularly shark. These are 
smaller in size in comparison to the naturally occurring whole antibodies and possess 
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comparative affinities for antigen molecules. These smaller sized variants could also 
provide certain advantages for immunoassays and for in-vitro studies.  
Antibodies, due to their high antigen specificity and affinity, [6,7] can make excellent 
probes and, therefore, have multiple applications in many fields of biological research 
such as biosensors and diagnostics. The development of these bioanalytical detection 
systems requires antibody immobilization on various solid supports. Therefore, a precise 
knowledge of the chemical and functional properties of an antibody, along with the 
chemical nature of the solid supports that will be employed to capture antibody, is 
essential for designing a suitable immobilization strategy. Strategies that allow the 
retention of functional conformation of the antigen binding sites of antibody molecules 
are essential and can be achieved by site-specific and orientated presentation of the 
antibodies on the surface used for immobilization [3,8]. However, the information 
pertaining to the development of an understanding of controlled immobilization is 
limited. In addition, the susceptibility of antibody to the loss of functional conformation 
and specificity due to steric hindrance [9,10] or molecular flattening and spreading [11-
16] have restricted the development of highly sensitive immunoassay strategies. 
In this introduction, antibody immobilization strategies (Table 1.1 and 1.2), particularly 
tag-assisted [17,18] and domain-specific protein-mediated methodologies [19-21], will 
be critically analyzed in terms of their efficiency, capability of capturing antibody in a 
site-directed fashion and their suitability for immunoassay development.  
1.2 Overview of the available immobilization strategies and their implications for 
conformation-associated functionality 
1.2.1 Adsorption of antibody on chemically active surfaces 
Adsorption is a process of adhesion of biomolecules on surfaces as a consequence of net 
free energy change (ΔG), which must be negative in magnitude. This ΔG may be entropy 
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or enthalpy driven [24]. Entropy, which is governed by second and third law of 
thermodynamics, is a state function of a thermodynamic system that describes the 
 
H2N
NH2H2N
Carbohydrate
(Carboxyl group) 
NH2 (Amine group)
Fc
Fab
S   S 
C   OH 
O
OH   C 
O
C   OH 
O
OH   C 
O
S   S 
NH2
Carbohydrate
Reacts with amine, carboxyl and sulfhydryl group
Reacts with amine and
Sulfhydryl group
Reacts with amine and sulfhydryl group
Reacts with amine group
HS   
HS   
C   OH 
O
C   OH 
O
(a)
(b)
 
Figure 1.1 (a) Model of a typical IgG with the available functional groups. An antibody 
consists of two heavy (black bars) and two light (blue bars) chains. Each chain has 
carboxyl (-COOH) and amine (-NH2) groups, which are contributed by terminal and 
internal amino acids. Both the heavy chains are linked together with two disulfide 
bridges at the hinge region. Similarly, each light chain is linked to its respective heavy 
chain through a disulfide bridge. (b) Reactive functional groups present on the heavy 
and light chains of an antibody. Amine and carboxyl groups are the only reactive 
functional groups present in an antibody in its native state. Sulfhydryl groups can be 
generated after reducing the disulfide bonds of an antibody with DTT or TCEP. 
Carbohydrates in the Fc section can be activated by periodate treatment [22,23]. 
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Table 1.1. Details of commonly employed antibody modification strategies for conjugation/ immobilization 
 
Strategy for Antibody  
Modification 
Target Functional Group/ Point 
of Modification 
Reaction 
 
Activation of carbohydrates by 
oxidisation with sodium (NaIO4)/ 
potassium periodate (KIO4) 
 
Hydroxyls of  carbons at position 3 
and 4 in the sugar ring of 
carbohydrate, which is present in 
the Fc region of antibodies 
 
>CH(OH) – C(OH)<  →  2(-CHO) 
 
 
 
Alkylation by reduction  
 
 
(a)  disulfide bonds (-S-S-) 
 
 
 
 
(b)  amines of lysine (-NH2) 
 
 
(a) disulfide bonds: 
 
(Step 1) -S-S-  (DTT/ TCEP) →  -SH + -SH 
(Step 2) -SH + Alkylating agent → -S-alkane 
 
(b) lysine: 
 
-NH2 + Alkylating agent → -NH-alkane 
 
Acetylation 
 
α-NH2 of the protein located at the 
N-terminal  
 
CH3COOCH3 + α-NH2-PROTEIN→ CH3CO-NH-PROTEIN 
 
(a) Chlorination/ tosylation 
(Tresyl and Tosyl chloride         
derivatives Fig. 1.4) 
 
 
 hydroxyl group (-OH) 
 
 
 
CH3C6H4SO2Cl + PROTEIN-OH → CH3C6H4SO2-O-PROTEIN + HCl 
 
 
(b) Sulfonamidation 
(Tresyl and Tosyl chloride         
derivatives Fig. 1.4) 
amine groups (-NH2 1o, 2o) 
 
CH3C6H4SO2Cl + PROTEIN-NH2 → CH3C6H4SO2-NH-PROTEIN + HCl 
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Table 1.2. Available functional groups on the antibody and surface and their chemical reactivity toward each other.  
 
Functional 
group on antibody
Functional 
group on surface
  
 
 
 
 
   
 
 
 
Amine 
× ×× ×× +        
 
Hydrazine 
× ×× ×× +        
 
Diazine 
P P +  P  +    NS 
 
 
chloride 
 
+ 
    
+ 
 
H 
 
H 
    
 
 
Aldehyde 
 
+ 
 
+ 
    
+ 
 
+ 
    
 
 
Formaldehyde 
 
+ 
 
+ 
    
+ 
 
+ 
 
+ 
 
+ 
  
          
+ 
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Biacetyl 
 
 
Anhydride 
 
+ 
    
+ 
 
H 
 
H 
    
 
 
Halo-ketone 
 
+ 
 
+ 
    
+ 
 
+ 
 
+ 
  
+ 
 
 
Thiol 
×× ×, +  +        
 
Sulfonyl halide 
 
+ 
 
+ 
    
+ 
 
+ 
 
+ 
   
 
Argon halide 
+ +    + +     
 
Epoxide 
 
+ 
 
+ 
 
+ 
  
+ 
 
+ 
 
+ 
    
 
Aziridine 
 
+ 
 
+ 
        
+ 
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Pyrollidine-2,4-dione 
 
+ 
    
+ 
 
+ 
     
 
Benzoquinone 
 
+ 
 
+ 
   
+ 
   
+ 
   
 
Azidobenzene 
 
P 
 
P 
   
P 
 
P 
 
P 
 
P 
   
NS 
 
Triazine 
 
+ 
    
+ 
      
 
R Alkyl or aromatic group of the main carbon backbone 
X halogen group 
× Homo-bifunctional crosslinker required 
×× Hetero-bifunctional crosslinker required 
+ High reactivity towards each other  
×, +    High reactivity towards each other but can also react through a homobifunctional crosslinker 
P Photoactivation required for reaction 
NS Non-selective reaction      
H Strong tendency for hydrolysis 
Blank boxes indicate that no interaction is possible between the corresponding moieties 
Prefix ‘Ab’ in the first row of table represents antibody followed by the functional group on the antibody involved in the reaction with the 
chemical groups listed in the first column of the table. 
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disorderliness or uncertainty within matter. In addition, entropy is a measure of the 
amount of energy that cannot be used to perform work. According to the laws governing 
thermodynamics, entropy of an isolated system can never decrease assuming the system 
is in its ground energy state. Therefore, thermodynamically a certain amount of entropy 
is always possessed by a system at any given time and this governs the reactivity of that 
system [25]. However, considering that matter is in dynamic state with its surroundings, 
the amount of entropy in a given system could either increase or decrease according to 
the nature of the body with which given system is interacting. The change in entropy 
(ΔS) describes the nature of the thermodynamic reaction undergone by the system in a 
dynamic state such that the given system is, either stabilized by losing its entropic 
contents, or destabilized by gaining entropy from the surroundings [26]. Enthalpy is the 
total energy content of a system that is required to maintain its physical and chemical 
form [26]. The change in enthalpy (ΔH) of a given system governs the conformational 
and functional stability of the proteins in the given surroundings. There is always a 
continuum between enthalpy and entropy, which is known as enthalpy-entropy 
compensation [25]. This compensation is the mathematical relation between both of 
these thermodynamic parameters and is described in the following equation as Gibb’s 
free energy change (ΔG),  
ΔG = ΔH - T ΔS 
where, 
ΔG: Gibb’s free energy change, ΔH: enthalpy, T: temperature of the whole system, and 
ΔS: entropy. 
It can be seen from this equation that a linear rise in enthalpy and entropy will not 
change the free energy of the system and, therefore, no change in the chemical or 
physical parameters will be observed. However, an increase in enthalpy without 
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changing entropy of the system will introduce structural and chemical changes in the 
given system. Therefore, this enthalpy-entropy compensation is the most important and 
basic thermodynamic expression that governs every physical or chemical change that 
matter undergoes. 
An antibody in solution continuously interacts with the solvent, the surface and other 
antibody molecules present in solution. Hydrophobic, van der Waals, and ionic 
interactions prevail in antibody-solvent interactions [27]. Hydrogen bonding could also 
be present depending on the chemical nature of the solvent [28,29]. These antibody-
solvent interactions are in dynamic state, where new interactions are continuously 
formed replacing the previous interactions. On account of system thermodynamics, this 
interaction dynamics is directly regulated by ΔS and ΔH, as described previously [24]. 
Similarly, interaction of an antibody with other antibody molecules follows the 
‘antibody-solvent’ type of interaction behaviour in terms of basic thermodynamics such 
that ΔS and ΔH govern the antibody self-interaction process. Hydrophobic, van der 
Waals, ionic and coordinate bonding types of interactions are predominant when an 
antibody interacts with a surface. Therefore, it could be inferred that antibody 
interactions are in dynamic state with their surroundings and are not isolated events. This 
suggests that the entropy of the antibody interactions with surface could therefore, either 
increase or decrease according to their surroundings such as temperature, pH, nature of 
solvent and nature of the chemicals used [30]. In addition, the chemical composition of 
an antibody also significantly affects its thermodynamic properties [31]. Therefore, 
adsorption of antibody could be either driven by enthalpy or entropy depending on which 
of these two components is predominant in the given system [31,32].  
Entropy-based adsorption mainly favours hydrophobic interactions where the adsorption 
is achieved by the release of water of hydration [24,33]. Enthalpy-based adsorption 
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mainly leads to hydrophilic, weak van der Waals and electrostatic interactions along with 
hydrogen bonding [24]. All these interactions that play important roles in adsorption are 
mainly governed by the surface energy of either the solid support or the antibody. A 
subtle change in ΔG can significantly change the surface energy of an antibody or solid 
support. This change in the surface energy affects the number of these interactions and 
hence the stability of the adsorption of an antibody molecule on the surface. The 
conformation of an antibody is stabilized by various weak interactions. 
Thermodynamically, a subtle change in the number of these weak interactions could lead 
to conformational and structural changes [12,13,34,35].  
There are two different types of adsorption i.e. physisorption and chemisorptions, such 
that the critical energy threshold between binding energies of physisorption and 
chemisorptions is about 0.5 eV. Physisorption involves mainly weak van der Waals 
forces and hydrophobic interactions. As mentioned previously, these interactions may be 
entropic or enthalpic in origin. Hydrophobic interactions develop when hydrophobic 
pockets are generated around pendant non-polar groups of an antibody on their exposure 
to water in the solution [24] and are described elsewhere [36]. The exposure of non-polar 
groups to water results in repulsion of the non-polar groups due to hydrophobicity 
[37,38]. Similarly, the interaction of hydrophobic clusters on the surface of solid support 
also follows the same interaction behaviour. However, the hydrophobic clusters on the 
surface of solid support are rigid and therefore have a tendency to repel water without 
changing their position, whereas, an antibody is in a dynamic state with water and 
repulsion is experienced by both the interacting partners, i.e. antibody and water. The 
interaction with water of these non-polar groups on antibody and surface, therefore, 
creates hydrophobic pockets in the system. The generation of these pockets increases the 
entropy of the system because the bonds between water-to-water molecules, which 
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surround the system, have to rearrange in order to stabilize the system. Therefore, to 
reduce the overall entropy, the hydrophobic pockets on the antibody come together such 
that antibody comes into close proximity with the surface of the solid support. In 
addition, since antibody molecules have hydrophobic pockets, these pockets will also 
tend to interact with each other. The close proximity of antibody with the surface 
facilitates a range of interactions between them. However, the interaction of antibody 
molecules with each other may result in temporary self-aggregation. An increase in the 
number of these interactions thus, increases the enthalpy of the system following the 
entropy-enthalpy compensation law [25]. This increase in the enthalpy of the system 
decreases the entropy and favours the physisorption. Additionally, the interaction of non-
polar groups of the antibody with the surface may lead to the loss of water of hydration 
from antibody, which could, in turn, adversely affect the overall structural stability of the 
antibody. These interactions are suitable for immobilizing antibody on hydrophobic 
surfaces such as polystyrene, fluorocarbon polymers etc.  
Chemisorption is the process whereby an antibody is adsorbed on the surface by forming 
electrostatic interactions and/or dative bonds with it. The basic mechanism of 
chemisorption is similar to physisorption where the initial antibody-surface interaction is 
controlled by weak forces. However, in case of chemisorption, the major stabilization of 
antibody-surface interactions is achieved by chemical reactions performed in a specific 
ΔG range, which is depicted as the chemisorption potential. Chemisorption also follows 
the previously explained rules of thermodynamics [24,39]. Antibody immobilization on 
positively charged surfaces, such as polyaniline or poly-L-lysine films, by the means of 
electrostatic interaction, is an example of an ionic ‘binding-type’ chemisorption (Figure 
1.2). In addition, certain functional groups on an antibody (such as thiols (-SH) and 
amines (-NH2)) have an inherent capacity to make co-ordinate or dative bonds with 
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metals or metal-coated surfaces [40,41] and this is referred to as dative ‘chemistry-type’ 
chemisorption.  
 
+ + + + ++ + + ++
pH > pI for a net negative charge
+ + + + ++ + + ++
‐ve
‐ve
Overall negative charge 
on antibody
+ + +++ + ++
Antibody molecule
Polyaniline
Polyaniline-coated surface
Interaction of negatively charged antibody
with positively charged surface  
Figure 1.2 Role of electrostatic interactions in antibody immobilization. An antibody will 
attain a net negative charge at a pH higher than its pI. A buffer, such as a carbonate 
buffer, with a pH of ~ 10, will introduce a net negative charge on the antibody. Antibody 
molecules may then be immobilized on positively charged surfaces by ionic/ electrostatic 
interactions. The polyaniline-coated surface in this figure represents a positively 
charged surface. 
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Adsorption is a complex phenomenon that is governed by numerous factors such as the 
shape, structural complexity and chemical properties of antibodies. The solubility and 
self-association of antibodies also plays an important role in achieving efficient 
adsorption [42,43]. Solubility of antibody in a given solvent strictly depends on the 
polarity of the solvent, where, solvents are categorised as polar, non-polar and neutral. 
Typically, antibodies present in highly polar solvents have a higher tendency to develop 
hydrophobic pockets in comparison to when in non-polar solvents.  The higher the 
number of such hydrophobic pockets on the antibody, the higher will be the propensity 
of an antibody to develop hydrophobic interactions and, hence, the greater the adsorption 
of antibodies on the surface of the solid supports [24].  
The chemical nature of the surface also plays an important role in adsorption-based 
antibody immobilization. Adsorption, being favoured by hydrophobic interactions, is 
better on hydrophobic surfaces. However, a few reports claim comparable adsorption of 
antibodies on hydrophilic and hydrophobic surfaces [44]. Short chain Fv (scFv) 
antibodies were also reported to be successfully adsorbed on hydrophilic polymer-coated 
glass slides [45]  and custom-synthesized mesoporus silicates [46] with restricted loss of 
binding capacity.  In addition, the physisorption of antibodies is partially reversible from 
hydrophilic surfaces when highly non-polar solvents are used. This is the case because a 
highly non-polar solvent can significantly reduce the number of hydrophobic pockets on 
an antibody following a conformational rearrangement [47]. This reversible antibody 
adsorption may also be controlled by other factors such as the introduction of water of 
hydration. The antibody after adsorption loses its water of hydration, which is initially 
bound to the biomolecules. However, non-polar solvents may re-introduce water in the 
adsorbed antibodies rendering them more hydrophilic. This hydration-induced 
hydrophilicity could play a crucial role in reversible adsorption. 
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Adsorption is a simple method of antibody immobilization, which makes it the 
preferential choice when developing certain immobilization-based immunoanalytical 
methods such as ELISA. However, there are some drawbacks associated with adsorption 
such as conformation-associated activity loss [13,34,48,49], and antibody leaching off 
the surface [50]. In addition, uncontrolled orientation, and random antibody packing on 
the surface, are other major drawbacks that may occur [51]. These processes are 
responsible for steric hindrance compromising antigen recognition ability of antibodies 
[52-54]. However, the problem of random orientation of antibody can effectively be 
overcome by employing an adsorbed sub-layer of capture proteins that leads to 
controlled and systematic capture of antibody molecules in an active binding orientation. 
Hence, a homogeneous molecular packaging of antibody over the surface can be 
achieved. The most commonly employed capture proteins include Fc-binding molecules 
such as protein A (prA) [55], G [56] and the kappa-light (kL)-specific protein L [57], 
which can bind to specific regions on an antibody, and hence allowing them to be better 
orientated. Anti-antibodies could also serve as a capture stage for directed capture of a 
desired antibody on a given surface. Anti-tag capture methods also employ anti-tag 
antibodies such as anti-HIS antibody [58] and others, which are listed in Table 1.3 (page 
40 et seq). In addition, hapten-conjugated antibody/fragments could be immobilized on 
anti-hapten-antibody-pre-adsorbed surfaces [19].  
Protein exchange [59] is another phenomenon observed in adsorbed antibody systems. 
Adsorbed antibody has a tendency to interact with proteins present in solution. These 
interactions of an antibody with other proteins favour conformational rearrangements in 
order to attain a stable state. The change in conformation might disrupt some of the 
antibody-surface interactions. This will result in leaching of antibody from the surface. 
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In addition, a protein with a higher tendency to interact with the surface can replace a 
physisorbed antibody/fragment [24].  
Biosensor-based applications require well designed strategies for immobilization of 
antibodies onto the appropriate surfaces. Since adsorption is a complex process, the 
design of a highly repeatable adsorption-based immobilization strategy is a very 
important, if laborious, task. Some of the problems associated with adsorption-based 
immobilization strategies may be overcome by covalent methods, which are discussed in 
the next section.  
1.2.2 Covalent immobilization 
In covalent immobilization antibody molecules react chemically with the functional 
groups of the surface via free reactive groups such as amine or carboxyl groups. 
Covalent strategies are generally categorized on the basis of the chemical reaction 
approaches used. The importance of covalently immobilized antibody systems for 
achieving high sensitivity assays has already been demonstrated with various diagnostic 
platforms [60-63]. Improved analyte sensitivity may be attributed at least in part to 
reduced protein losses due to antibody leaching and antibody exchange, which could 
increase the antibody surface coverage [60,61].  
1.2.2.1 Direct chemistries for antibody capture 
In this approach at least one of the reacting functional groups involved, on either the 
antibody molecule or the surface, readily reacts with the other without any activation or 
use of mediators. These strategies are mainly single step immobilization procedures. The 
most common direct chemistries that have been used for immobilization include 
epoxide-, chloride-, and aldehyde-based strategies and several examples of such 
strategies are outlined. 
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In aldehyde-based strategies either the antibody or the binding surface can be activated to 
generate free aldehydes, which can subsequently be used to immobilize the antibody. 
Active aldehydes can be generated on an antibody by oxidizing hydroxyl (-OH) groups 
of carbohydrates present in the Fc region of an antibody using meta-periodates of highly 
reactive alkali metals such as sodium (NaIO4) or potassium (KIO4). The resulting 
activated diol-groups can be captured efficiently on amine-functionalized surfaces 
[22,23,64]. In addition, the oxidized antibody molecules could be conjugated to labels 
such as biotin [65] and subsequently, be immobilized on surfaces coated with avidin or 
streptavidin. However, the major drawback associated with oxidizing an antibody is that 
the chemicals used for oxidation are highly reactive and, apart from activating 
carbohydrates, they may oxidize amino acids such as methionine, tryptophan or histidine 
at different points on antibody [66-68]. Therefore, another approach is preferable where 
the native antibody can be immobilized on surfaces functionalized with aldehydes 
[69,70]. Polymeric, metallic and nanoparticle surfaces may be functionalized with 
aldehyde to capture antibodies for various bioanalytical applications [69,70].  
Epoxide-grafted solid supports are also widely used for antibody immobilization. An 
epoxide is cyclic ether containing one oxygen atom in the ring and its strained structure 
makes it highly reactive in comparison to other ether molecules. It is highly reactive 
towards secondary amines of amino acids, particularly histidine, and sulfhydryls of an 
antibody/fragment (Figure 1.3) [23,71,72]. The strong reactivity of an epoxide toward 
amine groups allows the immobilization of an antibody via lysine-rich regions or poly-
histidine (HIS) tags. In addition, either a full-length antibody or a fragment or genetic 
variants (e.g. scFv, Fab), with exposed sulfhydryl groups, could also be captured on 
epoxide-functionalized surfaces [23,71,72].  
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Another direct chemistry is based on surface activation of solid support using aromatic 
chlorides e.g. trisyl (2,4,6-triisopropylbenzenesulfonyl chloride) and tosyl chlorides (p-
toluenesulfonyl chloride). 
0 oC
Monomer unit 
of the polymeric surface
3-Chlorobenzoperoxoic acid
Epoxylated monomer unit
of the polymeric surface
Chloroform
Ab captured on 
epoxylated polymer
– Ab
 
Figure 1.3 A schematic representation of surface epoxylation and antibody 
immobilization. A typical organic polymer, such as polystyrene, is first epoxylated using 
3-chlorobenzoperoxoic acid in the presence of chloroform at 0 oC. An antibody may then 
be immobilized on the epoxy-functionalized surface by the reaction of an amine or 
sulfhydryl group of the antibody and the epoxy group of the surface. ‘NH—/ S—Ab’ 
represents amine or sulfhydryl groups of an antibody that reacts with the epoxy groups 
of the surface. This is single step chemical reaction and no crosslinkers or intermediate 
molecules are required. 
 
These aromatic chlorides are highly reactive toward hydroxyls and could easily be 
incorporated on the hydroxyls of the desired surface [73]. Such aromatic chloride-
activated surfaces react with nucleophiles such as amine, sulfhydryl, imidazole, and 
hydroxyl groups of tyrosine that are present on an antibody (Figure 1.4) [74-77]. The 
only drawback of this strategy is that it is non-selective towards the previously 
mentioned functional groups. Therefore, the interaction of these chlorides with primary 
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amines of the antigen-recognition region on the antibody may lead to loss of antibody 
activity.  
 
Figure 1.4 Covalent immobilization of an antibody on a hydroxylated surface. Hydroxyl-
functionalized surfaces, such as agarose, are activated with tosyl or trisyl chloride. The 
hydrogen ‘H’ of hydroxyl surface reacts with the chlorine moiety of tosyl/ trisyl chloride 
and generates HCl with subsequent attachment of these sulfonyl groups to the surface. 
The tosyl/ trisyl-activated surface then undergoes a displacement reaction such that the 
sulfhydryl, primary amine, hydroxyl group of tyrosine and imidazole groups of an 
antibody react with the surface displacing the tosyl/ trisyl group as shown . ‘NH—/ S—/ 
O—Ab’ represents binding of an amine, sulfhydryl or hydroxyl groups of an antibody 
bound to the sulfonate group of the trisyl or tosyl chloride-activated surface. 
 
Immobilization of various protein molecules onto PEG-functionalized surfaces was 
demonstrated with Diels-Alder reactions and azide-alkyne [3+2] cycloadditions [78]. 
However, their use in antibody immobilization is restricted. In the associated reports 
customized PEG was synthesized with cyclopentadiene on one end at the ‘α’ carbon and 
biotin or protein A on the other end at ‘ω’ carbon (Figure 1.5). These customized PEG 
constructs were immobilized on a N-maleimide-functionalized surface (Figure 1.5) 
[79,80]. Subsequently, antibody was captured on the biotin or protein A present at ‘ω’ 
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carbon of the PEG chain. This strategy is advantageous as it generates homogeneous 
surface functionalization and results in highly specific antibody capture.  
          
+
N-maleimide-functionalized surface
PEG chain
α-Cyclopentadiene
ω- protein A/ biotin
Custom-synthesized 
PEG  molecule with cyclopentadiene at one end 
and biotin/ protein A at the other
 
Figure 1.5 Mechanism of covalent immobilization of Fc-binding and other proteins 
(including antibody) with Diels-Alder’s [2+3] cyclo-addition reactions. Customized 
PEG was synthesized with cyclopentadiene at the ‘α’ carbon and biotin or protein A at 
the ‘ω’ carbon, which was immobilized on N-maleimide-functionalized surfaces. 
Similarly, an antibody molecule could also be bound directly to the ‘ω’ position of PEG 
replacing the biotin or protein A. 
 
Since cycloaddition is specific to ringed structures, the surface functionalization is highly 
specific. In addition, protein A and biotin-based antibody capture can introduce a high 
degree of immobilization specificity and orientation. Moreover, the length of the PEG 
chain can be varied enabling control of the distance of the antibody from the surface and 
the degrees of freedom of movement of the immobilized antibody.  The degrees of 
freedom are a measure of the independence of movement of an antibody in space with 
21 
 
respect to its surroundings. Immobilization of an antibody on a surface restricts this 
spatial freedom of motion in different directions such that the smaller the separation-
distance between antibody and surface, the lower will be the degrees of freedom and 
vice-versa (Figure 1.6).  
                
Vibrational Di
Spatial degree of freedom (Di)
Rotational Di
L = 100 nmL = 5 nmL = 0 nmL = 0 nmL = 0 nm  
Figure 1.6 Analysis of the effect of cross-linker length on degrees of freedom of 
immobilized antibody. The antibody is cross-linked to the functionalized surface via a 
crosslinker of variable length. The crosslinker length, as depicted, increases in the order 
of L = 0 nm < = 5 nm < = 100 nm. With increasing crosslinker length the distance of the 
antibody from the surface also increases. Distance of the immobilized antibody from the 
surface governs the flexibility of antibody. At L = 0 nm, the antibody is rigidly 
immobilized on the surface and possesses little or no flexibility whereas, at L = 100 nm, 
antibody is highly flexible. In general, the greater the flexibility of immobilized antibody 
molecule the lower the steric strain on it, thus maintaining its functional conformation.  
 
Therefore, shorter separation distances may result in higher steric stress, which may 
cause conformational changes and functionality loss. However, this strategy is very time 
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consuming and requires long preparatory phases to conjugate PEG with protein and 
cyclopentadiene, making it less attractive. 
Ab
*
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hυ (340 nm) Ab = Antibody; the antibody could also be replaced with biotin or other domain-specific proteins such as protein A
Antibody (Ab) with p-benzoyl-L-phenylalanine (pBpa)
ß-cyclodextrin-grafted surface
Free radical generation at oxygen present in
p-benzoyl-L-phenylalanine (pBpa)
Free radical attack of pBpa on 
the ß-carbon of cyclodextrin
 
Figure 1.7 Photoactivable cross-linking of antibody to a cyclodextrin-modified surface. 
The antibody, antibody fragment or an antibody-capturing protein is modified with p-
benzoyl-L-phenylalanine (pBpa). The pBpa is photoactivated. This generates an oxygen 
radical on the benzoyl moiety. The oxygen radical attacks the hydroxyl-containing 
carbon centre of cyclodextrin with the subsequent formation of a covalent bond. 
 
Photoactivation-based antibody immobilization is another potential approach. Recently, 
several groups [81,82] reported the successful immobilization of photoactive variants of 
amino acids such as p-benzoyl-L-phenylalanine (pBpa), attached to a modified antibody, 
on β-cyclodextrin (βCD)-modified surfaces, by irradiating the desired surface with 
ultraviolet (UV) light (340-360 nm). This mechanism of antibody immobilization is 
shown in Figure 1.7. However, unlike most other direct chemistries, it is highly selective 
in immobilizing antibodies on to a surface because the reaction will only take place at the 
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position where pBpa is present on the antibody. In addition, pBpa can be genetically 
introduced to the antibody at a desired position as explained in [83,84]. 
In addition to the direct chemistries, there is another important category for covalently 
immobilizing an antibody where linkers are employed. These linker types provide a 
range of choice for immobilization and may be easier to use than other covalent 
immobilization strategies.  
1.2.2.2 Linker-mediated strategies to capture antibody 
Linkers are chemical species that contain highly reactive moieties at one or both ends 
and, hence, are capable of creating bonds between given functional groups. These linkers 
facilitate the reaction of the desired functional groups of an antibody by creating highly 
reactive intermediates that can subsequently be bound to the functional groups of the 
surface. The linker choice strictly depends on the chemical reactivity of the selected 
functional groups on the antibody and the desired surface. These linkers may be 
categorized as homo- and hetero-bifunctional [85]. Homo-bifunctional linkers have the 
same chemically-reactive groups at both the ends and react with the same entities on the 
target molecules, whereas hetero-bifunctional linkers have two different chemically 
reactive centres at each end. 
A variety of such cross-linkers is commercially available in different combinations 
[73,85] e.g. amine-amine and sulfhydryl-sulfhydryl homo-bifunctional, and amine-
sulfhydryl and amine-carboxyl hetero-bifunctional linkers. Widely used cross-linkers 
representing homo- and hetero-bi-functional categories are glutaraldehyde and 1-ethyl-3-
(3-dimethylaminopropyl) carbodiimide (EDC), respectively (Figure 1.8). Other specific 
bifunctional linkers such as sulfhydryl-hydroxy, amine-carbohydrate and sulfhydryl-
carbohydrate are also available with specific chemistries and associated linkages. 
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Figure 1.8 Schematic reaction of carboxyl-amine (Strategy A), and amine-amine 
(Strategy B) cross-linkers. Carboxyl-amine crosslinkers represent hetero-bifunctional 
chemistry such as carbodiimide (EDC). The carboxyl group of the antibody reacts with 
the carbodiimide group of EDC to generate an intermediate urea derivative, which 
further reacts with the amine on the surface. Similarly, amine-amine coupling cross-
linkers generally posses homo-bifunctional reaction centres reactive towards amines 
such as glutaraldehyde and react with an amine on the surface followed by amines on 
the antibody molecule.  
* Glutaraldehyde has a potential tendency to multimerize and it is advisable to distil and 
aliquot it prior to use [86]. 
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Amine-targeting linkers possess functional moieties that react with amine groups. Such 
reactive centres mainly have esters of NHS/ imide and phenyl hydrazide or aldehyde that 
preferably bind to primary amines irrespective of their position [73]. Amine-targeting 
strategies may result in the loss of antibody activity [87]. However, the addition of 
‘lysine-rich’ pockets at locations on the antibody away from the region associated with 
antigen-recognition may be employed for minimizing activity loss [88].   
Hetero-bifunctional crosslinkers that target carboxyl groups mainly possess carbodiimide 
or azide reactive groups [73] and could be used as alternatives to the amine-targeting 
linkers. These linkers are probably the most commonly used in antibody immobilization 
over a modified surface because of their robustness in delivering cross-linking on a wide 
range of functionalized surfaces with amine, sulfhydryl and epoxy coatings.  
Maleimide or vinyl sulfone-containing linkers are used for targeting sulfhydryl groups of 
the antibody or the surface [73,85]. These linkers are commercially available in various 
combinations and can cross-link sulfhydryl functional groups to amine, carbohydrate or 
sulfhydryls. The utility of sulfhydryl-based hetero-bifunctional cross-linkers in protein 
coupling is already proven [89]. However, their use in immobilization is fairly restricted 
to either amine-functionalized or gold-coated surfaces [89,90]. The major drawback of 
this approach is that either the antibody has to be chemically processed to introduce a 
thiol group on it or it must be modified genetically to introduce a cysteine.  Cysteine, a 
sulfhydryl-containing amino acid, is also a widely exploited chemical species for 
immobilizing antibody molecules on amine or sulfhydryl-functionalized and gold-coated 
surfaces. A cysteine-tagged antibody can be captured on amine and sulfhydryl-
functionalized surfaces with bi-functional cross-linkers, whereas, on gold surfaces it can 
be immobilized via co-ordinate bonds formed between the sufhydryl group and gold in a 
chemical-free single step. Cysteine-based antibody/fragment immobilization using 
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chemical modifications such as cyanogen bromide-activated surfaces was also reported 
[91]. This strategy provides robustness to the approach with minimum antibody leakage 
[92]. However, introduction of cysteine in the basic antibody structure could introduce 
conformational changes leading to a non-functional antibody. This drawback could 
easily be controlled by the introduction of cysteine on the antibody/fragment away from 
the antigen recognition domains, using reduction and alkylation chemistries [93], which 
may enable the more efficient use of sulfhydryl linkers in solid phase immobilization 
[76,94-96] or by genetic approaches.  
Photoswitchable linkers, which comprise the most advanced class of linkers, could also 
be employed for antibody immobilization [85]. These linkers mainly possess a 
photoactivable group at one terminal and a reactive chemical group at the other. The 
photoactivable group can be activated to either react with the surface or the antibody. 
However, photoactivable chemistry is not selective. Therefore, the linkers are mainly 
allowed to react first with the surface via their photoactivable terminal group and, 
subsequently, facilitating capture of the antibody through the other end of the cross-
linker that possesses a reactive group e.g. NHS ester or maleimide.  
These linker-based chemistries are important because these are easy to perform with 
minimum preparation. In addition, the most advantageous use of linkers is that they may 
be of variable length and can be used to control the distance of the immobilized 
antibodies from the surface. Hence, the linker arm-length could impact on antibody 
functionality by controlling the immobilization-associated steric stress on the antigen-
binding site [97]. A spacer/linker of zero-length chemistry (e.g. carbodiimide (EDC)-
succinimide (NHS)) immobilizes antibody on the surface with a rigid bond that 
minimizes the freedom of rotation (degrees of freedom) (Figure 1.6, page 20), which 
may result in ‘functionally-challenged’ antibody. However, this rigidity could 
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significantly be decreased by increasing the spacer arm-length. Therefore, in many cases 
the functional antibody density on the surface may be enhanced. 
All the covalent strategies described have been used in the fabrication of different 
biosensor formats. The advantages of using covalent immobilization-based strategies are 
the higher density and homogeneous loading of the captured antibody on the surface 
along with leach-proof immobilization. However, the major drawback is the random 
immobilization of antibody as it may drastically affect the antibody functionality.  
1.2.3 Site-specific Immobilization of antibody 
Site-directed immobilization is where an antibody can be captured specifically through a 
desired region. Many approaches are reported claiming strong site-directed antibody 
immobilization. These strategies include either the use of affinity biomolecules such as 
biotin-avidin, enzyme or domain-specific proteins (e.g. protein A) for antibody capture. 
A high degree of orientation can be introduced to the immobilized antibodies using this 
strategy and the antigen binding region of the antibody is always correctly positioned for 
antigen recognition. 
1.2.3.1 Affinity Tag-based site directed antibody capture 
Affinity is the strength of interaction between two molecules where the interaction may 
be stabilized by multiple bonds. In an antigen-antibody interaction, affinity can be 
described as the strength of interaction of an antigen with the single binding site of an 
antibody. If a tag has a strong affinity towards a certain molecule and binds with 
significantly high specificity, it is referred to as an ‘affinity tag’. These tags are 
successfully used for affinity-based protein immobilization [17,98-100]. Tags can also be 
incorporated into the antibody either genetically or chemically [17,18]. There is an array 
of commercially available affinity tags but those used for the antibody immobilization 
are described. 
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In a polyhistidine tag [101] there is a long repeated sequence of histidine residues of 
varying numbers (ranging from six to ten). This tag has a strong affinity for divalent 
transition metal ions including divalent nickel (Ni+2) and copper (Cu+2) [102-
104](Figure 1.9).  
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Figure 1.9 Mechanism of ‘His-tag-mediated’ immobilization on a nitrilotriacetic acid 
(NTA)-modified surface. The NTA-functionalized surface is chelated with divalent metals 
such as Ni+2. The histidine of the tag reacts with the hydrated Ni+2 via the nitrogen of the 
imidazole ring, thus immobilizing scFv or recombinant antibodies labelled with the His-
tag. 
 
The transition metal ions are chelated on the support layer, which consists of nitriloacetic 
acid (NTA) or iminodiacetic acid (IDA). They provide a matrix for the selective 
immobilization of tagged antibodies where this tag is genetically incorporated at either 
the N- or C-terminal of the antibody [105]. However, there are many drawbacks 
associated with this strategy. Non-homogenous antibody distribution on the NTA-grafted 
surface is the foremost [106,107]. The non-homogeneous distribution of antibody is due 
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to the immobilization of a mixture of functional and non-functional antibody on the NTA 
matrix. In addition, the selectivity of NTA to distinguish the HIS tagged antibody from 
other histidine-rich naturally occurring cellular proteins is very poor [108].  This will 
result in competition between tagged antibody and histidine-rich cellular proteins (e.g. 
histidine-rich glycoprotein (HRG) and histidine-rich calcium-binding protein (HRC) 
[109-111]) for binding with the NTA present on the surface and results in heterogeneous 
immobilization on the surface. There are several reports that describe the non-specificity 
associated with this system as an attribute of histidine’s relatively low affinity toward 
metal ions (Kd in the order of 1-10 μM). However, a better affinity may be achieved 
either by increasing the number of histidine residues in the tag or employing two tandem 
tags [112,113].  
Biotin is a water soluble vitamin known as vitamin B7. It is a fused ring structure 
composed of tetrahydroimidazolone and tetrahydrothiophene with valeric acid (C5H10O2) 
substitution on the thiophene ring. It is an important biomolecule and plays a critical role 
in gluconeogenesis. Biotin can act as an affinity tag if incorporated into the antibodies 
either genetically or chemically. These biotinylated antibodies then can easily be 
captured on avidin or streptavidin or genetically derived combinations of both proteins, 
which are conjugated with functionalized polymeric and metallic [114,115], silicate 
[116] and amino-polypyrrole-coated surfaces [117]. Initially, this tag was often used for 
histochemical diagnostics [118] but its commercial relevance in immobilization and 
purification was realized later.  In addition, this approach was successfully employed in 
the development of microarrays [119] and optical sensors based on surface plasmon 
resonance [120]. However, due to the mulitivalency of avidin, which can accommodate 
four biotin molecules per avidin, high densities of the immobilized antibody molecules 
may be obtained. Such a high density of antibody may induce interactions between 
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closely bound antibody molecules that may lead to a high degree of steric hindrance 
[121]. In addition, endogenous biotin could also compete for the surface-bound avidin or 
streptavidin. This non-specific competition may reduce the overall binding efficiency of 
the immobilization procedure [122]. The strong affinity (Kd ≈ 10-15 M) of the biotin to 
avidin is a major advantage and the interaction is effectively irreversible until a 
temperature-dependent regeneration method was developed using a hydro-thermostat 
[123]. However, this strong affinity may introduce steric hindrance in the immobilized 
antibodies, as an antibody bound through biotin loses freedom of rotation [124,125]. 
Reducing the affinity of biotin, using genetically-engineered variants of streptavidin or 
biomolecules mimicking the biotin-binding event with streptavidin could be used to 
minimize steric stress on antibody and improve the regenerative capacity of the bound 
antibody [126].   
Use of peptide nucleic acids (PNAs) is another approach that was employed for antibody 
immobilization. The PNAs are chemically synthesized single stranded nucleic acid 
analogs. The backbone repeat unit of the PNA consists of an amino acid derivative of 
alkylamide and is shown in Figure 1.10. Nucleotide is attached to the PNA backbone 
repeat unit at the 4-oxoethyl position via an aminoethyl-glycine linkage.  PNA is then 
synthesized by repeated addition of these nucleotide-functionalized amino acids via 
peptide bonds replacing the normal phosphodiester backbone [127,128]. Therefore, 
PNAs can interact with other nucleic acids in a highly specific manner forming PNA-
PNA, PNA-RNA and PNA-DNA hybridization constructs similar to the hybridization of 
complementary DNA strands. In addition, PNAs are non-ionic and achiral molecules. 
Their non-ionic nature and achirality makes them resistant to enzymatic hydrolysis. 
Achiralilty also provides a high degree of thermal stability. These properties of PNA 
could be harnessed in developing efficient immobilization strategies such that the PNA-
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conjugated antibody could be immobilized on surfaces grafted with the anti-sense 
oligonucleotide or PNA by hybridization (Figure 1.10) [129,130]. Subsequently, the 
distance between surface and antibody could be controlled by varying the number of 
PNA monomers in the backbone [131-134]. Although this strategy is not commonly used 
for antibody immobilization, it could be an efficient single-step approach that could 
provide high steric freedom to the captured antibodies, with strong site specificity and 
orientation. There are few reports pertaining to the use of complementary 
oligonucleotide tags[135], which are relatively simpler than PNAs. In addition, the 
hybridized oligonucleotide tags can be separated from their complementary strands 
grafted on the surface by a variation in either pH or divalent ion strength. 
Elastin-like polypeptides (ELP) are a relatively novel category of small thermally 
responsive proteins [136,137]. They can easily be tagged on to various antibodies, 
antibody fragments or other proteins [138]. ELPs possess ‘biopolymer-like’ properties 
such that they polymerize in a temperature range of 4-37 oC. At temperatures above 37 
oC these proteins precipitate out of the solution and below 4 oC they remain in solution 
phase. Therefore, ELP-tagged antibodies could efficiently be captured as a monolayer on 
a specifically tailored surface [139]. ELPs have been successfully used for antibody 
immobilization in microarrays and related applications [140]. 
FLAGR proteins, commercially available from Sigma Aldrich, may also be employed for 
immobilization. These are octa-peptides (NH2-DYKDDDDK-COOH) that could be 
genetically incorporated into antibodies and antibody fragments (Fabs and scFvs) [141]. 
Antibodies tagged with FLAG can be captured on the surfaces immobilized with 
monoclonal anti-FLAG antibody. Use of the FLAG tag introduces specificity and 
orientation for the immobilization [142-144].  
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Figure 1.10 Immobilization of an antibody-functionalized with a peptide nucleic acid 
(PNA) on a surface grafted with a complementary nucleotide base sequence. Antibody 
could be covalently linked to a PNA sequence. This PNA-functionalized antibody can be 
immobilized on a second PNA sequence that contains complementary nucleotide 
sequences, which easily hybridize directly to it. 
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1.2.3.2 Enzyme-substrate reaction-based site-directed antibody capture 
Antibody immobilization using enzyme-mediated coupling is also feasible. There are 
many different enzyme-catalyzed reactions. The participating substrates react in the 
presence of the enzyme and products are formed. This very fundamental principle of 
enzymology can also be used for antibody immobilization. The enzyme-mediated 
reaction must be a ‘two substrate component’ system, where the enzyme facilitates the 
reaction of one substrate moiety with the other, as shown in Figure 1.11. An antibody 
can be conjugated to one substrate of the ‘two substrate component system’. This 
antibody-substrate complex can then be immobilized on the surface and grafted with the 
second substrate of the ‘two substrate component system’ via an enzyme-catalyzed 
reaction.   
Antibody could also be conjugated to the active domain of an enzyme that is involved in 
catalyzing some reaction. These conjugates can subsequently be captured on the 
surfaces, grafted either with the substrate or their analogs. The enzyme’s substrate-
binding domain interacts with the substrate (via interactions such as hydrogen bonding 
and electrostatic interactions, along with the formation of covalent bonds). Various 
examples of this strategy that are used for antibody immobilization are discussed in this 
section. 
The immobilization of cutinase-conjugated calmodulin was one of the first 
demonstrations of this strategy. Cutinase-conjugated calmodulin was captured on the 
phosphonate inhibitor-functionalized thiolated self-assembled monolayer (SAM) on a 
gold surface [145]. Although, this report was not specific for antibody immobilization, 
its potential implications will be discussed. 
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Figure 1.11 Illustration of enzyme-mediated reaction of two substrates. Substrate 1 
binds to the specific site on the enzyme forming enzyme-substrate 1 complex. This 
complex then binds to the second substrate. Enzyme catalyzes the reaction between the 
two substrates by forming a covalent bond between them. This strategy could be used to 
immobilize antibodies tagged with substrate 1 on the surfaces grafted with substrate 2.   
 
Human O6-alkylguanine transferase (hAGT) plays important role in DNA repair during 
DNA synthesis. It binds to a DNA molecule at a specific error site and alkylates it by 
transferring an alkyl group from its substrate (Figure 1.12). Methyltransferase is one of 
the most important enzymes of this category. Immobilization of proteins tagged with this 
enzyme has already been demonstrated [146-149]. Similarly, the hAGT-fused antibody 
can be covalently captured on surfaces functionalized with benzylguanine. Fused hAGT 
enzyme replaces the guanine by covalently binding to a benzyl moiety. Immobilization 
of hAGT-fused glutathione S-transferase and tandem repeats of ‘immunoglobulin-type’ 
domains of a muscle protein, called titin, was demonstrated [150]. This technology is 
commercially available under the name SNAP-tag® with New England Biolabs. In 
addition, if the enzyme’s substrate is changed from benzylguanine to benzylcytosine then 
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it is known as a CLIP-tag™. These tags can be genetically incorporated in recombinant 
antibodies or chemically fused to full length antibodies [151]. There are many 
applications of these tags for specific and covalent immobilization of antibodies. 
Micropatterning of antibody is also feasible using these strategies [152]. 
HNO
O
HS
SNAP tag (hAGT enzyme)-tagged antibody (Ab)
Benzylguanine-functionalized surface
Guanine
Benzyl-hAGT covalent complex 
immobilizing antibody on the surface
S-
Ab
S
Ab
 
Figure 1.12 Mechanism of SNAP-tag-mediated antibody immobilization. Antibody is 
tagged with human O6-alkylguanine transferase (hAGT), which is a DNA repair enzyme. 
This enzyme removes guanine and forms covalent bonds with the benzyl group of the 
benzylguanine that is grafted on the surface, thus immobilizing the tagged antibody by 
displacement catalysis of the benzylguanine group on the surface.  
Transglutaminase (TGase) is another enzyme system, which specifically catalyzes the 
formation of covalent cross-linking of the peptide-bound glutamine with a primary 
amine. This enzyme is specific to a 12 peptide long sequence that is known as 
‘glutamine-donor substrate’ sequence and is designated as T26 (HQSYVDPWMLDH). 
Flank of (GGGS)3 spacer is incorporated on either side of the T26 sequence prior to 
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molecular tagging onto the N- or C-terminal of the antibody fragment. This strategy was 
demonstrated for the immobilization of tagged anti-BSA antibody on aminated surfaces 
by inducing the TGase-mediated amine-T26 reaction [153]. The underlying mechanism 
of immobilization is shown in Figure 1.13. This technique is efficient as it involves no 
chemical modification of the antibody or fragment.  
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Figure 1.13 Mechanism of transglutaminase-mediated antibody immobilization on 
aminated surfaces. Antibody tagged with T26 and glutamine spacer reacts with the 
amine of the surface in TGase-catalyzed acyl-transfer-mediated isopeptide bond 
formation by facilitating the reaction between carboxamide of glutamine and the amine 
of the side-chain of lysine on the surface.  
 
The use of enzymes on poly-L-lysine (PLL) and polyethylene glycol (PEG)-grafted 
surfaces to capture cells and peptides had also been demonstrated. This strategy was also 
demonstrated for immobilizing antibodies with preserved functionality [154]. 
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CBD-tagged antibody
R = Tyrosine (214),
Aspartic acid (142)
NAG (Chitin)
Chitin-grafted surface
Antibody-captured on 
chitin-grafted surface  
Figure 1.14 Schematic representation of immobilization of an antibody conjugated to the 
substrate-binding domain of an enzyme on surfaces grafted with the substrate of the 
respective enzyme. Antibody tagged with chitin-binding domain (CBD) can interact with 
chitin via hydrogen bonds formed between the hydrogen of the aspartic acid (142) of the 
CBD and oxygen of the amide of the chitin, which is grafted on surface. Hydrophobic 
interactions between the tyrosine (214) of the CBD and N-acetylglucoseamine of chitin 
also play a crucial role in this immobilization.  
 
The chitin-binding domain (CBD), which is the hydrolase part of the enzyme chitinase, 
catalyses the hydrolysis of chitin polymers. These domains can be incorporated 
genetically into recombinant antibodies and can be chemically conjugated to full length 
antibodies. Immobilization of a CBD-conjugated antibody on the chitin-grafted surface is 
shown in Figure 1.14. An early use of CBD in immobilization was reported by Kuranda 
and co-workers [155]. Later, this strategy was employed for whole cell-based assay 
development whereby whole cells were immobilized on chitin-grafted surfaces via their 
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surface-expressed CBD [156]. This strategy is primarily used to immobilize antibodies 
on the chitin-functionalized chromatographic resins [157]. In addition, several CBD-
antibody constructs were developed [158-160] to capture antibodies on chitin-coated 
surfaces for immunoassay-based applications [157,161,162]. Similarly, 
polyhydroxyalkanoate (PHA) depolymerase substrate-binding domain (PSBD) [163] was 
also reported for use in antibody immobilization-related applications. 
1.2.4 Site-specific orientation-based antibody capture 
Site specificity can be easily introduced using the tag-based strategies and enzyme-
mediated methods (section 1.2.3, page 27-38). However, the orientation of immobilized 
molecules is of major importance for immunoassay development. Strategies based on 
domain-recognition proteins (DRPs), such as protein A, are widely used for 
immobilizing antibody molecules. These DRPs have high avidity toward specific 
domains on the antibody and bind strongly to them introducing strong directed 
orientation to the antibodies when immobilized (Figure 1.15). In addition, the covalent 
immobilization of these DRPs on a surface could certainly achieve a homogenous 
distribution of antibody over the surface [164,165] minimizing leaching and protein 
exchange-associated variability in assays [166]. However, DRPs must be correctly 
orientated on the surface to provide proper orientation to the antibody molecules. Use of 
DRPs with multiple antibody-binding domains, such as protein A with five antibody-
binding domains, may minimize the concerns associated with the orientation of these 
DRPs. The applications of these orientated antibodies could be enzyme immunoassays 
(ELISA) [166], surface plasmon resonance (SPR), microdevices such as QCM [167,168] 
and chromatography [169]. 
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Antibody captured 
an adsorbed prA
Fc-specific protein (prA) Antibody captured 
an covalently immobilized prA  
Figure 1.15 Orientation of an immobilized antibody by capture on a sub-layer of protein 
A, which is either adsorbed or covalently captured on the surface. 
 
1.3 Conclusions and Perspective 
Adsorption of antibody is very commonly used approach for immobilization. This is a 
cost-effective and simple method with no expertise required for its use. However, it has 
many drawbacks. These is no control over the (a) amount and packing density of the 
antibody, (b) antibody distribution on the surface, (c) site-specificity,  orientation and 
conformation of the antibody [13,34,48,49], and (d) susceptibility of the antibody to 
leaching and protein exchange [24,59]. Introduction of capture stages that include a sub-
layer of Fc-binding proteins or anti-antibody molecules may introduce a higher degree of 
orientation with a controlled antibody packing [170]. However, this will significantly 
increase the time and cost involved for immunoassay development.  Tag-assisted 
strategies could be employed to address some of these issues, such as site-specificity and 
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improved control over the active conformation of the immobilized antibody. However, 
stability of the interaction of the tag with its affinity ligand is strictly dependent on 
various physical and chemical parameters such as temperature, solvent polarity, pH and 
salt concentration. Therefore, a slight change in the optimum conditions may introduce 
leaching [171,172] and activity loss. In addition, the homogeneous distribution of the 
tagged-antibody is dependent on the distribution of the affinity ligand on the surface. 
Therefore, a strategy is required that could provide an approach to respond to most of 
these drawbacks whilst maintaining the cost-effectiveness of the immunoassay 
development.  Employing covalent strategies could deal with most of the previously 
mentioned drawbacks. Covalently-captured antibodies have least susceptibility for 
leaching and protein exchange. In addition, a high degree of site-specificity and 
orientation could be introduced to the antibody by employing enzyme-mediated covalent 
strategies. However, covalent immobilization may require activation of the antibody 
prior to immobilization. This may result in self-conjugation of antibodies forming 
multimeric complexes. This multimerization could be a drawback in the case of 
antibody-based imaging, whereas in assay development, this multimerization may mask 
the active site of antibody along with the introduction of conformational stress. This 
multimerization can be restricted by optimizing the molar ratios of antibody to cross-
linker. This could also be addressed by employing direct chemistries. Strong orientation 
could also be employed by capturing antibody on a covalently-immobilized sub-layer of 
Fc-binding proteins [165]. A summary of all the available techniques, along with their 
advantages and drawbacks, is given in Table 1.3.   
Theoretically, covalent strategies offer great potential to tag-assisted strategies in terms 
of the cost and time involved. Introduction of a tag is performed either by using 
recombinant molecular biological approaches or by chemical methods. Therefore, in this 
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thesis, covalent immobilization-based strategies will be employed for developing 
immunoassays. 
This thesis covers the development and optimization of a mild surface activation and 
modification method that could be employed on most of the polymeric surfaces 
irrespective of their chemical nature. In addition, the various available chemistries will 
be critically analyzed for their immobilization efficiency with the aim of developing 
high-sensitivity immunoassays on various bioanalytical platforms including microtiter 
plates and nanoparticles. 
 
Table 1.3 
 
Strategy Overview Advantages (+) 
Disadvantages (-) 
Physisorption (Section 
1.2.1) 
Antibody (Ab) 
immobilization with physical 
interactions between Ab and 
surface. 
Involves hydrophobic and 
electrostatic interactions with 
hydrophobic and charged 
surfaces, respectively. 
(+)  
i. could be used for any type of 
antibody  
ii. ‘Label-free’ and ‘reagent-free’ 
(no Ab modification or 
surface modification required) 
(-) 
i. Highly susceptible to protein-
exchange and leaching 
ii. Conformational instability of 
the adsorbed antibody 
(denaturation) due to the 
underlying processes such as 
molecular spreading  or 
flattening 
iii. Random molecular 
distribution (non-homogenous 
density of Ab on surface and 
no control over functional 
orientation of the molecules) 
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Covalent immobilization 
(Section 1.2.2) 
  
Linker-mediated 
chemistries 
 
 
 
 
Linker length plays important 
role in minimizing the coupling-
related conformational stress  
 
EDC-mediated (Figure 
1.8 (a)) 
• For surfaces with amine 
or carboxy-
functionalization 
• A classical example of 
heterobifunctional cross-
linking (carboxy to 
amine) 
 
 
The EDC linker activates the 
carboxyl group followed by 
transferring the activated 
carboxyl adduct to primary 
amine 
Immobilization on amine-
functionalized surfaces: Ab 
should be activated prior cross-
linking 
Immobilization on carboxyl-
functionalized surfaces: the 
carboxy groups of surface 
should be activated first 
 
 
(+) 
i. No leaching after cross-
linking 
ii. No Ab modification required 
(could be performed with 
native proteins) 
iii. Commercially available from 
all major suppliers 
(-) 
i. High susceptibility of EDC 
toward hydrolysis 
ii. Random orientation 
iii. Activated Ab molecules are 
susceptible to multi-
merization (could be 
minimized by optimizing the 
molar ratio of antibody to 
EDC and using a pH at which 
only carboxyl groups will 
interact with EDC) 
iv. Ab functionality may be 
compromised in few cases if 
amine groups of the antibody 
are conjugated to the carboxyl 
groups of the functionalized 
surfaces 
 
Glutaraldehyde (Figure 
1.8 (b)) 
• For surfaces with amine  
functionalization 
• A classical example of 
homobifunctional 
cross-linking (amine to 
amine) 
 
 
Glutaraldehyde activates amine 
groups irrespective of their 
position on Ab 
 
 
 
(+) 
i. Strong coupling, hence ‘leach-
proof’ 
ii. No Ab modification required 
iii. Commercially available 
(-) 
i. Multimerization of Ab (this 
could be compensated by 
activating the amine-
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 functionalized surface with 
glutaraldehyde prior to Ab 
cross-linking) 
ii. Ab functionality may be 
compromised (if the amine-
rich regions of antigen 
recognition portion of the Ab 
get involved in cross-linking) 
iii. No specificity 
iv. High degree of randomness in 
immobilized Ab molecules  
v. Inappropriate cross-linking 
 
Sulfhydryl-targeting 
linkers 
Primarily contains maleimide 
or vinyl sulfone as reactive 
centres which target the 
sulfhydryl goup 
These could be either homo- 
(SH-SH) or heterobifunctional 
(SH-NH2) 
(+) 
i. Site specific immobilization 
in the case of cysteine-tagged 
Ab 
ii. Commercially available 
(-) 
i. Generation of thiol groups is 
required on the antibody 
either by converting pendant 
amino groups of Ab into 
sulfhydryl (this may change 
the amines of the antigen 
recognition domain of the Ab 
causing compromised Ab 
functionality) or by reducing 
disulfide bonds to generate 
free sulfhydryl groups with 
chemical agents such as DTT, 
TCEP etc. 
 
Direct chemistries 
  
 
Epoxide-mediated 
(Figure 1.3) 
 
 
 
Epoxide-functionalized surface 
Epoxide ring opens up 
following the reaction of 
oxygen species with amine or 
sulfhydryl 
 
 
 
(+) 
i. ‘Leach-proof’ immobilization 
ii. No Ab modification required 
iii. ‘Reagent-free’, ‘label-free’ 
single –step immobilization 
iv. Commercial availablity 
(-) 
i. An epoxide functionalization 
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of the surface is required 
ii. Randomly-orientated Ab   
 
Aldehyde-mediated Aldehyde-functionalized 
surface 
Aldehyde reacts with amino 
group that results in an imine 
group between surface and Ab 
Reduction of imine to amine 
should be performed in order 
to stabilize the bond 
(+) 
i. No Ab modification required 
(native Ab) 
ii. Single step strategy 
iii. ‘Label-free’ and ‘reagent-free’ 
(-) 
i. Reversible imine-bond 
formation (require additional 
step of reduction for 
stabilization of the imine 
bond) 
ii. No site-specificity 
iii. Uncontrolled orientation 
 
Amine-mediated Amine-functionalized surface 
Ab oxidation activates the diol 
of the sugar moieties on the Fc 
region, which reacts with 
amine of the surface to form 
imine bond 
(+) 
i. Highly site-specific  
(-) 
i. Oxidation of Ab is required 
(uncontrolled oxidation) 
ii. Restricted to full-length Ab 
which has sugar moiety 
 
Aromatic sulfonate 
chloride-mediated 
(Figure 1.4) 
 
 
Tosyl and trisyl chlorides are 
widely used 
Aromatic chloride activates 
hydroxyl of the surface and 
conjugates it to the sulfhydryl, 
primary amine, imidazole and 
tyrosine hydroxyl of the Ab  
 
 
(+) 
i. Covalent attachment 
ii. Robust approach (could 
couple a variety of Ab’s 
functional groups) 
iii. Site-selective 
iv. Single-step method 
v. Commercially available 
(-) 
i. Non-orientated 
immobilization 
 
Diels-Alder cyclo-
addition  
(Figure 1.5) 
 
 
PEG-functionalized with 
ligand such as biotin or 
domain-specific protein A at 
ω-carbon and cyclopentadiene 
at α-carbon. 
PEG grafted through the 
(+) 
i. Covalent attachment with 
higher steric freedom (PEG 
chain length can control the 
steric freedom of the captured 
Ab) 
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cyclopentadiene on the N-
maleimide-functionalized 
surface 
 
 
ii. Orientated capture of Ab on 
protein A or biotin 
iii. Site-specific 
iv. ‘Label-free’ and ‘reagent-free’ 
v. Single-step procedure to 
generate functionalized 
surface 
 
Photoactive chemistry 
(Figure 1.7) 
β-cyclodextrin-functionalized 
surfaces 
genetically-incorporated p-
benzoyl-L-phenylalanine 
(pBpa) Ab 
 
 
 
(+) 
i. Covalently captured Ab 
ii. Site-specific 
iii. ‘Label-free’ and ‘reagent-free’ 
single step procedure 
iv. Commercially available 
(-) 
i. Incorporation of pBpa may 
introduce conformational 
changes in Ab fragments such 
as scFv and Fab 
 
Site-specific 
immobilization (Section 
1.2.3) 
  
 
Affinity tags 
 
  
PolyHistidine (His-tag) 
(Figure 1.9) 
Nitrilotriacetic acid (NTA) or 
iminodiacetic acid (IDA)-
functionalized surface 
Imidazole of histidine forms a 
metal co-ordination complex  
 
 
 
(+) 
i. Single step methodology 
ii. Non-covalent co-ordination 
complex formation 
iii. Site-specific 
iv. Reusable  
v. Commercial availability  
 
(-) 
i. Poor ligand affinity (histidine 
repeats could be increased to 
6 to 10 in number to obtain 
higher affinity) 
ii. Leaching (it could be 
minimized with multimeric 
histidine tags) 
iii. Low selectivity (metal-
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functionalized surface does 
not discriminate tag from the 
endogenous histidine-rich 
proteins) 
 
Biotin-Avidin system  Avidin/streptavidin-
functionalized surface 
Chemical conjugation or 
genetic incorporation of biotin 
to the Ab 
(+) 
i. Strong specificity and 
selectivity 
(-) 
i. Conformational stress could 
be introduced due to Ab 
congestion on avidin surface 
(tetrameric molecule) 
 
Peptide-Nucleic Acid 
(PNA) tags 
(Figure 1.10) 
Surface-functionalized with 
complementary nucleic acid 
sequence 
PNA could be incorporated to 
Ab in a selective way either by 
its carboxyl end or amine end 
using routine EDC chemistry 
 
(+) 
i. High stability over a  thermal 
and pH range 
ii. Single step, ‘reagent-free’ and 
‘label-free’ method 
iii. High degree of steric freedom 
by varying length of the 
backbone 
 
Elastin-like polypeptides 
(ELP) 
Thermally responsive 
protein 
ELP-functionalized surface 
ELP-fused Ab or fragments 
 
 
 
 
(+) 
i. Reversible temperature-
dependent immobilization 
ii. Highly selective 
(-) 
i. Immobilized system must be 
stored in a temperature range 
2-37 oC (below which the 
ELP depolymerises and above 
which it precipitates) 
Enzyme-mediated   
O6-alkylguanine 
transferase (AGT) SNAP-
tag 
(Figure 1.12) 
Benzylguanine-functionalized 
surface 
AGT-fused Ab 
 
(+) 
i. Covalent immobilization 
ii. Site-specific 
iii. Commercially available 
 
 
Transglutaminase 
(TGase) 
(Figure 1.13) 
 
T26 tagging on N- or C-
terminal of Ab with a flank of 
(GGGS)3 
 
(+) 
i. Site-specific and covalent 
immobilization 
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Amine-functionalized surface 
 
 
ii. ‘Reagent-free’ and ‘label-free’ 
single step immobilization 
 
 
 
 
Site-specific orientation-
based (Section 1.2.4) 
  
 
Enzyme domains 
  
 
Chitin-binding domain 
(CBD) 
(Figure 1.14) 
 
Chitin-functionalized surface 
CBD-fused Ab 
 
 
 
(+) 
i. High selectivity and site 
specificity 
ii. Covalently-captured Ab 
(enzyme domain interact 
covalently with substrate) 
(-) 
i. Enzyme domain could be 
susceptible to conformational 
change in different 
physiological conditions 
 
Polyhydroxyalkanoate 
(PHA) depolymerase 
substrate-binding domain 
(PSBD) 
 
PHA-functionalized surface 
PSBD-fused Ab 
(+) 
iii. High selectivity and site 
specificity 
iv. Covalently-captured Ab 
(enzyme domain interact 
covalently with substrate) 
(-) 
ii. Enzyme domain could be 
susceptible to conformational 
change in different 
physiological conditions 
 
 
Proteins specific to Ab 
domains 
(Figure 1.15) 
  
 
Fc-specific 
  
Protein A (prA), protein G 
(prG) and recombinant 
Immobilization of Fc-specific 
protein on surface 
(+) 
i. Strong orientation 
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protein A/G (prA/G) 
 
ii. Site-specific and high 
selectivity 
iii. Ab captured in its native state 
iv. Strong binding  
(-) 
i. Could only be used on Ab 
with Fc domain 
kL-specific   
Protein L (prL) prL immobilized on surface (+) 
i. Strong orientation 
ii. Site-specific and high 
selectivity 
iii. Ab captured in its native state 
iv. Strong binding  
(-) 
i. Could only be used on Ab 
with kL domain 
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1.5 Aims 
The aims of this research were: 
1. Development of a generic surface modification strategy which can be used over a 
variety of solid supports. This section was dedicated to develop an approach that, 
unlike labour-intense chemical methods of surface modification, would be easy to 
perform under ambient conditions/ routine laboratory set-ups and would be cost-
effective at the same time. A strategy was developed based on KOH- and O2-plasma-
based surface activation followed by silane-mediated functionalization. This strategy 
could be employed on surfaces that are hydrophobic, hydrophilic and chemically 
inert.  
2. Development of high-sensitivity assays on the aforementioned modified surfaces. 
The bioanalytical platforms chosen were of commercial interest and included 
polymer-based microtitre plates for enzyme-linked and fluorescence immunoassays 
and fluorocap platforms (Bristol Myers Squibb, Syracuse, NY, USA, licensed 
platform) for fluorescence immunoassays. The other major analytical strategy 
involved custom-functionalized gold surfaces for surface plasmon resonance. This 
section was directed towards demonstrating the application of the activated surfaces 
following functionalization with silanes and employing them to immobilize 
antibodies for immunoassay development in direct (model antigen: IgG) and 
sandwich (model antigen: human fetuin A) formats. Fluorocap and chromatographic 
resin-based technologies were developed and transferred to Bristol Myers Squibb, 
Syracuse, NY, USA. 
3. Development of antibody-conjugated nanoprobes using high brightness 
nanoparticles, developed within our group, for detection of activation phases of 
platelets. This section involved nanoparticle functionalization, optimization and 
conjugation to platelet-specific anti-CD41 antibody for surface marker probing.  
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rapid sandwich ELIA procedure with 
picogram sensitivity 
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2.1 Abstract 
A highly sensitive and rapid sandwich enzyme-linked immunoassay (ELIA) procedure was 
developed for the detection of human fetuin A/AHSG (α2-HS-glycoprotein), a specific 
biomarker for hepato-cellular carcinoma and atherosclerosis. Anti-human fetuin A antibody 
was immobilized on aminopropyltriethoxysilane-mediated amine-functionalized microtitre 
plates using 1-ethyl-3-[3-dimethylaminopropyl]carbodiimide hydrochloride and N-
hydroxysulfosuccinimide-based heterobifunctional cross-linking. The analytical sensitivity 
of the developed assay was 39 pg/mL, compared to 625 pg/mL for the conventional assay. 
The generic nature of the developed procedure was demonstrated by performing human 
fetuin A assays on different polymeric matrices i.e. polystyrene, poly(methyl methacrylate) 
and polycyclo-olefin (Zeonex), in a modified microtitre plate format. Thus, the newly 
developed procedure has considerable advantages over the existing method. 
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2.2 Introduction 
Conventional enzyme-linked immunosorbent assay (ELISA) procedures have been followed 
for decades for the detection of analytes of importance in industrial, healthcare, and 
academic research. However, improvements on existing ELISA technologies are 
continuously attempted by many groups [1, 2]. The development of a high-sensitivity 
enzyme-linked immunoassay (ELIA)-based assay for human fetuin A (HFA), with lower 
detection limits and a higher sensitivity than commercially available assays is reported. The 
biological importance of HFA, a member of the cystatin superfamily, which is commonly 
present in the cortical plate of the immature cerebral cortex and hemopoietic matrix of bone 
marrow, is discussed elsewhere [3-10]. There are many commercially available ELISA kits 
for fetuin A, which are listed in Table 2.1. The assay was demonstrated on various 
commercially relevant solid supports. The developed ELIA is better than the conventional 
procedure in terms of greatly reduced overall assay duration, higher sensitivity, and greater 
reproducibility.  
HFA was taken as the model analyte system to demonstrate the utility of the developed 
ELIA procedure since all the assay components were commercially available in kit form. 
This enables the performance of a robust and highly precise comparison of the developed 
ELIA with the commercially existing conventional ELISA procedures, as the same assay 
components were used under the same conditions. The developed procedure can be 
employed on any commercially relevant substrate. Therefore, this approach of immobilizing 
antibody on chemically-modified solid supports (Figure 2.1) has potential applications in 
many other assays and formats.  
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Figure 2.1 Schematic of the developed sandwich ELISA procedure for the HFA assay. Plate 
functionalization was performed by treatment with 1% (w/v) KOH, treatment with oxygen 
(O2)-plasma and then silanization with 2% (v/v) APTES. KOH oxidizes the organic moiety 
of the polymer generating a carbonyl (-CO) or a hydroxyl (-OH) group according to the 
nature of the polymer. The alkoxy groups of APTES subsequently react with the carbonyl or 
hydroxyl groups of the surface in a hydrolysis-dependent reaction [11, 12]. Anti-HFA/α-
Herman Schmidt glycoprotein (AHSG) antibody was then activated using EDC and SNHS 
chemistry on the aminated 96-well plate, where the EDC-SNHS was used in a ratio of 1:100 
with the antibody.  
 
2.3 Materials 
EDC, SNHS, phosphate buffered saline (PBS, 0.1M, pH 7.4), 2-(N- 
morpholino)ethanesulfonic acid (MES, pH 4.7), 3,3',5,5'-Tetramethylbenzidine (TMB) 
substrate kit and bovine-serum albumin (BSA) were purchased from Fisher Scientific 
(previously Pierce), Ballycoolin, Dublin, Ireland. Potassium hydroxide (KOH), 3-APTES, 
76 
 
absolute ethanol and Nunc 96-well polystyrene plates (P7491) were obtained from Sigma-
Aldrich, Blessington, Co. Wicklow, Ireland. The HFA duoset kit, with all HFA assay 
components, was procured from RnD Systems, Abingdon, Oxon, UK. The capture antibody 
used was mouse anti-HFA/α-Herman Schmidt glycoprotein (AHSG) while detection was 
achieved through the use of biotinylated goat anti-HFA/AHSG antibody and streptavidin-
conjugated horseradish peroxidase (HRP).   
 
Table 2.1 A comparative analysis of various commercially available ELISA techniques with their 
respective formats and the high sensitivity modified ELISA procedure reported here. 
Manufacturer Format of antibody 
capture 
Sensitivity 
(ng/mL) 
Refer to 
Covalent assay  Chemically cross-
linked 
0.03 Reported in Chapter 2 
Passive assay Passively adsorbed 0.31 Reported in Chapter 2 
RnD systems Passively adsorbed 0.37 http://www.rndsystems.com/pdf/DY118
4.pdf 
 
Biovendor  Passively adsorbed 0.35 http://www.biovendor.com/product/im
munoassays/fetuin-a-ahsg-human-elisa 
 
Alpco Diagnostics Passively adsorbed 5.00 http://www.alpco.com/pdfs/43/43-
NSEHU-E01.pdf 
 
Immunology Consultants 
Laboratory, Inc. 
Passively adsorbed 6.25  http://www.life-
sciences.com.br/pdf/icllab.pdf 
 
Genway Biotech, Inc. Passively adsorbed 6.25  http://www.genwaybio.com/images/gw
_tds/elisa_kits/40-374-130036.pdf 
 
Assay Pro Passively adsorbed 6.25  http://www.assaypro.com/datasheet/eg
3501_1.pdf 
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All assay components were reconstituted in 0.1M PBS, pH 7.4, with 1% (v/v) BSA. Buffers 
and solutions were prepared in Milli-Q deionised water (DIW). The dilutions of all HFA 
assay components and BSA were made in 0.1M PBS, pH 7.4, whereas KOH and 3-APTES 
were diluted in DIW. EDC and SNHS were reconstituted in 0.1M MES buffer, pH 4.7. 
Poly(methyl methacrylate) (PMMA), polystyrene (PS) and zeonexTM slides were purchased 
from Microfluidic Chip Shop GmbH, Jena, Germany. Pressure-sensitive adhesive (PSA) 
was obtained from Adhesive Research, Limerick, Ireland. Bottomless 96-well microtitre 
plates were purchased from Greiner Labortechnik, Germany.  The Optec Micro-Master CO2 
Laser was procured from Optec S.A., Belgium. The assay temperature was maintained at 37 
oC using a thermostat which was obtained from Labnet International Inc., Edison, NJ, USA. 
2.4 Experimental Section 
2.4.1 Microtitre plate functionalization with amine-silane and anti-human fetuin A 
antibody immobilization 
Each well of the 96-well plate was treated with 100 µL of absolute ethanol for 5 min at 37 
oC and washed five times with 300 µL of deionised water (DIW).  Subsequently, each well 
was treated with 100 µL of 1.0% (w/v) KOH at 37 oC for 10 min followed by five washings 
with 300 µL of DIW. The KOH-treated wells were then treated with O2-plasma and were 
functionalized with amino groups by incubation with 100 µL of 2% (v/v) 
aminopropyltriethoxysilane (APTES) per well at 80 oC for 1 h inside a vacuum-desiccator, 
in order to achieve maximum silanization.  It is important to mention here is that KOH-
based chemical oxidation followed by O2-plasma treatment facilitates generation and 
stabilization of the surface functional groups. The reaction mechanism following the KOH 
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activation and APTES-based surface functionalization involves mild oxidation followed by 
a hydrolytic APTES polymerization on the oxidized surface through its alkoxy groups [11, 
12]. The desiccator was equilibrated to room temperature for 20 min. The amine-
functionalized plate was subsequently washed five times with 300 µL of DIW in order to 
remove excess unbound 3-APTES from the surface. Afterward, the anti-HFA/AHSG (990 
µL of 4 µg/mL) was incubated with 10 µL of a pre-mixed solution of 1-ethyl-3-[3-
dimethylaminopropyl]carbodiimide hydrochloride (EDC) (4 mg/mL) and N-
hydroxysulfosuccinimide (SNHS) (11 mg/mL) for 15 min at 37oC. The resulting EDC cross-
linked anti-HFA/AHSG antibody solution was added to each of the functionalized wells 
(100 µL) and incubated for 1 h at 37oC.  The anti-HFA/AHSG-coated wells were then 
washed five times with 300 µL of PBS. The conventional ELISA was performed with the 
protocol supplied by the manufacturer. 
2.4.2 ELIA on anti-HFA/AHSG antibody-immobilized microtitre plates  
Plates with covalent and passively immobilized anti-HFA antibody were blocked with 1% 
(v/v) BSA diluted in 0.1M phosphate buffered saline (PBS), pH 7.4, for 30 min at 37 oC and 
subsequently washed five times with 300 µL of PBS. Varying concentrations of 
HFA/AHSG (from 4.8 pg/mL to 20 ng/mL) were prepared in 0.1M PBS, pH 7.4, and 100 
µL of each of these concentrations were incubated in the antibody-coated plates for 1 h at 37 
oC, and, subsequently washed five times with PBS. One hundred microliters of biotinylated 
anti-HFA/AHSG detection antibody (200 ng/mL) was added and incubated for 1 hr at 37 oC 
followed by five PBS washes. HRP-conjugated streptavidin (100 µL per well), at a dilution 
of 1:200, was added and then incubated for 20 min at 37 oC followed by five washes with 
PBS. The 3,3’,5,5’-tetramethylbenzidine (TMB) substrate was subsequently added (as per 
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the manufacturer’s recommendations) and the reaction was stopped after 20 min by addition 
of 50 µL of 0.5M H2SO4. The absorbance was recorded at a primary wavelength of 450 nm 
with a reference wavelength of 540 nm. The dual wavelength system of absorbance 
measurement in 96-well plates is designed to eliminate or greatly reduce the optical 
imperfections at the well-to-well level.  
All the experiments were carried out in triplicate. The control for this study was zero ng/mL 
concentration of HFA in 0.1M PBS, pH 7.4, and the absorbance of the control was 
subtracted from all the assay values. The respective analytical sensitivity (detection limit) of 
the assay were determined where it was calculated using the formula [mean absorbance of 
blank + 3σ (standard deviation of the blank)]. Additionally, data sets obtained from the 
ELIA and conventional ELISA were analysed using standard curve analysis of Sigma Plot 
software, version 11.0.  
2.5 Results and Discussion 
2.5.1 Developed ELIA and conventional ELISA formats for HFA detection 
The range of detection of HFA for the developed ELIA (Figure 2.2) was 9 to 20 pg/mL 
(r2=0.99). An analytical sensitivity of 39 pg/mL was recorded for the developed ELIA, 
where  analytical sensitivity was calculated using the formula [average absorbance of blank 
+ 3 (SDblank)]. Assay variability parameters for this high-sensitivity assay for HFA are 
described in Table 2.2, where intra-day assay variability was calculated from 5 repeats 
performed on a single day and inter-day assay variability from three repeats performed on 
three different days in triplicate.  
The half-effective concentration (EC50) obtained from the dose-response curve [13], which 
is a measure of analyte-ligand interaction, was found to be on an average of 3.3 ng/mL. The 
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EC50 for all the assay repeats was found to be in the range of 3-3.5 ng/mL. A lower EC50 
(3.3 ng/mL), which was obtained for the developed ELIA, suggests a strong interaction 
between HFA and anti-HFA antibody. This interaction behavior is attributed to the 
significant increase in the total amount of immobilized antibody achieved by using the 
covalent immobilization strategy, which increased the availability of anti-HFA antibody per 
HFA molecule, thus increasing the resultant HFA capture on the well surface.  
 
Table 2.2.  Comparison of assay performance parameters (precision and sensitivity) for 
conventional ELISA and developed ELIA 
 Intra-day precision 
range (CV%), (n=5) 
Inter-day precision 
range (CV%), (n=3) 
Sensitivity 
Developed ELISA 2.4-10.4 1.7-17.6 39 pg/mL 
Conventional ELISA 4.7-17.4 3.6-20.0 312.0 pg/mL 
Intra-day precision was calculated from the five repeats (n=5) of the same assay on a single day but 
at different times while inter-day precision was calculated from assay repeats on three different days 
(n=3). All the assays were carried out in triplicate. Analytical sensitivity was determined using the 
formula [average absorbance of blank + 3 (SDblank)]. 
 
Conversely, EC50 for the conventional ELISA format was 23 ng/mL, (r2=0.99), which was 
significantly higher than the developed ELIA. This suggests a less sensitive conventional 
assay (Table 2.3). The most important factor that may be attributed to the enhanced 
sensitivity of the modified assay is the covalent immobilization of the anti-HFA/AHSG 
capture antibody, since the covalently-crosslinked antibodies should not leach out during the 
assay procedure in comparison to the use of passively-adsorbed antibodies, where leaching 
may occur more easily.  
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Performance of the developed sandwich ELIA procedure was compared with the 
conventional protocols (Figure 2.2), both involving passively adsorbed antibody on normal 
unmodified microtitre plates (one performed using the modified protocol and the other as 
per the manufacturer’s recommendations). All the assays were performed simultaneously on 
the same day under same set of conditions in order to minimize variability, where variability 
was reported as percentage coefficient of variation (% CV). 
 
Table 2.3 Comparative analysis of the modified sandwich ELISA procedure which was 
developed for HFA/AHSG and the commercially used conventional sandwich ELISA 
procedure in terms of timings of various assay steps (Table 2.2).   
Immunoassay  
Steps and Parameters 
Conventional HFA ELISA 
(passively adsorbed Ab) 
Modified HFA ELIA 
(covalently captured Ab) 
Immobilization of mouse anti-HFA Overnight at room temp (RT) 2 hrs 30 min 
Blocking buffer (BSA) 2 hrs at RT 30 min at 37o C 
Recombinant HFA  2 hrs at RT 1 hr at 37o C 
Incubation of biotinylated goat anti-HFA 2 hrs at RT 1 hr at 37o C 
Binding of Streptavidin-HRP 20 min at RT 20 min at 37o C 
TMB substrate assay 20 min at RT 20 min at 37o C 
Total immunoassay duration  ~ 20 hrs  ~ 6 hrs  
Detection limit 156 pg/mL 9.76 pg/mL  
Sensitivity 624 pg/mL 39 pg/mL 
Immobilization strategy applicable to 
many polymeric surfaces 
Not possible Possible 
 
The technique employed here for chemically modifying the polymeric surface was 
developed and standardized by our group and a standard EDC-based cross-linking strategy 
was deployed to immobilize anti-HFA/AHSG antibody.  The developed sandwich ELIA 
procedure decreased the overall assay duration from 20 h to 6 h, which is more than a 3-fold 
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decrease. Thus, the reported procedure is a rapid ELIA format having the additional benefit 
of being generic in nature, i.e. it can be used with sandwich ELISAs on different polymeric 
matrices for a range of different analytes. Hence, using the surface modification technique 
reported here, it is possible to develop rapid and high sensitivity assays on various categories 
of solid supports including those that are chemically inert.  
 
Figure 2.2 Comparative analysis of developed sandwich ELISA (black circles) with 
conventional formats. Anti-human fetuin A (anti-HFA) antibody was covalently bound to the 
amine-modified surface in the developed ELISA, whereas antibody adsorbed on the 
unmodified surface was used in the conventional assay format. The assay was performed 
with the manufacturer-recommended protocol (white circles) and the protocol developed in 
this study (filled circles). The error bars represents the standard deviations. 
 
As far as can be ascertained, this developed ELIA procedure is the most sensitive assay 
reported for the detection of HFA/AHSG (Table 2.2), which is based on the comparison 
between different commercially-available ELISA kits for HFA. The sensitivity of the assay 
may be attributed to the use of monoclonal antibody at the capture stage, which was 
83 
 
covalently immobilized on the surface, and a polyclonal antibody to detect the antigen. The 
covalently cross-linked monoclonal antibody that is used as capture antibody in this study 
was found to capture significantly higher amounts of HFA, which has improved the 
detection limit and the overall assay sensitivity of the developed ELIA procedure in 
comparison to other conventional formats. However, the commercially available ELISA 
kits, as described in Table 2.1, have different capture and detection antibody combinations 
that may be a factor in their reduced sensitivities [14]. The sensitivity and specificity of any 
immunoassay is dependent on the antigen capture efficiency of an antibody which is 
subsequently governed by the nature of antibody [15, 16] and accounts for the different 
assay sensitivities of the commercially-available kits employing different types of antibodies 
that are monoclonal or polyclonal at the capture stage in ELISA. 
 
2.5.2 Generic nature of the developed sandwich ELIA procedure on different 
substrates 
Five different substrates were demonstrated for the use of the developed surface 
modification strategy and antibody immobilization followed by immunoassay performance 
(Figure 2.3b), whereas, three different types of commercially relevant substrates, 
polystyrene (PS) (hydrophobic), polymethyl methacrylate (PMMA) (hydrophilic) and 
cyclolefin polymer (zeonex) (inert), were demonstrated for the assay development (Figure 
2.3a). The HFA assay was performed on these matrices in the modified microtitre plate 
format.  
The HFA assays performed on different solid substrates could not be directly compared 
because of their different thicknesses. Theoretically, the optical path length contributes 
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toward the absorbance (A). Therefore, a thick solid support increases the path length and 
hence significantly changes the absorbance. However, generic nature of the developed 
strategy was successfully demonstrated (Figure 2.3). 
a b
 
Figure 2.3 Generic nature of the antibody immobilization procedure that enables 
performance of the developed sandwich ELIA for human fetuin A (HFA) on different solid 
support matrices. (a) ELIA performance on three categories of solid supports that were 
chosen on the basis of their chemical properties, namely polystyrene (PS) which is 
hydrophobic (white circles), polymethyl methacrylate (PMMA), a hydrophilic polymer 
(black circles) and polycyclolefin polymer, trade name Zeonex that is a neutral matrix 
(inverted black triangles). (b) Demonstration of ELIA on a range of various polymeric solid 
supports that have been regularly employed in biosensor development. The error bars 
represent the standard deviations.  
The HFA assay performed on Zeonex support, which is an inert cyclic polyoolefin derivate, 
had an analytical sensitivity of 39 pg/mL, while for the assay performed on PS and PMMA, 
it was 78 pg/mL. The EC50 for the HFA assay performed on Zeonex and PMMA was 
approximately 7 ng/mL (r2=0.98) and for PS it was 9 ng/mL. The analytical sensitivities for 
the HFA assays and the dose-response, which determines the slope-dependent linearity 
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range of the assay, of HFA-anti-HFA for all the solid supports used in this study suggests 
that this modified protocol increases the overall assay sensitivity and is not confined to the 
nature of the solid support used for capturing antibody.  
2.6 Conclusions 
A rapid sandwich ELISA procedure was developed for the detection of HFA/AHSG. It was 
based on the covalent immobilization of anti-HFA capture antibody on a 3-APTES 
functionalized microtitre plate and had an analytical sensitivity of 39 pg/mL of HFA/AHSG. 
The antibody immobilization procedure is generic in nature for capturing antibody on solid 
supports irrespective of their chemical nature of the support. This strategy can also be used 
in research for rapid assay development on various commercially relevant substrates and the 
screening of substrates for a particular biosensor/diagnostic application.  
2.7 References 
1. Kaur J, Boro RC, Wangoo N, Singh KR, Suri CR: Direct hapten coated immunoassay 
format for the detection of atrazine and 2,4-dichlorophenoxyacetic acid herbicides. Anal 
Chim Acta 2008, 607(1):92-99.  
2. Jia C, Zhong X, Hua B, Liu M, Jing F, Lou X, Yao S, Xiang J, Jin Q, Zhao J: Nano-
ELISA for highly sensitive protein detection. Biosens Bioelectron 2009, 24(9):2836-2841.  
3. Kalabay L, Graf L, Voros K, Jakab L, Benko Z, Telegdy L, Fekete B, Prohaszka Z, Fust 
G: Human serum fetuin A/alpha2HS-glycoprotein level is associated with long-term 
survival in patients with alcoholic liver cirrhosis, comparison with the Child-Pugh and 
MELD scores. BMC Gastroenterol 2007, 7(1):15-23.  
86 
 
4. Srinivas P, Wagner A, Reddy L, Deutsch D, Leon M, Goustin A, Grunberger G: Serum 
alpha 2-HS-glycoprotein is an inhibitor of the human insulin receptor at the tyrosine kinase 
level. Mol Endocrinol 1993, 7(11):1445-1455.  
5. Mathews ST, Srinivas PR, Leon MA, Grunberger G: Bovine fetuin is an inhibitor of 
insulin receptor tyrosine kinase. Life Sci 1997, 61(16):1583-1592.  
6. Kalabay L, Prohaszka Z, Fust G, Benko Z, Telegdy L, Szalay F, Toth K, Graf L, Jakab L, 
Pozsonyi T, Arnaud P, Fekete B, Karadi I: Human fetuin/alpha2HS-glycoprotein levels in 
sera of patients with liver disease. In Liver Cirrhosis: New Research. Ed. Chen TM. Nova 
Science, New York, USA; 2005:63-75.  
7. Reynolds JL, Skepper JN, McNair R, Kasama T, Gupta K, Weissberg PL, Jahnen-
Dechent W, Shanahan CM: Multifunctional Roles for Serum Protein Fetuin-A in Inhibition 
of Human Vascular Smooth Muscle Cell Calcification. J Am Soc Nephrol 2005, 
16(10):2920-2930.  
8. Jethwaney D, Lepore T, Hassan S, Mello K, Rangarajan R, Jahnen-Dechent W, Wirth D, 
Sultan AA: Fetuin-A, a Hepatocyte-Specific Protein That Binds Plasmodium berghei 
Thrombospondin-Related Adhesive Protein: a Potential Role in Infectivity. Infect Immun 
2005, 73(9):5883-5891.  
9. Ix JH, Shlipak MG, Brandenburg VM, Ali S, Ketteler M, Whooley MA: Association 
Between Human Fetuin-A and the Metabolic Syndrome: Data From the Heart and Soul 
Study. Circulation 2006, 113(14):1760-1767.  
87 
 
10. Hermans MMH, Brandenburg V, Ketteler M, Kooman JP, van der Sande FM, 
Boeschoten EW, Leunissen KML, Krediet RT, Dekker FW: Association of serum fetuin-A 
levels with mortality in dialysis patients. Kidney Int 2007, 72(2):202-207.  
11. Park S, Jung W: Effect of KOH activation on the formation of oxygen structure in 
activated carbons synthesized from polymeric precursor. J Colloid Interf Sci 2002, 
250(1):93-98.  
12. Cass T, Ligler FS: Immobilized biomolecules in analysis: a practical approach (ed.1). 
Oxford University Press, New York, USA; 1998.  
13. Armbruster D, Schwarzhoff R, Hubster E, Liserio M: Enzyme immunoassay, kinetic 
microparticle immunoassay, radioimmunoassay, and fluorescence polarization immunoassay 
compared for drugs-of-abuse screening. Clin Chem 1993, 39(10):2137-2146.  
14. Wild D: Immunoassay troubleshooting guide. In The Immunoassay Handbook (ed.2). 
Ed. Wild D. New York, USA: Nature Publishing Group; 2001:483-518.  
15. Byrne B, Stack E, Gilmartin N, O'Kennedy R: Antibody-based sensors: principles, 
problems and potential for detection of pathogens and associated toxins. Sensors 2009, 
9(6):4407-4445.  
16. Lacy A, Dunne L, Fitzpatrick B, Daly S, Keating G, Baxter A, Hearty S, O’Kennedy R: 
Rapid analysis of coumarins using Surface Plasmon Resonance. J AOAC Intern 2006, 
89(3):884-892.  
 
 88 
 
 
 
 
 
Chapter 3 
Evaluation of apparent non-specific protein 
loss due to adsorption on sample tube surface 
and/ or altered immunogenicity 
(Published in the Analyst, 2011, 136(7), 1406-1411)
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3.1 Abstract 
The non-specific loss of protein analytes can have a major effect on assay results particularly 
where the concentrations of such analytes are extremely low and the matrix is complex. This 
report assesses how the protein incubated in sample tubes may be lost due to adsorption. Use 
of proteins, such as bovine serum albumin (BSA), may be used to pre-treat tubes to reduce 
such losses. However, such losses may also be associated with structural perturbations 
leading to changes in immunogenicity (as a result of alterations in specific epitope-related 
conformations). This can lead to erroneous results or lack of comparability with a range of 
methodologies such as the bicinchoninic protein assay and immunoassays, or when surface 
plasmon resonance (SPR)-based approaches are used. A model system to evaluate these 
phenomena is proposed.  
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3.2 Introduction 
Analytical techniques such as surface plasmon resonance (SPR) and enzyme-linked 
immunosorbent assay (ELISA) may involve sample preparation [1-5]
 
and long incubation 
periods of analyte in sample tubes. Thus, there is a possibility of analyte loss due to non-
specific binding to matrix-associated interferents or adsorption of protein molecules onto the 
surface of the sampling tubes or onto devices used in the preparation procedure [6-14].
 
This 
may result in a low analyte recovery and/or a considerable decrease in the signal obtained 
with specific techniques (e.g. antibody-based methods such as ELISA). Therefore, it is 
critically important to prevent such analyte loss, particularly for those antigens that are 
present at very low concentrations (such as cardiac troponins, tumor biomarkers or 
cytokines) [15].
 
The use of relevant controls and standards can be used to compensate for 
some losses due to this phenomenon. However, it can have very significant effects if the 
technique or assay used is no longer able to detect the low levels of the analyte present, due 
to the amount lost in the pre-analysis steps.  
This report describes analyte losses both as a function of duration of incubation and due to 
the chemical nature of the tube material. The model analytes employed for this study were 
human fetuin A (HFA) and HRP-labeled mouse IgG. Analyte loss was characterized by 
comparative analysis of sampling performed in tubes that were either treated with blocking 
proteins such as BSA or were used without any prior treatment (untreated). Known 
quantities of the analyte were incubated in BSA-treated and untreated tubes made of 
polypropylene (PP) and low protein-adsorbing chrome-coated glass (GT) (customized for 
SPR studies) for 0, 0.5 and 12 h. The analyte loss was characterized as a function of 
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decrease in absorbance obtained with the bicinchoninic acid (BCA) assay (which is a direct 
method for calculation of total protein concentration in solution and hence, to quantitate 
protein recovery). After confirming protein analyte loss with the BCA assay, enzyme-linked 
immunoassay (ELIA) and surface plasmon resonance (SPR) were employed to determine 
the apparent concentration of the targeted analytes. Results indicated that in immunoassay-
based analyses the reduction in concentration may be due to a combination of losses 
associated with non-specific adsorption and to structural changes that may result in altered 
epitope conformation, leading to reduced immunogenicity.  
3.3 Materials 
1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC), sulfo-N-hydroxysuccinimide 
(SNHS), phosphate buffered saline (PBS, pH 4.7), tetramethylbenzidine (TMB) substrate 
kit, BCA assay kit and bovine serum albumin (BSA) were purchased from Fisher Scientific 
(Ireland), Ballycoolin, Dublin, Ireland. HRP-labeled mouse IgG, goat anti-mouse IgG, 
potassium hydroxide (KOH), 3-APTES, absolute ethanol, Nunc 96-well polystyrene plates 
(P7491) and Eppendorf polypropylene (PP) microtubes were obtained from Sigma-Aldrich, 
Blessington, Co. Wicklow, Ireland. SIA gold chips (BR-1004-05) and glass vials (BR-1002-
09) were obtained from GE Healthcare, Buckinghamshire, HP7 9NA, UK. Human fetuin 
A/AHSG duoset kit, with all human fetuin A assay components, was procured from R&D 
Systems Europe, Abingdon, Oxon, UK. The kit consisted of the capture antihuman fetuin 
A/AHSG (anti-HFA) antibody from mouse, human fetuin A/AHSG standard, biotinylated 
goat anti-HFA detection antibody and streptavidin–HRP. All the assay components were 
reconstituted in 0.15 M PBS, pH 7.4, with 1% (w/v) BSA. All buffers and solutions were 
prepared using Milli-Q deionised water (DIW). The dilution of BSA was made in 0.15 M 
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PBS, pH 7.4, whereas KOH and 3-APTES were diluted in DIW. EDC and SNHS were 
reconstituted in 0.1 M MES buffer, pH 4.7. 
S0 St
S0‐St
% ΔS (Loss)
% ΔSadsorption
% ΔSimmunogenicity‐associated
S0: Total signal obtained for sample incubated at 0 h in
BSA-treated tubes
St: Signal obtained at given incubation time for
corresponding samples in BSA-treated and untreated tubes
S0-St: Signal loss for the sample incubation at a given time
% ∆S (Loss): Total % signal loss at a given time (refer to
eqn (1))
% ∆Sadsorption: Contribution of the adsorption-related loss in
the total signal for the samples incubated for 12 h in BSA-
treated and untreated tubes (refer to eqn 4)
S12h, 4oC: Total signal obtained for sample incubated at 4oC
for 12 h
S12h, RT: Signal obtained for samples incubated at RT for 12
h
S 12h, 4oC - S 12h, RT: Total signal loss corresponding to the
analyte fraction with compromised immunogenicity as a
result of longer incubations (refer to eqn 2)
% ∆Simmunogenicity-associated: Contribution of the
immunogenicity-related loss in the total signal for the
samples incubated for 12 h in BSA-treated and untreated
tubes (refer to eqn 3)
S 12h, 4oC S 12h, RT
S 12h, 4oC ‐ S 12h, RT
 
Figure 3.1 This model is designed to illustrate that the losses in analyte (e.g. HFA) 
concentration, as determined by  antibody-based methods, result from a combination of both 
adsorption on the tube surfaces and loss of conformation-related immunogenicity and that 
these increase over time of incubation and also are temperature dependent. 
3.4 Experimental  
3.4.1 Tube blocking 
Polypropylene (PP) and glass (GT) tubes were treated with 1% (w/v) BSA for 30 min 
followed by extensive washing with PBS (0.15 M, pH 7.4). The tubes were dried under 
nitrogen (N2).  
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3.4.2 Sampling 
For initial experiments, HFA (2 µg/mL) and HRP-labeled mouse IgG (2 µg/mL) were 
employed. After performing all the analyses, HFA (0–20 000 pg/mL) and HRP-labeled 
mouse IgG (0–1210 ng/mL), reconstituted in 0.15 M PBS, pH 7.4, were employed for the 
immunoassay studies. All samples were incubated in BSA-treated and untreated tubes (PP 
and GT) for 0, 0.5 and 12 h at room temperature (RT). Additionally, HFA was also 
incubated in BSA (1% (w/v))-treated and untreated tubes at 4 oC for analysis essential to 
quantify the contribution of sample incubation conditions to the altered immunogenicity. 
‘Blank’ controls for this study had zero analyte concentration and were incubated for 0 h in 
blocked PP and GT tubes. These controls also facilitate the detection of any BSA leaching 
into solution from the tube surfaces following blocking.  
3.4.3 Analytical techniques 
ELIA was performed over the stated concentration range of analytes for all sets of 
sampling, whereas the BCA and SPR assays were performed at concentrations of 10 
ng/mL and 300 ng/mL for HFA and HRP-labeled mouse IgG, respectively. The BCA 
assay, performed according to the manufacturer’s instructions, was used to determine the 
HFA recovery in the samples incubated for different durations. ELIA was performed 
with covalently immobilized anti-HFA antibody, as previously described [16]. The 
microtiter plate wells were activated using 1% (w/v) KOH. The amine-functionalization 
was performed with 3-aminopropyltriethoxy silane (APTES). The anti-HFA antibody 
was conjugated to the aminated surface via EDC chemistry. 
For SPR (Biacore 3000) analysis each flow-cell of the amine-activated gold chip had 
approximately 5000 response units of anti-HFA antibody immobilised, using EDC 
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chemistry. The sample buffer (HEPES, pH 7.0) was passed over all the flow-cells serving as 
a blank. Four different concentrations of HFA (1.25–10 ng/mL) in two sets were incubated 
in BSA-treated and untreated tubes and were then subjected to SPR analysis. The 
corresponding control values were subtracted from each signal value. The absorbance and 
RU signals obtained for ELIA and SPR were analysed and reported as the % analyte loss, 
where the % signal loss for each set of experiments was calculated as a loss relative to the 0 
h sampling performed in blocked (B) tubes and discussed in detail in the Theory and 
analysis section. Similarly, goat anti-mouse IgG was immobilized on the chip and HRP-
labeled mouse IgG was assayed at a concentration of 300 ng/mL
 
(concentration just above 
the EC50 value). SPR was performed on all samples that were used in the BCA assay and 
ELIA.  
3.4.4 Theory and analysis 
The model developed is an attempt to capture key elements that can impinge on the accuracy 
and potential sensitivity of an assay and to suggest approaches that may help to quantitate 
and minimise the sample loss. It is also the case that there are inherent limitations in the 
analytical methods used but the model attempts to take these into consideration.  
The model describing various theoretical considerations is presented in Figure 3.1. The 
model follows the sequence of events according to the ‘A–B’ rule, where the contributing 
factors are calculated by deducting individual fractions at each step from the total. All the 
calculations performed with the results obtained from BCA, ELIA and SPR were based on 
an assumption that there was no significant analyte loss for the samples incubated in blocked 
tubes for 0 h incubation. The difference in signals obtained for samples incubated for 
various durations in blocked and unblocked tubes with respect to those in blocked tubes at 0 
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h quantifies the adsorption-based analyte loss (% ΔS). This is summarized as eqn (1).  
     
% ΔS = [1 – (St / S0hB)] X 100----------------------(1) 
where, 
St: Signal obtained for the HFA or HRP-labeled mouse IgG samples at a given 
incubation time 
S0h B: Signal obtained for the HFA or HRP-labeled mouse IgG sample incubated in BSA-
treated tubes at 0 h incubation (equivalent to 100% signal) 
The loss was expressed as the relative percentage signal loss (Table 1, marked with *), 
where the signal corresponds to the absorbance (for ELIA-based analysis) or response units 
(for SPR-based analysis) for each set of sampling performed in either PP or GT tubes.  
Similarly, the signal loss contributed by the reduced analyte immunogenicity (% 
ΔSimmunogenicity-associated) was calculated as the difference in signals obtained with the samples 
incubated for 12 h in blocked tubes at RT with respect to those in blocked tubes for 12 h at 4 
oC. This is shown in eqn (2). This assumption was based on the fact that when protein 
molecules in solution are adsorbed onto surfaces, their conformation may become more 
unstable and a loss of structural integrity can occur [17-21]. There may also be aggregation-
dependent activity loss where the aggregation may either be due to solvent [22, 23]
 
or 
temperature effects [24].
 
Additionally, an increase in protein adsorption occurs in the 
temperature range 20-40 oC. However, at lower temperatures there is a significant reduction 
in adsorption [25, 26]. 
For this study, the analyte samples were incubated in the BSA-treated tubes under two 
conditions (a) at RT and (b) at 4 oC with the same experimental set-up. The percentage 
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fraction of the signal loss relative to the samples incubated at 4 oC for 12 h was 
calculated using the following equation 2,  
%ΔSimmunogenicity-associated = [{(S0B – S12h RT B) / S12h 4oC B)} – {1 – (S12h RT B / S12h 4oC B)}] X 100---(2) 
where, 
S12h RT : Signal of the HFA or HRP-labeled mouse IgG samples incubated for 12 h at RT 
and, 
S12h 4 oC B : Signal of corresponding sample incubated for 12 h at 4 oC in BSA-treated 
tubes (equivalent to the estimate of signal loss contributed mainly by adsorption in 
blocked tubes only) 
This fraction, as exemplified by equation (2), corresponds to losses associated with 
altered immunogenicity in samples due to longer incubations. However, the total analyte 
loss (eq. 1) for 12 h incubation at RT consists of two different loss fractions 
corresponding to adsorption and altered immunogenicity. Therefore, in order to obtain 
how much the comporomized immunogenicity (eq. 2; Table 2 marked with **) 
contributes toward the total signal loss equation (3) may be devised.  
%(ΔS/ΔSimmunogenicity-associated) = [(Bn) . (An)]--------------(3)  
where, 
Bn: altered immunogenicity-associated loss (% ΔSimmunogenicity-associated) for ‘n’ h of 
incubation at RT, 
An: Total signal loss (%ΔS) in the samples for corresponding incubation time (as 
calculated using eqn (1)). 
Similarly, the adsorption-associated analyte loss can be obtained by deducting the 
altered immunogenicity fraction (eqn (3)) from the total analyte loss corresponding to 
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100% loss (eqn (1)). The percentage fraction of total signal loss corresponding to the 
loss due to non-specific adsorption (Table 1 marked with **) was calculated using 
equation (4), 
  [(100 – Bn). An] ----------------------(4) 
The fractions corresponding to loss due to adsorption and immunogenicity are listed in 
Table 1. Moreover, the immunogenicity-associated loss in untreated tubes could be 
determined by eqn (5) (Table 2), which is based on assumptions that adsorption is 
insignificant in blocked tubes and there is negligible immunogenicity-associated loss of 
analyte in blocked tubes incubated at 4oC.  
 
%ΔSimmunogenicity-associated in untreated tubes = [{(S0B – S12h RT U)/ S12h 4 oC B)} - {( S12h 4 oC B – S12h 4 oC 
U )/ (S12h 4 oC B – S12h RT U)}] X 100------------(5) 
 
Where, 
[{(S0B – S12h RT U)/ S12h 4 oC B): signal loss of analyte incubated in unblocked at RT relative to 
those incubated in blocked tubes at 4 0C, 
{( S12h 4 oC B – S12h 4 oC U )/ (S12h 4 oC B – S12h RT U): signal loss of analyte incubated in unblocked 
tubes at RT relative to those incubated in unblocked tubes at 4 0C eq.  
3.5 Results and discussion 
3.5.1 Evaluation of protein loss in unblocked PP tubes 
The loss of HFA (initial concentration (C0)=10 ng/mL) and HRP-labeled mouse IgG 
(initial concentration (C0)=300 ng/mL) over time was quantified by the BCA assay 
(Figure 3.2). The relative loss was calculated as a difference between the initial (C0) and 
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recovered (CT) concentrations of the analyte in solution  [C0 – CT]. The analyte loss 
obtained with the BCA assay was also compared and correlated with SPR and ELIA 
(Figure 3.2, 3.3, Table 3.1). However, the analyte loss shown with the BCA assay was 
considerably lower than that found with SPR and ELIA. 
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Figure 3.2 Analysis of protein analyte (HFA) loss due to non-specific adsorption and 
conformation-related immunogenicity as a function of percentage signal loss. The BCA 
assay was employed initially to quantify HFA loss (initial concentration (C0) of 10 ng/mL) in 
the BSA-treated (B) and untreated (U) sample tubes (the numerical value before B and U 
correspond to the time of incubation in hours). The findings of the BCA assay were cross-
validated to immunoassay formats with a sandwich ELIA and SPR. The ‘12B 4’ and ‘12U 4’ 
correspond to the 12 h incubation of HFA performed at 4 oC in BSA-treated and untreated 
tubes, respectively. Error bars represent the standard deviation. The % loss was expressed 
relative to the signal obtained for samples incubated in blocked tubes at 0 h incubation 
(equivalent to 100% signal) and was calculated using equation 1. 
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Figure 3.3 Assay performance for the HFA samples incubated in BSA-treated (B) and 
untreated (U) PP tubes. ELIA was performed to analyze the effect of HFA loss on the assay 
performance with the sample incubated in untreated (a) and BSA-treated (b) PP tubes.  It is 
evident that sampling performed in BSA-treated tubes efficiently reduces the adsorption-
associated decline in absorbance. Similar results were obtained with the SPR assay 
performed with the samples incubated in BSA-treated (d), and untreated (c) PP tubes. A 
significant difference in assay signals obtained for  incubation for 0.5h in BSA-treated and 
untreated tubes demonstrates the analyte loss as a function of incubation time as 
characterized by ELIA and SPR. Error bars in assay points correspond to standard 
deviations.  
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This difference in loss calculated using the BCA assay with respect to ELIA and SPR is 
due to the nature of the analytical approach. BCA measures the total protein content in 
the solution and does not distinguish the conformationally compromised analyte from its 
active form. Therefore only the protein loss attributed to adsorption is accountable in the 
case of BCA assay. However, ELIA and SPR are highly sensitive approaches and losses 
due to both adsorption and the analyte conformation changes are detectable. This results 
in a higher % signal loss due to analyte loss. There was no significant loss obtained with 
the BCA assay for the samples incubated in untreated tubes for 0h and 0.5 h. Whereas, a 
consistent increase in the percentage loss was obtained with ELIA and SPR as a function 
of  increasing incubation time.  
The protein loss was higher in GT tubes in comparison to PP tubes (Figure 3.4). This 
differential analyte loss behaviour was attributed to the chemical nature of the tube 
material used. The data obtained for HFA was validated with a HRP-labeled mouse IgG-
based two component system (Figure 3.5). Similar results were obtained with the HRP-
labeled mouse IgG and were in accordance with the previous reports on the loss of 
immunoglobulin from solution [27]. However, HFA (59 kDa) is a relatively smaller 
molecule in comparison to the HRP-labeled mouse IgG molecule (194 kDa). This 
significant size difference between HFA and the mouse IgG-HRP conjugate significantly 
changes the adsorption behaviour although the loss behaviour follows the same pattern 
for both analytes. 
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Figure 3.4 Assay performance for the HFA samples incubated in BSA-treated (B) and 
untreated (U) glass tubes (GT tubes). The BCA assay was performed to analyze the total 
protein content available in solution. The protein loss can be quantified by relative analysis 
with respect to samples incubated in blocked tubes at 0h (0B). Results for the BCA assay are 
designated as ‘0B BCA’ to ‘12U BCA’. ELIA and SPR were performed to analyse the effect 
of HFA loss on assay performance with both sandwich and direct immunoassay detection 
approaches, respectively. The samples results corresponding to ELIA and SPR are suffixed 
as ‘ELIA’ or ‘SPR’ on the X-axis. Since losses due to adsorption and altered 
immunogenicity are determined in both the ELIA and SPR-based detection approaches, 
therefore, the percentage signal loss obtained for the HFA in all the sets of ELIA and SPR is 
higher than that obtained with the BCA assay. Error bars correspond to standard 
deviations.  
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Figure 3.5 Assay performance analysis for HRP-labeled mouse IgG incubated in BSA-
treated (B) and untreated (U) (a) PP and (b) GT tubes. A similar analyte loss pattern was 
obtained for PP and GT tubes. This loss was higher with the use of GT tubes, as obtained 
with BCA assay. However, higher signal loss obtained in PP tubes relative to GT tubes 
corresponding to SPR and ELIA may be attributed to the losses due to impaired 
functionality of analyte. The symbols used are as in previous diagrams 
 
3.5.2 Effect of tube-blocking on protein analyte loss 
The tube surface was treated with 1% (w/v) bovine serum albumin (BSA), which is a 
routine blocking agent for various immunoassays. Tubes were incubated with 1% (w/v) 
BSA for 30 min followed by washing with 0.15M PBS, pH 7.4, and dried under N2.  
The percentage signal loss (protein analyte loss) in the blocked tubes was analyzed using 
the same procedure as described previously for the untreated tubes. A comparative 
analysis was made for the analyte loss obtained for test samples incubated in BSA-
treated and untreated tubes over a 12 h incubation period (Figure 3.2). A significant 
decrease (p ≤ 0.05) in the amount of protein loss was achieved by blocking the tubes 
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with 1% (w/v) BSA. However, it is advisable to optimize the surface blocking as a 
function of BSA concentrations and tube-treatment times for all type of polymers as the 
adsorption kinetics of the blocking proteins are dependent on the chemical nature of 
surface to be treated. 
The tube treatment significantly improved the available antigen concentration in solution 
and, hence, various analytical features of the assays (Table 3.2). However, while a 
certain amount of analyte loss was observed in the BSA-treated tubes with  12 h 
incubation, it was significantly less (p≤0.05), in comparison to the untreated tubes 
(Figure 3.3a-d). This signal loss in blocked tubes may be due to the  nature of BSA, 
which has a  tendency to bind reversibly to a variety of potential analytes thus, 
developing a dynamic interaction between the BSA adsorbed on the tube surface and the 
free analyte in solution [28, 29].  
The effect of tube-blocking was also analyzed in a direct assay format by incubating 
HRP-labeled mouse IgG in the untreated and BSA-treated tubes, and assaying with 
immobilized goat anti-mouse IgG (Figure 3.3.). The results obtained were found to 
correspond to those with  HFA.  
3.5.3 Evaluation of the contribution of HFA fraction with conformation-related 
impaired immunogenicity 
The loss of protein activity as a result of conformational changes on solid-liquid 
interfaces [29-32] or due to molecular flattening/spreading [33] have already been 
demonstrated. However, analysis of  protein losses due to these phenomena and their 
effects on bio/ immunoassay performance have not been reported.  
 
 104 
 
Table 3.1. Determination of total HFA loss due to non-specific adsorption and 
conformation-related immunogenicity changes  
 
Incubation 
time (h) 
Sample tube Percentage signal loss* relative to 
samples of 0h B incubation time 
Correlation studies 
  ELIA BCA BCA v/s ELIA 
0RT 
 
BSA-treated PP 0 0 BSA-treated PP 
r2 = 1.00  
(p = 0.76) 
Untreated PP 
r2 = 0.78 
 (p = 0.48) 
 
Untreated PP 
 
7 5 
0.5RT BSA-treated PP 11 2 
 Untreated PP 
 
23 7 
12RT BSA-treated PP 34 (24**) 24 
 Untreated PP 
 
65 (49**) 30 
12 (4 oC) BSA-treated PP 24*** 9 
 Untreated PP 48*** 24 
 
*The percentage signal loss for each set of HFA samples at a defined incubation time was 
calculated using eq. (1). The control used for this study was blocking performed at 0h 
incubation.  
** The fraction of the total signal loss contributed by adsorption-based non-specific losses 
and calculated using eq.  (4).  
***The percentage signal loss obtained for sampling performed at 12 h in BSA-treated 
and untreated tubes (**) after subtracting the fraction corresponding to the immunogenicity 
loss (marked with** in Table 3.3) corresponds closely with the percentage signal loss 
obtained for the samples incubated in BSA-treated and untreated tubes at 4 oC for 12 h. This 
indicates that immunogenicity-related losses in HFA samples were minimized for 
incubations at 4 oC. 
PP stands for polypropylene tubes. 
r2 is the coefficient of determination of the techniques used for cross-validation and the p-
value (at 95% confidence) represents the level of significance between the analysis 
performed with both the experimental approaches used. The r2 and p-values for this study 
were calculated using SigmaPlot software version 11.0. 
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Table 3.2. Effect of varying incubation time of analyte on the sensitivity of the 
immunoassay as observed by the increase in EC50. 
 
Treatment ((Un)blocked) 
and Tube composition 
 
*Increase in EC50 values (ng/mL) 
over a period of 12 h of  incubation 
( EC5012h -  EC500h) 
Δ EC50 
Analytical error 
(% CV) 
Unblocked PP 87 24 
BSA-blocked  PP 31 2 
Unblocked GT 85 19 
BSA-blocked GT 11 3 
EC50 for each set of assay was calculated using SigmaPlot version 11.0.  
PP = polypropylene tubes; GT = glass tubes. 
SD is standard deviation 
% CV corresponds to the coefficient of variation in all the assay repeats and is calculated 
as (SD/ Mean of the obtained signal   for all repeats) X 100. 
*EC50 is a measure of assay performance and is described as the half-maximal effective 
concentration. 
 
It was shown that adsorption may be a potential source of conformational stress on 
protein molecules, which may result in compromized immunogenicity. Therefore, in this 
study an attempt was made to assess the contribution of immunogenicity loss to the loss 
of signal in samples incubated for 12 h at room temperature. This fraction of signal loss 
was quantified by calculating the difference in the signals obtained for  samples 
incubated in BSA-treated and untreated tubes at room temperature and comparing them 
with samples incubated in BSA-treated tubes at 4 oC using the eqn (2). These 
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calculations were initially based upon previous reports stating that conformation-
associated activity of a protein is retained at lower temperatures in order of  4 oC > RT > 
37 oC [34-38]. Therefore, the signal loss contributed by the fraction of HFA with 
impaired immunogenicity will be minimal for the samples incubated in BSA-blocked 
tubes at 4 oC. There was a substantial signal loss due to this phenomenon, which was 
significantly greater in the samples incubated in untreated tubes. As claimed in many 
studies the compromised immunogenicity loss may be a result of conformational 
stress/change induced either by solid-liquid interface or by molecular spreading of 
proteins in physisorbed systems that increases over the period of incubation [29-33].  
The adsorption-associated loss (%ΔSadsorption) obtained for samples incubated at RT and 
the total loss (%ΔS)  in samples incubated at 4 oC was equivalent (p ≤ 0.001) for 12 h 
(Table 3.1 and 3.3). These findings justify our assumption that there were significant 
reductions in the losses due to the impaired immunogenicity of the HFA samples 
incubated at 4 oC for a duration of 12 h. One explanation may be that the kinetics of 
proteins in solution reduces significantly at lower temperatures. Therefore, with less 
movements in solution, the probability of analyte interactions with the surface is also 
reduced.  
3.5.4 Evaluation of the signal loss due to the nature of tube material  
The dependence of protein loss on the chemical composition of the sample tubes (PP and 
glass (GT)) was analyzed. The % signal losses obtained for HFA sampling in BSA-treated 
and untreated PP tubes were significantly lower than the corresponding values obtained in 
GT tubes even though GT tubes were customized for low protein adsorption. 
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Table 3.3. Determination of immunogenicity-associated loss for HFA samples incubated in 
BSA-treated and untreated PP tubes for 12 h at 4 oC 
 In BSA-treated tubes In untreated tubes 
 eq. (2) eq. (5) 
 
%ΔSimmunogenicity-associated  
 
 
30* 
 
28* 
 
Immunogenicity-associated 
loss as a % of total loss 
 
10** 
 
17** 
 
* The calculations pertaining to immunogenicity-associated analyte loss were performed 
using either the eq. (2), as mentioned in the methods section, or modified version of eq. (2) 
as mentioned in eq. (5) (Theory & Analysis section) 
 
 ** Contribution of %ΔSimmunogenicity-associated toward total signal loss (Table 3.1 **) was 
calculated using eq. 3. 
 
This protein adsorption behaviour strongly supports the previous reports, where 
hydrophilic self-assembled monolayers (SAMs) were found to be more active in terms of 
protein adsorption than hydrophobic SAMs [11, 39, 40]. A similar finding was also 
reported for silica-based nanoparticulate material [41]. However, the BSA-treatment 
significantly reduced the analyte losses due to non-specific adsorption in both types of 
tubes (Figure 3.5). Therefore, the use of pre-treated sample tubes significantly reduced  
analyte losses and this is of major significance to generate accurate assay results, 
minimise the loss of analytes and to yield greater reproducibility in immunoassays based 
on different assay/biosensor formats. The results obtained indicate that epitope-
conformation changes and related immunogenicity alterations contribute significantly to 
the apparent loss of analytes during sample preparation and processing, and may be  
significantly  minimized by using BSA-blocked tubes at 4 oC.  
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3.6 Conclusions 
In the design of any assay involving protein analytes it is necessary to carefully select the 
tubes used and it may be necessary to pre-treat (block) them to minimize losses due to non-
specific adsorption or alterations in the immunogenicity. Careful selection of temperature is 
also required. It is advisable to optimize these parameters in relation to each protein studied. 
A modeling-based approach was developed to assist in the rationale understanding of the 
issues involved. 
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Chapter 4 
Effect of antibody immobilization strategies 
on the analytical performance of a surface 
plasmon resonance-based immunoassay 
(Published in the Analyst, 2011, 136(21), 4431-4436) 
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4.1 Abstract 
Antibody immobilization strategies (random, covalent, orientated and combinations of each) 
were examined to determine their performance in a surface plasmon resonance-based 
immunoassay using human fetuin A (HFA) as the model antigen system. The random 
antibody immobilization strategy selected was based on passive adsorption of anti-HFA 
antibody on 3-aminopropyltriethoxysilane (APTES)-functionalized gold (Au) chips. The 
covalent strategy employed covalent crosslinking of anti-HFA antibody on APTES-
functionalized chips using 1-ethyl-3-[3-dimethylaminopropyl]carbodiimide (EDC) and 
sulfo-N-hydroxysuccinimide (SNHS). The orientation strategy used passive adsorption of 
protein A (PrA) on Au chips, with subsequent binding of the anti-HFA antibody in an 
orientated fashion via its fragment constant region (Fc) region. In the covalent-orientated 
strategy, PrA was first bound covalently, to the surface, which in turn, then binds the anti-
HFA antibody in an orientated manner. Finally, in the most widely used strategy, covalent 
binding of anti-HFA antibody to carboxymethyldextran (CM5-dextran) was employed. This 
immobilization strategy gave the highest anti-HFA antibody immobilization density, 
whereas the highest HFA response was obtained with the covalent-orientated 
immobilization strategy. Therefore, the covalent-orientated strategy was the best for SPR-
based HFA immunoassay and can detect 0.6-20.0 ng/mL of HFA in less than 10 min.  
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4.2 Introduction 
Immunoassays based on the immobilization of antibodies on a substrate have been widely 
used in different biosensing or bioanalytical techniques for the detection of specific antigens. 
Surface plasmon resonance (SPR)-based immunosensors are ‘real-time’ and ‘label-free’ 
rapid assay formats that provide highly useful information on biomolecular interactions  [1, 
2] and provide highly reproducible immunoassays.    
The immobilization of antibodies on sensor chips plays a very important role in the 
analytical performance of a SPR-based immunoassay. The affinity, orientation and stability 
of the antibodies are often affected by the immobilization strategy employed [3, 4]. In 
addition, the size of the antibodies/fragments used and their surface distribution and the size 
of the analyte are of significance in relation to the minimization of steric hindrance, which 
may affect the immunoassay performance. Antibodies present in the solution phase have 
three dimensional freedom of movement and maintain their native structure. Immobilization 
of antibodies at an interface restricts their freedom of movement and may impact on their 
three dimensional conformation [5]. Therefore, a critical understanding of the interactions 
between macromolecular receptor and ligand is important [5]. 
A large number of chemistries are available for immobilizing antibodies on biosensor 
surfaces; however, those introducing orientation [6] and maintaining native antibody 
conformation [7] are of major importance. CM5-dextran is often used where the antibody is 
linked via its amine groups to the EDC-NHS-activated carboxyl groups of CM5 by 
heterobifunctional crosslinking and this chemistry leads to a high density of antibody 
immobilization. However, immobilization using this strategy can result in interference with 
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the antigen detection capability if the antibody is inadvertently captured via amine groups of 
or adjacent to the antigen binding site [8]. 
 In another format, poly-histidine tagged antibodies are bound to nitriloacetic acid (NTA)-
modified surfaces. However, problems may arise from the strong non-specific adsorption of 
other metal-binding proteins to the poly-histidine tag and continuous leaching of the bound 
ligand [9, 10]. Biotin-avidin systems have also been used for immobilization in SPR assays. 
Streptavidin-coated SPR chips are preferred for the site-directed immobilization of 
biotinylated antibodies. This strategy introduces steric freedom along with site-directed 
orientation. However, as with other proteins, immobilization of streptavidin on the surface 
may introduce conformational-stress that may reduce its binding affinity for biotin. This can 
also occur with other physical parameters such as temperature [11]. Conversely, strategies 
employing thiols, which can be immobilized on the gold surface with high-affinity and 
without any prior surface modification, provide strong site-directed orientation. This 
strategy is useful if the antibody naturally has free thiol groups. However, if the thiol group 
is introduced chemically, involving reaction with the antibody’s amine groups, then this can 
affect activity.  
A high degree of orientation for the capture antibody on a sensor surface can be attained 
with a sub-layer of proteins such as protein A or protein G [12]. These proteins are specific 
for binding the Fc region of the antibodies, which keeps the fragment antigen-binding (Fab) 
region free for antigen binding thus obviating the need of any chemical modification of the 
antibody.  However, randomly immobilized Fc-binding protein molecules may affect the 
orientation of antibody to some degree but this is significantly lower in comparison to the 
degree of orientation actually achieved. Nevertheless, due to steric considerations, a 
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maximum of two antibodies may only be accommodated by each of these protein binding 
molecules [7]. Drawbacks associated with random immobilization and the introduction of 
conformational strain will not affect, to a significant degree, the antibody molecules 
captured on the sub-layer of Fc-binding proteins. Moreover, Fc-binding protein-antibody 
interaction is generally regenerative [13]. 
The present study is aimed at determining the effect of various antibody immobilization 
strategies, i.e. random, orientated, covalent, covalent-orientated and covalent-CM5-dextran 
on a SPR-based immunoassay for HFA (Figure 4.1). Recently we reported a multi-substrate 
compatible novel antibody immobilization strategy [14], which is based on the APTES 
functionalization of the surface and the covalent binding of antibodies to it by EDC-SNHS 
heterobifunctional crosslinking. The same strategy was employed for SPR immunoassays 
and the schematic representation of the strategy is depicted in Fig. 4.1. An alternative 
covalent-orientated strategy was also devised by introducing an additional step in the 
covalent strategy, where PrA was initially bound covalently and anti-HFA antibody was 
immobilized, thereafter, in an orientated manner. The random strategy employed the passive 
adsorption of anti-HFA antibody on APTES-functionalized chips, whereas the orientated 
strategy used the passive adsorption of PrA on SIA Au chips followed by the orientated 
immobilization of anti-HFA antibody. The covalent-CM5-dextran strategy employed the 
covalent binding of amino groups of anti-HFA antibody to the carboxyl groups of CM5-
dextran using EDC-SNHS.  Each strategy was compared on the basis of their SPR 
immunoassay performance, anti-HFA antibody immobilization density and mass-density of 
captured HFA. This study provides an insight as to how antibody orientation strategy may 
influence immunoassay performance.  
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Figure 4.1 Schematic representation of APTES functionalization of Au surface and effect of 
antibody immobilization strategies on the performance of immunoassays in surface plasmon 
resonance format. 
 
4.3 Materials 
EDC, SNHS and 2-(N-morpholino)ethane sulfonic acid (MES, pH 4.7) were purchased from 
Thermo Scientific. 3-APTES (purity 98%, w/v), 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES), Tween 20, H2O2 (30%, v/v), H2SO4 (97.5%, v/v), 
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ethylenediaminetetraacetic acid (EDTA), NaCl, HCl and protein A (soluble, Cowan strain, 
recombinant, expressed in Escherichia coli) were procured from Sigma-Aldrich, Singapore. 
The human Fetuin A/AHSG kit with all the necessary components was obtained from R&D 
Systems Inc., USA. All buffers and solutions were prepared with 18MΩ Milli-Q ultrapure 
water (UPW) filtered through a 2-µm filter. Oxygen-plasma cleaner was obtained from 
Harrick Plasma, Ithaca, New York, USA. UVISEL spectroscopic ellipsometer was obtained 
from Jobin Yvon Horiba, ChillyMazarin, France. Surface Plasmon Resonance was 
performed on BIAcore 3000 purchased from GE Healthcare, Uppsala, Sweden. The SIA kit 
(BR-1004-05) containing SPR Au chips, carboxymethyl dextran (CMD)-functionalized Au 
chips, and ethanolamine hydrochloride (1M, pH 8.5) were purchased from GE Healthcare, 
London, U.K. 
The SPR Au chip was assembled according to the instructions supplied by the manufacturer. 
HEPES-buffered saline (HBS) buffer (10mM) pH 7.4, (running buffer for BIAcore) was 
made up, filtered through 0.2µm Millipore filter paper and degassed overnight in order to 
remove any air bubbles, which may cause interference with SPR analysis. All the sample 
dilutions were made in the running buffer (10mM HBS, pH 7.4). The dilutions of HFA were 
made in BSA-preblocked glass vials, prepared by incubating with 1% (w/v) BSA for 30 
min, to minimize the sample loss due to non-specific adsorption on sample tube surfaces 
and/or effects due to altered immunogenicity [15]. 
4.4 Methods 
4.4.1 Surface cleaning of SIA Au chip and APTES functionalization  
The Au chip was cleaned with piranha etch [60 µL of H2SO4 (97.5%, v/v): 30 µL of H2O2 
(30%, v/v)] for two minutes followed by extensive washing. Piranha treatment oxidizes the 
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gold surface, as evident by the contact angle, which is 9.3o. When the piranha-treated chips 
are washed with deionized water, the water molecules get strongly adsorbed on the surface 
thereby generating ‘hydroxyl’ groups [16, 17], as evident by the increase in contact angle to 
28o-32o.  
The chip was then incubated with 100 µL of 2% (v/v) APTES for 1h at room temperature 
(RT) in a fume hood followed by five washes with UPW. Following this, different 
immobilization strategies were applied. 
4.4.2 EDC activation of anti-HFA antibody  
Anti-HFA antibody (990µL of 100 µg/ml in HBS) was incubated at room temperature for 15 
min with 10 µL of cross-linking solution containing EDC (4 mg/mL) and sulfo-NHS (11 
mg/mL) in 0.1 M MES buffer, pH 4.7. The procedure led to the activation of carboxyl 
groups on the anti-HFA antibody with EDC. The EDC-activated anti-HFA antibody was 
captured on the APTES-functionalized Au chip (previously described) for the covalent 
immobilization strategy.  
Similarly, PrA was also activated with EDC and captured on the APTES-functionalized Au 
chip surface for the orientated strategy. 
4.4.3 Immobilization of anti-HFA antibody 
For the random antibody non-covalent immobilization strategy, 50 µL of anti-HFA antibody 
(100 µg/mL) was injected over all the four flow cells of an APTES-functionalized Au chip 
at a flow rate of 10 µL/min and the baseline was allowed to stabilize. BSA (20 µL of 1% 
(w/v)) was subsequently used for blocking. 
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For the covalent immobilization strategy, 50 µL of the EDC-activated antibody (100 µg/mL) 
was injected over all the four flow cells of an APTES-functionalized Au chip, and BSA was 
used for blocking as previously described. 
For orientated immobilization strategy, 50 µl of the protein A (100 µg/mL) was injected 
over the four flow cells of piranha-treated Au chip at a flow rate of 10 µL/min. Twenty 
microliters of 1% (w/v) BSA was then injected for blocking.  After baseline stabilization, 50 
µL of anti-HFA antibody (100 µg/mL) diluted in 10 mM HBS, pH 7.4, was injected over all 
the flow cells at a flow rate of 10 µL/min.  
For the covalent-orientated immobilization strategy, 50 µl of EDC-activated PrA was 
injected over all four flow cells of an APTES-functionalized Au chip at a flow rate of 10 
µL/min. The chip was blocked with BSA, as previously described, followed by the addition 
of anti-HFA antibody. 
4.4.4 Covalent-CM5-dextran immobilization strategy 
A CM5 dextran-functionalized Au chip was docked into BIAcore 3000 and primed. Pre-
concentration studies were performed in order to obtain the optimum pH of the sodium 
acetate buffer for use with anti-HFA antibody immobilization (pH range of 4.0-5.0). Further 
activation was performed at a pH of 4.2 (optimum). Afterwards, the CM5-dextran chip was 
activated by injecting a 50 µL solution containing  200 µg of EDC and 550 µg of SNHS in 
0.1M MES buffer, pH 4.7, through all the flow cells at a flow rate of 10 µL/min. Thereafter, 
the procedure employed for the random immobilization strategy was used, with the 
exception that blocking was initially performed with 20 µL of 1M ethanolamine 
hydrochloride, pH 8.5, followed by 20 µL of 1% (w/v) BSA. Ethanolamine hydrochloride 
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(1M), pH 8.5, blocks the unreacted ester groups in the CM5-dextran matrix, while BSA 
blocks the non-specific binding sites on the chip surface. 
4.4.5 HFA-detection 
Fifty microlitres of the dilution buffer (10mM HBS, pH 7.4) was passed through all the flow 
cells before HFA capture and the resultant changes in the SPR response units (RU) for each 
of the four flow cells were recorded. Fifty microlitres of HFA at six different dilutions (0.6, 
1.2, 2.5, 5.0, 10.0 and 20.0 ng/mL) were then passed through the flow cells (sample volume 
was chosen arbitrarily). Subsequently, the RU values obtained for the blanks were 
subtracted from the RU values obtained for captured HFA of the corresponding flow cells.  
All the experiments pertaining to different immobilization strategies were repeated three 
times in triplicates and the standard deviation was calculated. The SPR-based HFA detection 
curves were plotted with SigmaPlot software, version 11.2 based on a four parameter 
logistic. The analytical parameters such as EC50 and Hillslope, generated by the software 
analysis report, were then used to evaluate the analytical performance [18] of SPR 
immunoassayswith the various antibody immobilization strategies. 
4.4.6 Complete regeneration of the APTES-functionalized gold surface 
4.4.6.1 Siloxane bond lysis by acid treatment and O2-plasma 
The functionalized chips were subjected to acid-lysis of siloxane bonds [19-21] by HCl. The 
acid-mediated lysis based regeneration was optimized using various HCl strengths (5, 10, 12 
and 15M), and exposure times (5, 10, 20 and 30 min). The O2 plasma etching was also 
optimized at three different plasma powers viz. 12, 20 and 29W at different exposure times 
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of 3, 6, 9, 12 and 15 min. Subsequently, the combined HCl and O2 plasma treatment 
procedure was optimized for Au surface regeneration. 
Thickness of the APTES layer on Au chip was measured using UVISEL spectroscopic 
ellipsometer. The measurements of psi (ψ) and delta (Δ) spectra were conducted at an 
incident angle of 70o over a wavelength range of 350-1000 nm. The silicon dioxide 
dispersion layer fitting model was then followed to determine the effective thicknesses of 
Au on glass, and of APTES on Au. This model was based upon fitting of the spectra on a 50 
nm thick gold layer deposited on a glass base. The silane layer thickness was then predicted 
with this model. Each thickness obtained was an average of 50 measurements of the 
thickness at each given point. 
Additional surface studies were performed using Rutherford backscattering (RBS) analysis. 
The APTES-functionalized SPR Au chip was loaded into the scattering chamber that was 
maintained under high vacuum conditions. A collimated beam of 2 MeV He+ ions, generated 
by a 3.5 MV HVEE Singletron accelerator, was normally incident onto the sample. The ions 
backscattered at 101.25° scattering angle were collected and their energy was measured by 
an Ortec Ultra silicon solid-state detector. The resultant spectra were fitted using the 
SIMNRA software. The total Si areal density for each sample was extracted from the target 
structure that provides the best fit for the respective spectrum.  
4.4.6.2 SPR-based HFA immunoassay procedure 
Anti-HFA antibody (990 µL of 100 µg/mL reconstituted in HBS) was incubated for 15 min 
at RT with 10 µL of the cross-linking solution containing EDC (4 mg/mL) and sulfo-NHS 
(11 mg/mL) in 0.1 M, pH 4.7 MES buffer. Later, 100 µL of the resulting EDC-sulfo-NHS 
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activated antibody solution was passed over the silanized Au chip at 10 μL/min to prepare 
anti-HFA antibody-coated chip. The anti-HFA antibody immobilized chip was then blocked 
using sulfo-NHS acetate, which reacts to free amino groups on the surface. This was 
followed by BSA-blocking in order to fill the void space on the chip thus, minimizing non-
specific protein adsorption on the surface. Subsequently, the HFA at 0.6 to 20 ng/mL 
dilutions was assayed on the anti-HFA antibody immobilized chips for 30 cycles of 
regeneration.  
4.4.6.3 SPR-based reproducibility analysis of antibody immobilization on the 
regenerated Au chips 
The SPR Au chip was regenerated by treatment with 12 M HCl for 10 min followed by the 
29 W O2-plasma treatment for 5 min. The regenerated Au chips were re-functionalized with 
APTES as described and immunoassay was performed. This cycle of regeneration and 
antibody immobilization for immunoassay development was repeated over 30 cycles.  
Surface properties such as hydrophilicity, amine-density and silane layer-thickness were 
monitored with contact angle, Rutherford back-scattering (RBS) and ellipsometry, 
respectively.   
4.5 Results and Discussion 
4.5.1 Comparison of antibody immobilization strategies as a function of antibody 
immobilization density 
The development of the APTES-functionalization of Au chips, used for various antibody 
immobilization strategies in this study, was optimized for APTES concentration, APTES 
functionalization time and APTES density (Figure 4.2).  
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Figure 4.2 Optimization of APTES functionalization of Au surface as a function of 
immunoassay performed for HFA detection with the anti-HFA antibodies immobilized on the 
surfaces exposed to (a) various concentrations of APTES; (b) Various incubation times of 
optimum APTES concentration (2% (v/v)); and, (c) APTES molecule density at different 
concentrations using Rutherford backscattering (RBS) method.  
 
The effect of employing various antibody immobilization strategies in a SPR immunoassay 
was initially observed by determining the immobilization density of anti-HFA antibody on 
the SPR chip. The highest and lowest anti-HFA antibody immobilization densities, as shown 
in Table 4.1, were obtained with covalent-CM5-dextran immobilization and random 
immobilization strategies, respectively.  The anti-HFA antibody immobilization densities 
were found in the decreasing order of covalent-CM5-dextran > covalent > covalent-
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orientated > orientated > random strategies (Figure 4.3a), which were qualitatively analysed 
with atomic force microscopy (AFM) (Figure 4.4), qualitatively.  
Table 1 Determination of molecular densities of immobilized anti-HFA antibody and 
detected amount of HFA when different SPR immunoassay formats, based on various 
antibody immobilization strategies, were employed.  
Antibody 
Immobilization 
Strategy 
Immobilization of anti-HFA antibody HFA***  
ΔRU Mass 
density* 
(ng/cm2) 
Molecular 
Density** 
(molecules/cm2) 
ΔRU Mass 
density* 
(ng/cm2) 
Molecular 
Density** 
(molecules/cm2) 
EC50 
(ng/mL) 
Random 816 .0± 11.7 81.6 ± 1.2 3.3 x1011 63.0 ± 16 6.3 ± 1.6 (0.9 ± 0.2) x1011 5.7 
Covalent 1536.0 ± 10.4 153.6 ± 1.0 6.1 x1011 149.0 ± 9.6 14.9 ± 1.0 (2.1 ± 0.1) x1011 3.8 
Orientated 1112.0 ± 9.6 111.2 ± 1.0 4.4 x1011 113.0 ± 10.5 11.3 ± 1.0 (1.6 ± 0.1) x1011 4.0 
Covalent-orientated 1457.0± 8.8 145.7 ± 1.0 5.8 x1011 194.0 ± 9.5 19.4 ± 1.0 (2.8 ± 0.1) x1011 3.7 
Covalent-CM5-
dextran 
1728.0 ± 12.4 172.8 ± 1.2 6.9 x1011 138.0 ± 10.4 13.8 ± 1.0 (1.9 ± 0.1) x1011 4.1 
Space here 
ΔRU: Change in resonance units (RU) caused by binding 
*Calculated using the commonly used conversion factor i.e. 1000 RU=100 ng/cm2 [13, 14].  
**Calculated by [Mass density (ng/cm2) / Molecular weight (in ng)]. Molecular weight of anti-HFA 
antibody and HFA were 150 kDa and 43.5 kDa, respectively. In order to calculate molecular weight 
in SI units, the conversion factor 1 kDa = 1000 Da = 1000 g was used. The molecular weight of anti-
HFA antibody and HFA are 24.9x10-11ng and 7.0x10-11ng, respectively. 
***Calculations were performed for the detection of 5 ng/mL of HFA i.e. the concentration just 
above the EC50.  
 
The immobilization densities were calculated using a conversion factor i.e. 1 ng/mm2 of 
biomolecule corresponds to a change of 1000 RU [22-24]. The lowest antibody 
immobilization density in the random immobilization strategy was attributed to the irregular 
and uncontrolled binding of the antibody over the surface mainly by electrostatic and 
hydrophobic interactions [23]. Additionally, many other factors, such as molecular 
spreading and inter-molecular interactions, may affect the immobilization-density of 
adsorbed antibodies at the interface [24, 25], which, in turn, determines the functionality of 
adsorbed antibodies [25]. However, the introduction of PrA molecules enables the orientated 
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immobilization of antibodies in a site-directed fashion. The anti-HFA immobilization 
density of the orientated immobilization strategy was greater than that of the random 
immobilization strategy as PrA binds very strongly to the Au surface, which is the main 
reason that it has been used extensively for biosensing applications in various biosensor 
formats.  
The capture ratio of 1:1 for anti-HFA antibody bound to PrA is in line with previous 
findings, which state that one PrA molecule can bind to a maximum of two antibody 
molecules based on conformational and intermolecular restrictions [26]. However, the anti-
HFA antibody immobilization density was lower than that of the covalent-orientated 
immobilization strategy. This might be because PrA molecules adsorbed in the orientated 
format still have a tendency to undergo conformational changes and/or leaching off the 
surface. The higher antibody immobilization density of the covalent-orientated strategy may 
be due to the fact that covalently bound PrA molecules could resist leaching whilst 
maintaining their active conformation for binding.  
The antibody immobilization density of the covalent strategy was higher than that of 
covalent-orientated strategy and this may be due to the fact that the total number of amino 
groups available for antibody crosslinking was significantly higher than the binding sites 
available on covalently immobilized PrA molecules. Therefore, there is a higher probability 
for an antibody to be directly crosslinked to the amino groups on the surface in comparison 
to binding in an orientated fashion to the covalently bound PrA molecules. 
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Figure 4.3 Analysis of performance of the antibody immobilization strategies. (a) anti-HFA 
antibody capture-density as a function of change in relative response units. Antibody was 
captured in an increasing order of random, oriented, cov-oriented, covalent and CM5-
dextran. (b) Capture efficiency analysis of immobilized anti-HFA antibody as a function of 
ratio of the amount of HFA captured and amount of antibody immobilized by the respective 
strategy. Highest amount of HFA was captured by the antibodies immobilized in cov-
oriented   format. (c) Performance of immunoassay for HFA detection (0.6-20 ng/mL) in 
each format. ‘Cov’ represents covalent. 
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Figure 4.4 Qualitative analysis of the surface for various steps of silane functionalization 
[bare Au (a), piranha activated Au (b), and APTES-coated Au surface (c)]. The surface 
analysis of antibody immobilized in various formats [random (d), oriented (e), covalent (f), 
and cov-oriented (g)] at a Z-scale of 150 nm in a scan area of 2 µm X 2 µm revealed that 
antibody distribution over the surface in oriented formats was highly uniform in comparison 
to non-oriented formats. Each section in main panel depicts an upside view numbered a-g 
and their corresponding 3D image. ‘Cov’ represents covalent. 
 
On the other hand, the covalent-CM5-dextran immobilization strategy had the highest anti-
HFA antibody density, which may be due to the fact that CM5-dextran has a long 
hydrophilic polymer chain with a large number of available carboxyl groups on the side 
chains. Moreover, apart from the increased effective surface area provided by the CM5-
dextran, electrostatic interactions of the positively-charged amino groups on anti-HFA 
antibody towards the negatively-charged carboxyl functional groups on the surface of CM5 
dextran can also occur.  
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Our results are very similar to the findings reported by Kausaite and collegues in 2010 [27], 
where it was observed that a carboxymethyl dextran hydrogel-based immobilization strategy 
had a very high antibody immobilization density in comparison to random and orientated 
immobilization strategies. Here the random immobilization strategy was based on the 
passive immobilization of antibodies on a self-assembled monolayer (SAM) formed by 11-
mercaptoundecanoic acid (MUA) whereas, the orientated immobilization strategy employed 
the capture of antibodies on the layer of covalently immobilized Protein G on the MUA 
SAM-functionalized surface. 
4.5.2 Comparison of antibody immobilization strategies as a function of HFA capture 
densities 
Anti-HFA antibodies bound to SPR Au chips, prepared by various antibody immobilization 
strategies, were employed for the detection of different concentrations of HFA (0.6-20.0 
ng/mL), as shown in Figure 4.3b. The blank for the assay was the running buffer i.e. 10 mM 
HBS, pH 7.4. The RU of the blank in each flow cell was then subtracted from the RU value 
corresponding to the detection of a particular concentration of HFA in that flow cell.  
All immobilization strategies used were evaluated using an HFA concentration of 5 ng/mL, 
which was the HFA concentration just above the EC50 of the random immobilization 
strategy. It was highest for the covalent-orientated strategy and lowest for the random 
strategy.  The mass densities of HFA detected by the various antibody immobilization 
strategies were in the decreasing order of covalent-orientated > covalent >covalent-CM5-
dextran > orientated > random. The EC50 of covalent-oriented strategy based anti-HFA 
bound SPR chip for HFA detection was also found to be the lowest (Table 4.1), which 
indicates that it was the most sensitive immunoassay format. The mass density of HFA 
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detected while using the covalent-orientated strategy was the highest of all the 
immobilization strategies employed. Conversely, the covalent-orientated strategy, which had 
a lower anti-HFA antibody mass density in comparison to the covalent-CM5-dextran and 
covalent strategies, had the highest response units for HFA capture and thus, the highest 
mass density. This clearly demonstrates that the total amount of antibody immobilized does 
not necessarily equate with maximum antigen (HFA) capture. The antigen-detection ability 
of adsorbed antibodies can be significantly compromised [24, 28]. It had been previously 
demonstrated that covalently-bound antibodies capture higher amount of antigen than 
adsorbed antibodies under the same set of conditions [3]. Therefore, the adsorption of 
antibodies can introduce certain conformational changes that may impact their antigen-
recognition behaviour, thereby ultimately resulting in reduced antigen detection. The results 
shown in Figure 4.3c demonstrate that the effectiveness of an immunoassay is clearly 
dependent on the antibody immobilization strategies. 
Our findings show that the covalent-orientated strategy, based on the binding of PrA to the 
chip and the orientated immobilization of capture antibodies, is ideal for the SPR-based 
immunoassay for HFA. There was no evidence of biofouling even after continuous HFA 
detection cycles or extended storage at 4ºC (Figure 4.5). 
4.5.3 Regeneration studies of the APTES functionalized Au surface 
Various silane-based Au surface modification strategies have been employed for 
immunoassays; however, their use for SPR applications is fairly recent [25, 29]. There are 
reports claiming the successful regeneration of thiol terminal silane-functionalized Au 
surfaces [30].  It was observed that strong acid treatment such as HCl can dissolve the 
siloxane bonds and remove upto the second APTES layer as the first APTES layer on the Au 
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surface was very strongly bound through Au- thiol interactions. 
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Figure 4.5 Analysis of the biofouling properties of functionalized Au surfaces to determine 
the any non-specific protein interaction with the surface over a period of 8 days at 4 oC. 
 
However, there was no critical assessment of reusability and functional characterization of 
SPR Au chip. In addition, HCl may also affect the homogeneity of Au coating. Here, a 
simple strategy, based on consecutive treatments with HCl and O2-plasma, for the complete 
regeneration of Au surface was developed.  
The regeneration studies, as depicted in schematic Figure 4.6, were performed on the Au 
chips that were (a) functionalized with APTES, and (b) bound to anti-HFA antibody after 
APTES-functionalization. The thickness of APTES self-assembled monolayer (SAM) and 
the areal density of APTES on the bare, silanized and regenerated Au chip surfaces were 
determined by ellipsometry and RBS, respectively (Figure 4.7a). 
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--- 12M HCl 10 min
--- UV cleaner  20 min/ O2 plasma 5 min
--- DIW wash
Regeneration of the surface (thickness = 0.7 nm)
Original APTES thickness with preparatory method 1 = 5 ± 1 nm  
Figure 4.6 Schematic representation of complete regeneration of the silane-functionalized 
Au surface by acid and/ or plasmolysis of the siloxane bonds. The surface was characterized 
with ellipsometry and Rutherford back scattering (RBS) analysis for detection of any 
residual APTES on the surface. 
  
Twenty chips were APTES-functionalized and different regions on each chip (four spots in 
the corner and one spot in the centre) were analyzed to assess the homogeneity of silane 
layer. A SAM thickness of 5 nm ± 1 nm was obtained in all the repeats. The thickness was 
calculated with the instrument software, which generates a differential reflection profile 
[designated as psi (ψ) and delta (Δ)] for each corresponding layer.  
The contact angle of water was obtained for the SAM of APTES on Au surface was 59o ± 
1o, which is consistent with previous findings [31]. The contact angle obtained for piranha-
treated bare Au was 25o, which was in agreement with previous reports that claimed the 
contact angle of cleaned Au in the range of 0-30o [32]. The regeneration of Au surface by 
the developed procedure was confirmed by RBS (Figure 4.7b) based on the absence of 
APTES signal on the regenerated SPR chip. XPS is routinely used for characterizing surface 
properties but due to poor spatial resolution and inability for absolute quantification of the 
species on the surface, the expected error would be less than 10%. Therefore, RBS was 
employed, which is capable of quantifying species to levels as low as 5%. XPS is useful 
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with thicker surface layers, but in this work 2-4 nm silane layers were only employed and, 
therefore, RBS, even with poor depth resolution was chosen to obtain silane layer 
quantification with less error. The areal density of APTES after APTES functionalization on 
the regenerated SPR Au chip was similar to that on the fresh SPR chip, which shows the 
complete regeneration of Au surface. During 30 consecutive HFA immunoassays, the areal 
density of APTES was highly-reproducible; this may imply that the developed regeneration 
procedure might not have any corrosive effect on the Au layer, hence maintaining its native 
surface properties.  
a b
 
Figure 4.6 (a) Evaluation of Au surface regeneration in SPR Au chips on the basis of 
thickness determination by ellipsometry. The data were recorded at 70o in the wavelength 
range of 300-1000 nm. A model was defined where gold on glass was used as the control to 
define the thickness of silane layer on 50 nm thick Au surface. Thickness values obtained     
were an average of 50 measurements at a given point. (b) Evaluation of areal density of 
APTES on bare, APTES-functionalized and regenerated Au surfaces by Rutherford back 
scattering (RBS). Error bars are standard deviation. 
  
The developed Au surface regeneration procedure was optimized by determining the 
appropriate strength and treatment time of HCl and O2-plasma (individually in the initial 
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stages, and in combination thereafter). Initially the efficiency of regeneration was assessed 
by treating with 5, 10, 12 and 15 M of HCl for varied duration i.e. 5, 10, 20 and 30 min. The 
treatment with 15 M HCl for 30 min was found to be most appropriate for regenerating 
down to 1.7 nm thickness (Figure 4.8a). However, the acid treatment does not regenerate 
the surface completely due to the role played by the respective anions generated by acid 
treatment in the dissolution of siloxane bonds [33]. These anions, such as hydroxyl (OH‾), 
sulfate (SO4‾2) and chloride (Cl‾), potentially destabilize the siloxane frame work in the 
presence of water. However, the acidic environment enhances the polymerization of silanes, 
which is responsible for incomplete regeneration. Therefore, our intial acid-treatment 
approach was followed by O2-plasma scrapping/ etching [34]. 
A plasma is a distinct yet complex state of matter, which is similar to a gas but contains 
ionized/charged species such as positive and negative ions and free radicals. Therefore, 
plasma can be described as an ionized state of gas where ionization can be achieved by 
exposing the gas to a strong electromagnetic field. The presence of considerable number of 
charges in plasma makes it suitable for various applications ranging from fusion power to 
plasma ashing. In addition, the nature of high energy charged particles and free radicals can 
be manipulated by breaking a specific gas such as oxygen, nitrogen and argon in plasma. 
Therefore, plasmas have the potential to break the molecular bonds of almost any solid 
support such as glass or polymers. Therefore, these plasmas have potential applications in 
surface chemistry and can be employed for regenerating the functionalized surfaces 
especially with an O2-plasma that contains highly reactive oxygen ions/radicals. The O2-
plasma discharges are known to ionize the siloxane bonds present in the liquid phase hence 
breaking the silanol bonds with surface [34]. Therefore, along with HCl treatment, O2-
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plasma was also incorporated. The O2-plasma scrapping was done at plasma strengths of 12, 
20 and 29W for 3, 6, 9, 12 and 15 min such that 29W O2 plasma treatment for 12 min was 
most effective and regenerated down to 1.3 nm thickness (Figure 4.8b).  
Finally, the surface regeneration was checked with various combinations of HCl and O2 
plasma. For the initial HCl treatment step, 12 M and 15 M HCl was used for 10, 20 and 30 
min; whereas, for the O2 plasma scrapping, 29W O2 plasma was employed for 5, 10, 12 and 
15 min. The complete regeneration of Au surface was obtained by treating it with 12 M HCl 
for 10 min followed by O2-plasma scrapping for 5 min, which completely removed the 
APTES coating. This was confirmed by the absence of silicon peak due to APTES 
functionalization on the Au surface by RBS. A negative ninhydrin test and a contact angle of 
28o cross-validated the absence of silane on the surface.  
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Figure 4.8 Optimization of siloxane bond lysis at various acid (HCl) (a) and O2 plasma (b) 
strengths as a function of exposure time (min). Thickness for each set was monitored using 
ellipsometry. Significant surface regeneration was obtained individually with 12 and 15M 
HCl strengths, and 29W plasma strength. However, complete surface regeneration was 
achieved with 12M HCl exposure for 10 min in conjunction with 29W plasma for 5 min. 
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The regenerated SPR Au chip was reused 30 times for SPR-based HFA immunoassay 
following the same bioanalytical procedure i.e. APTES-functionalization, anti-HFA 
antibody immobilization, HFA detection and surface regeneration. The reproducibility of 
APTES functionalization in each cycle was confirmed by ellipsometry and RBS, as 
discussed previously. The areal density of APTES after APTES functionalization was 
consistently uniform in each detection cycle. The immobilization density of anti-HFA 
antibody and the subsequent detection of HFA was also highly reproducible in each cycle, as 
confirmed by the SPR response (Figure 4.9).   
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Figure 4.9 Reproducibility of antibody immobilization and antigen detection on the SPR Au 
chip, which was reused 30 times after regenerating the Au surface using the developed 
procedure. The black dots correspond to the SPR signal obtained for anti-HFA antibody 
binding on the regenerated and re-functionalized Au surface whereas, the white dots 
represent the detection of HFA by anti-HFA antibody immobilized on such Au chip.  
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The percentage coefficient of variance in APTES functionalization, anti-HFA 
immobilization and HFA detection, during 30 consecutive HFA immunoassays on the same 
SPR chip after regeneration, were 3-5, 4-6 and 2-4%, respectively. The developed Au 
surface regeneration procedure completely regenerates the Au surface without affecting its 
surface properties. It has increased the cost-effectiveness of expensive SPR gold chip as the 
same SPR chip can be reused many times without any loss of activity.  
4.6 Conclusions 
A robust Au surface functionalization method was developed for SPR-based immunoassay 
applications. The developed strategy was optimized and employed to study the effect of 
various antibody immobilization strategies, i.e. random, covalent, orientated, covalent-
orientated and covalent-CM5-dextran, on the analytical performance of a SPR-based 
immunoassay for HFA. The highest anti-HFA antibody immobilization density was obtained 
with covalent-CM5-dextran, whereas the highest amount of HFA was captured with the 
covalent-orientated strategy. Therefore, the orientation of the antibody plays an important 
role in the analytical performance of the SPR immunoassay. The relative molar density of 
HFA detected, which corresponds to the functional antibody immobilization density, is a 
more reliable indicator of analytical performance than the total antibody immobilization 
density. Additionally, a novel strategy, based on the acid and/ or plasmolysis of the siloxane 
bonds, was developed to regenerate the APTES-functionalized Au surface completely 
allowing the reuse of same Au chip for performing multiple cycles of functionalization and 
immunoassay development.  
 
4.7 References  
 140 
 
1. Skottrup P, Hearty S, Frøkiær H, Leonard P, Hejgaard J, O'Kennedy R, Nicolaisen M, 
Justesen AF: Detection of fungal spores using a generic surface plasmon resonance 
immunoassay. Biosens Bioelectron 2007, 22(11):2724-2729.  
2. Stapleton S, Bradshaw B, O'Kennedy R: Development of a surface plasmon resonance-
based assay for the detection of Corynebacterium pseudotuberculosis infection in sheep. 
Anal Chim Acta 2009, 651(1):98-104.  
3. Dixit CK, Vashist SK, O'Neill FT, O'Reilly B, MacCraith BD, O'Kennedy R: 
Development of a high sensitivity rapid sandwich elisa procedure and its comparison with 
the conventional approach. Anal Chem 2010, 82(16):7049-7052.  
4. Vashist SK, O'Sullivan SA, O'Neill FT, Holthofer H, O'Reilly B, Dixit CK: Modified 
ELISA Plate. 2010, PCT/ IE2009/ 000072 (WO 2010/ 044083 A2).  
5. Snopok B, Boltovets P, Rowell F: Effect of the local environment and state of the 
immobilized ligand on its reaction with a macromolecular receptor. Theor Exp Chem 2006, 
42(4):217-223.  
6. Kausaite-Minkstimiene A, Ramanaviciene A, Ramanavicius A: Surface plasmon 
resonance biosensor for direct detection of antibodies against human growth hormone. 
Analyst 2009, 134(10):2051-2057.  
7. Danczyk R, Krieder B, North A, Webster T, HogenEsch H, Rundell A: Comparison of 
antibody functionality using different immobilization methods. Biotechnol Bioeng 2003, 
84(2):215-223.  
 141 
 
8. Gedig ET: Surface chemistry in SPR technology. In Handbook of Surface Plasmon 
Resonance. Ed. Richard BMS, Anna JT. RSC Publishing, Cambridge, UK; 2008: 173-218.  
9. Aslan K, Lakowicz JR, Geddes CD: Plasmon light scattering in biology and medicine: 
new sensing approaches, visions and perspectives. Curr Opin Chem Biol 2005, 9(5):538-
544.  
10. Yuan Y, He H, Lee LJ: Protein A-based antibody immobilization onto polymeric 
microdevices for enhanced sensitivity of enzyme-linked immunosorbent assay. Biotechnol 
Bioeng 2009, 102(3):891-901.  
11. Holmberg A, Blomstergren A, Nord O, Lukacs M, Lundeberg J, Uhlen M: The biotin-
streptavidin interaction can be reversibly broken using water at elevated temperatures. 
Electrophoresis 2005, 26(3):501-510.  
12. Svitel J, Boukari H, Ryk DV, Willson RC, Schuck P: Probing the functional 
heterogeneity of surface binding sites by analysis of experimental binding traces and the 
effect of mass transport limitation. Biophys J 2007, 92(5):1742-1758.  
13. Conti M, Falini G, Samorì B: How Strong is the coordination bond between a histidine 
tag and Ni+2 - nitrilotriacetate? an experiment of mechanochemistry on single molecules. 
Angew Chemie Int Ed 2000, 39(1):215-218.  
14. Dixit CK, Vashist SK, MacCraith BD, O'Kennedy R: Multisubstrate-compatible ELISA 
procedures for rapid and high-sensitivity immunoassays. Nat Protocols 2011, 6(4):439-445.  
 142 
 
15. Dixit CK, Vashist SK, MacCraith BD, O'Kennedy R: Evaluation of apparent non-
specific protein loss due to adsorption on sample tube surfaces and/or altered 
immunogenicity. Analyst 2011, 136(7):1406-1411.  
16. Palasantzas G, Svetovoy VB, van Zwol PJ: Influence of ultrathin water layer on the van 
der Waals/Casimir force between gold surfaces. Phys Rev B 2009, 79(23):235434.  
17. Pan L, Jung S, Yoon R-: Effect of hydrophobicity on the stability of the wetting films of 
water formed on gold surfaces. J Colloid Interface Sci 2011, 361(1):321-330.  
18. Kurtinaitiene B, Ambrozaite D, Laurinavicius V, Ramanaviciene A, Ramanavicius A: 
Amperometric immunosensor for diagnosis of BLV infection. Biosens Bioelectron 2008, 
23(10):1547-1554.  
19. Mitsyuk B: Mechanism of silica dissolution and state of silicic acid in hydrothermal 
solutions. Theor Exp Chem 1984, 19(5):554-559.  
20. Vasant EF, Voort P, Vrancken K: Characterization and chemical modification of the 
silica surface: Amsterdam. In Studies in surface science and catalysis Vol.93: Elsevier 
Science & Technology; 1995.  
21. Cypryk M, Apeloig Y: Mechanism of the acid-catalyzed si-o-si bond cleavage in 
siloxanes and siloxanols. a theoretical study. Organometallics 2002, 21(11):2165-2175.  
22. Jonsson U, Fagerstam L, Ivarsson B, Johnsson B, Karlsson R, Lundh K, Lofas S, 
Persson B, Roos H, Ronnberg I: Real time biospecific interaction analysis using surface 
plasmon resonance and a sensor chip technology. Biotechniques 1991, 11(5):620-627.  
 143 
 
23. Tang Y, Mernaugh R, Zeng X: Nonregeneration protocol for surface plasmon resonance: 
study of high-affinity interaction with high-density biosensors. Anal Chem 2006, 
78(6):1841-1848.  
24. Willard FS, Siderovski DP: Covalent immobilization of histidine-tagged proteins for 
surface plasmon resonance. Anal Biochem 2006, 353(1):147-149.  
25. Spencer MJS, Nyberg GL: Adsorption of silane and methylsilane on gold surfaces. Surf 
Sci 2004, 573(2):151-168.  
26. Jung A, Gronewold TMA, Tewes M, Quandt E, Berlin P: Biofunctional structural design 
of SAW sensor chip surfaces in a microfluidic sensor system. Sens Act B: Chem 2007, 
124(1):46-52.  
27. Kausaite-Minkstimiene A, Ramanaviciene A, Kirlyte J, Ramanavicius A: Comparative 
study of random and oriented antibody immobilization techniques on the binding capacity of 
immunosensor. Anal Chem 2010, 82(15):6401-6408.  
28. Snopok BA, Kostyukevich EV: Kinetic studies of protein surface interactions: A two-
stage model of surface-induced protein transitions in adsorbed biofilms. Anal Biochem 2006, 
348(2):222-231.  
29. Jung A, Gronewold TMA, Tewes M, Quandt E, Berlin P: Biofunctional structural design 
of SAW sensor chip surfaces in a microfluidic sensor system. Sens Act B: Chem 2007, 
124(1):46-52.  
 144 
 
30. Corrado DN (Ed): Proceedings of the Sensors and Microsystems: Proceedings of 8Th 
Italian Conference, Trento: 2004, World Scientific Publishing Co. Pte Ltd. Singapore. Pp 
45-69.  
31. Siqueira Petri DF, Wenz G, Schunk P, Schimmel T: An improved method for the 
assembly of amino-terminated monolayers on sio2 and the vapor deposition of gold layers. 
Langmuir 1999, 15(13):4520-4523.  
32. Smith T: The hydrophilic nature of a clean gold surface. J Colloid Interf Sci 1980, 
75(1):51.  
33. Bai S, Urabe S, Okaue Y, Yokoyama T: Acceleration effect of sulfate ion on the 
dissolution of amorphous silica. J Colloid Interf Sci 2009, 331(2):551.  
34. Leu GF, Brockhaus A, Engemann J: Diagnostics of a hexamethyldisiloxane/oxygen 
deposition plasma. Surf Coatings Technol 2003, 174-175:928.  
 
145 
 
 
 
 
 
Chapter 5 
Development of conjugates of Dye-doped 
Silica nanoparticle and anti-CD41 antibody 
for efficient platelet probing  
(Published in Langmuir, 2010, 26(17), 13741–13746) 
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5.1 Abstract 
Aminopropyltriethoxy silane (APTES)-based dye-doped silica nanoparticle (Si NP)-
functionalization strategy was developed that was intended to conjugate anti-CD41 antibody 
for imaging platelets. The functionalization of NIR664 dye-doped Si NP was optimized for 
duration of functionalization, APTES concentration to obtain maximum NP dispersion and 
stability. Various chemical and physical parameters were monitored using techniques like 
Fourier Transform infrared spectroscopy (FTIR), Zeta potential measurement, fluorescent 
lifetime correlation spectroscopy, transmission-electron, scanning-electron and confocal 
microscopy. Afterwards, a microtitre plate-based fluorescent immunoassay (FIA) was 
performed to characterize the assay potential of the developed NP-anti-CD41 antibody 
conjugates.   
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5.2 Introduction 
The use of fluorescence based nanoparticles (NPs) as high-brightness labels in the field of 
nanobiophotonics has potential in the broad area of clinical diagnostics [1]. The essential 
criterion to construct an efficient high-brightness label is the tuning of primarily two major 
properties (i) the brightness and (ii) the target specificity. Silica NPs have advantages such 
as high brightness compared to single dye molecule probes, tunability of size, ease of 
surface functionalization and relative biocompatibility. These properties are advantageous to 
design efficient bioassays with decreased limit of detection (LOD), [2] as well as the use of 
the NPs as cellular probes [3]. There are two main approaches to the synthesis of highly 
fluorescent silica NPs, the Stöber sol-gel process, [4] and the reverse micro emulsion [5] 
approach which is the approach used here. In our system, the near infrared dye, 4,5-Benzo-
5′-(iodoacetaminomethyl)-1′,3,3,3′,3′-pentamethyl-1-(4-sulfobutyl)indodicarbocyanine 
(NIR664) has been covalently encapsulated in the silica NPs by the micro-emulsion method. 
The cyanine-based dyes are very efficient sensors of chemical environment because of their 
strong fluorescence response to the hydrophobicity of the immediate microenvironment [6] 
that actually alters the equilibrium between the monomer and aggregate state of the dye, 
having distinct absorption peaks at 665 and 615nm, respectively. While encapsulated inside 
a nanoparticle, the dye is distributed in two distinct populations and thus any significant 
alteration at the immediate micro-environment of the dye doped nanoparticle, can be sensed 
by this dynamic equilibrium. 
The latter is achieved by functionalizing [7] the NP with appropriate surface chemistry that 
could facilitate the conjugation of the relevant ligand such as antibody to develop NP-based 
immunosensing [8, 9]. Standard conjugation strategies normally involve covalent linker-
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based attachment chemistry. Various surface functionalization strategies are available such 
as amination, carboxylation, thiolation and epoxylation particularly using silanization 
approach [10-12]. The approach used in this study was based upon the amine 
functionalization using aminopropyl tri-ethoxy silane (APTES) self-assembled layer (SAL) 
strategy [13]. The availability of free hydroxyl groups on the silica surface facilitates the 
reaction initiation of alkoxy groups with the hydroxyl of surface (Figure 5.1). Conversely, 
specificity of antibody-NP conjugates could be enhanced by monitoring the surface’s 
functional morphology and antibody’s leach-proof functional conjugation to NPs. Optimum 
conjugation is obtained when the layer containing functional groups on the surface is evenly 
distributed over the surface/highly-ordered, [8, 9] which enables the antibody capture with 
proper orientation maintaining a functional conformation so as to avoid steric hindrance of 
binding to the target antigen. 
Techniques like ellipsometry, [14, 15] Contact angle goniometry, [15] X-ray photoelectron 
spectroscopy (XPS) [16] are useful to measure the amine layer thickness on a flat surface, 
more popularly on the glass surface or silicon wafers [17]. But these techniques fall short for 
nanoparticle based systems because of the curved nature of the surface, along with 
possibility of NP agglomeration that could be recorded as the thickness. Therefore, Fourier-
transform infrared spectroscopy (FTIR) was used as a basic strategy to determine 
functionalization [18, 19]. To elucidate the dynamics of APTES-based amine layer growth 
on NPs, FTIR in conjunction with FCS and FLCS were also employed [20].  
5.3 Material 
NIR664 (1.6 mg), 1-hexanol (99%), Mercaptopropyltri-ethoxy silane (MPTES), Triton X-
100, cyclohexane,  hexanol, tetraethoxy silane, NH4OH, absolute ethanol (EtOH), 
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aminopropylotriethoxy silane (APTES) and anti-CD41 antibody were procured from Sigma 
Aldrich, Blessington, Co. Wicklow, Ireland. PBS (sachet), 1-ethyl-3-[3-
dimethylaminopropyl]carbodiimide hydrochloride (EDC), N-hydroxysulfosuccinimide 
(SNHS) and bovine serum albumin (BSA) were obtained from Thermo Fisher Ireland.  The 
formvar carbon-coated copper grids for TEM experiments were procured from Agar 
Scientific. 
 
Figure 5.1 A schematic representation of the amine-silanization reaction with the TEM 
image of the aminated NP having scale bar of 100 and 20nm length for the left and right 
image, respectively. Mechanism of APTES-mediated functionalization has been discussed in 
Chapter 2 in detail. 
5.4. Methods 
5.4.1 Synthesis of dye-doped NPs 
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The dye-doped silica nanoparticles were synthesized within our group and details could be 
found in the mentioned reference [21]. 
5.4.2 Amine-silanization of the NPs 
The kinetics study was performed in order to study silanization behaviour of APTES on 
NPs.  Silanization was performed with 2% (v/v) APTES prepared in absolute ethanol in a set 
of five different time points viz. 1, 2, 3, 5 and 12 h, considering non-functionalized NP as the 
control for this study (0 hr). Each sample set was fed with a starter batch of NP sample at a 
concentration of 10 mg/mL. Additionally, a set of NP functionalization with various amine 
concentrations was performed in order to find out the optimum working amine 
concentration. These NPs were subjected to 0.5, 1, 2, 3 and 4% APTES in absolute ethanol 
for the optimized period from the previous set of experiments, again with reference to un-
functionalized NPs as the control (0% (v/v) APTES).  
5.4.3 Bioassay performance to determine the efficiency of antibody-NP conjugation 
Aminated NPs were conjugated to anti-CD41 antibody produced in mouse by using 
conventional carbodiimide linker chemistry. NP (10 mg/mL) were incubated with 2% (v/v) 
APTES over five different durations that is 1, 2, 3, 5 and 12 h. The NP-APTES solution was 
continuously stirred for corresponding durations. Each set of NP-APTES solution was 
subjected to centrifugation (1260 X g) followed by washing with absolute ethanol (five 
times) and finally with 0.1M PBS (pH 7.2). The anti-CD41 (900 µL of 15 µg/mL in 0.1M 
PBS, pH 7.2) was incubated with a 100 µL pre-mixed solution of EDC (4 mg/mL) and 
SNHS (11 mg/mL) for 15 min at 37 oC. The resulting EDC-activated antibody solution was 
added to the APTES-functionalized NPs suspended in 0.1M PBS (pH 7.2) and incubated for 
1 h at RT. The IgG-conjugated NP solution was washed five times with 0.1M PBS, pH 7.2. 
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The platelet (obtained as a donation from healthy subject at School of Nursing, DCU) was 
physisorbed in chemically-activated microtitre plate [22] wells by incubating for 2 h at 37 
oC. Afterwards, the plate wells were washed five times with 0.1M PBS (pH 7.2) and blocked 
for 30 min with 1% (v/v) BSA in 0.1M PBS, pH 7.2 at 37oC. The plate was washed five 
times with PBS. The anti-CD41-conjugated NPs were incubated in the corresponding plate 
wells for 1 h at 37 oC followed by five PBS washes. The fluorescence was recorded using 
Tecan Safire2 monochromator-based microplate reader (Tecan GmBH, Austria) at 
excitation and emission wavelengths of 660 and 700 nm, respectively. Relevant controls 
were employed for each study. 
5.4.4 Characterization of the aminated NPs 
5.4.4.1 Zeta potential for the measurement of interfacial charge 
Zeta potential for the aminated samples was measured by a Beckman Coulter Instrument by 
using the flow cell. The averages obtained from three measurement sets were analyzed by 
the DelsaNano software in the result section where each measurement was the average of 50 
individual measurements performed at various positions (10 measurements each in 5 
positions) in the flow cell that is set as default. However, size of the NPs could also be 
measured using the same instrument but with dynamic light scattering (DLS) settings. 
5.4.4.2 Fourier Transform Infra Red spectroscopic studies 
Liquid FT-IR (Thermo Nicolet Corporation, Madison, USA) was used to characterize the 
chemical nature of the functionalization on  the NPs. NPs were re-suspended in two sets, 
one in absolute ethanol and the other in toluene at a concentration of 2 mg/ml in both cases. 
This was done in order to assess the effect of the solvent-based environment on the FT-IR 
spectral analysis. The functionalized samples from each set were subjected to FT-IR and 
152 
 
transmittance (%T) was recorded. The measurements were baseline-corrected with 
corresponding solvents. All these samples were later analyzed using various peaks in the 
transmission spectra. 
5.4.4.3 Miscellaneous physical characterization 
For UV-visible spectroscopy, a Cary 50 scan UV-visible spectrophotometer (Varian) was 
used. For fluorescence spectroscopy, a Fluoromax spectrophotometer was used.  Regarding 
TEM measurement, a Hitachi 7000 transmission electron microscope was operated at 
100kV. Image capture was performed digitally by a Megaview 2 CCD camera. Specimens 
were prepared by putting a drop of the ethanolic solutions of the nanoparticles on to a 
formvar carbon-coated copper grid. In conjunction with all these techniques, ninhydrin 
assay was also employed to determine the amination of the NPs. 
5.4.5 Antibody conjugation to the nanoparticle and characterization 
Bicinchoninic acid (BCA) assay of protein estimation was employed to characterize the 
antibody conjugation to the NPs and to quantify the amount/ number of antibodies on the 
NP surface. Fresh BCA solution was prepared according to the manufacturer’s 
recommendations. A known weight of antibody-NP conjugate was reconstituted in water 
and freshly prepared BCA solution was added to it in recommended ratio and the sample 
was incubated at 37 oC for 1 h. Additionally, anti-CD41 that was serially half-diluted from 
20 µg/mL to 20 ng/mL was also subjected to the BCA assay under the same conditions. The 
solution containing antibody-NP conjugates incubated in BCA was centrifuged (1260 X g) 
in order to obtain BCA solution without NPs. Later, conjugates and standard anti-CD41 
samples were subjected to spectrophotometry at a wavelength of 562 nm. A calibration 
curve was prepared with the standards such that at least five antibody dilutions are in the 
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linear range of the curve. The absorbance obtained for conjugates was then plotted on the 
standard curve in order to deduce the exact concentration of antibody that was conjugated to 
nanoparticle. The obtained concentration of antibody was then converted into the number of 
molecules in the given mass. Additionally, based on the mass density of silica in NPs, 
average volume and weight of the NP subjected to BCA assay, the number of Si NP was 
calculated. Therefore, an approximate number of anti-CD41 antibody per NP can be 
calculated as a ratio of total number of antibody present in the given sample and NPs. 
5.5 Results and Discussion  
Silica NPs were employed for this study because they are easy to develop. The current Si 
NP development methods also allow manipulation of NP morphology, such as size and 
shape. In addition, the most important property of these Si NPs is that there is a plethora of 
strategies to conjugate high-efficiency dyes to the core or surface of these NPs, which 
significantly increases their application. 
5.5.1 Zeta potential measurement to measure surface charge 
During the amine-silanization reaction of the NPs by APTES, the negative charge of Si NPs 
was replaced by a positive charge due to the presence of amine groups. This charge 
transition on the nanosurface can effectively be measured as zeta potential. The zeta 
potential results are shown in Figure 5.2a. The unmodified nanoparticle shows an average 
zeta potential of -35.8 mV.  The NP sample collected after 1 h of incubation with APTES 
shows a sharp increase of the zeta potential value to -8 mV. It continues to increase until it 
reaches saturation at 3 hr with a much higher positive value of over +35 mV signifying the 
stable deposition of the amine group all over the surface of the NPs. Additionally, higher the 
numerical value of the zeta potential of NPs, higher will their stability in a given solvent. 
However, although this technique is straightforward enough to report the effective 
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deposition of the positively charged amine groups on the negatively charged silica 
nanosurface, the finer details of the APTES deposition and the formation of the amine 
monolayer and cross linked super structures cannot be elucidated. The reason is attributed to 
the fact that upon reaching a critical value of the zeta potential (saturation point), any further 
conjugation of APTES to the nanosurface is involved in either cross-linking or 
intermolecular hydrogen bondings engaging the primary amine groups with -OH groups 
(nanosurface silanol group or –OH groups of surface attached APTES molecules) and thus 
limiting a further increase of positive zeta potential value. 
 
Figure 5.2.  (a) A plot of incubation time for APTES with aminated NP suspension versus 
the zeta potential, and (b) FTIR spectra for the same samples where the inset shows peak 
shift versus time of amine-silanization. 
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5.5.2. Confirmation of the amine-functionalization of silica nanoparticles by Fourier 
Transform Infra Red spectroscopic measurement  
FTIR has been performed in two solvents, ethanol and toluene, to investigate two different 
aspects of the silica nanosurface. In ethanol, the emphasis is given towards the replacement 
kinetics of the silanol (Si-OH) group by the amine group as a result of the siloxane bond 
formation and deposition of the protonated amine group on the nanosurface. In the toluene 
environment, however, the fine structure of the surface stabilized amine groups has been 
studied to make a detailed account of the whole process as there is no interference from the -
OH groups of the ethanol. Firstly, in the presence of ethanol the overall amine-silanization 
process was studied by following the gradual disappearance of the surface siloxane (Si-OH) 
bond and the corresponding appearance of the amine group for the NPs suspended in 
ethanol. Both the hydroxyl and amine groups are closely placed at the far end of the FTIR 
spectrum from 3300 to 3600 cm-1 signified by a broad peak in this region. But, there was a 
significant kinetic effect to monitor the amine-silanization by assessing the shift of the peak 
value of the broad peak from 3350 cm-1 to 3337 cm-1 as observed in Figure 5.2b (and inset).  
When this value of the wave number for the corresponding peaks was plotted against the 
time of NPs incubation with APTES, time kinetics was obtained showing saturation after 3 h 
which is shown in the inset of Figure 5.2b. Hence, like the zeta potential measurement, 
FTIR indicates saturation kinetics after 3h of reaction. 
FTIR studies performed on the NPs suspended in toluene have shown several fine structures 
arising from the amine groups attached to the nanosurface and the attachment between the 
silica surface and the APTES moiety. Therefore, all subsequent FTIR characterizations were 
performed in toluene. The FTIR spectrum has been divided in two major parts to analyse the 
kinetics; the first segment to be discussed is the region between 1200 and 1800 cm-1, which 
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deals with various responses from the amine groups and the second region spans from 900 
to 1200 cm-1, which mainly deals with the covalent attachment of the silica surface with the 
APTES.  Figure 5.3a shows the response of the 900 to 1200 cm-1 region. Its depicted in the 
FTIR curve, appearance of the 1110 cm-1 peak indicates that Si-O bonds began to form from 
the first hour of reaction. But, the effective conjugation has started from the 2nd h of the 
reaction with the appearance of the conjugation peaks like Si-O-Si at 1030 cm-1 and ethoxy 
group (-OCH2CH3)  at 1080 cm-1. Looking at the reaction steps of the amine-silanization 
given in the cartoon in Figure 5.3b, it is evident that the first step is the conjugation of 
surface –OH group with the hydrolyzed APTES which is followed by Si-O-Si bond 
formation between surface-attached APTES molecules to form the amine monolayer. This 
agrees well with the data. It can be seen that the rate of Si-O-Si peak formation is much 
higher up to the 3 h. For the NPs with higher APTES incubation time (i.e. 5 and 12 h) there 
is a steep increase of the ethoxy group (-OCH2CH3) at 1080 cm-1 signifying incomplete 
hydrolysis of APTES and significant increase in siloxane groups (Si-O-Si) at 1110 cm-1 
implying cross linking between the surface bound and free APTES leading to multiple 
inhomogeneous layers of amine groups on the nanosurface. In addition, the broad shoulder 
starting from 1125 cm-1 signifies the polymerized and/or physically adsorbed APTES on the 
nanosurface that is very prominent in the 12 h incubation sample.  A cartoon based on these 
detailed features during the amine-silanization process is presented in Figure 5.3b. In order 
to study the detailed amine group kinetics during this amine-silanization reaction the 1200 to 
1800 cm-1 spectrum of the aminated NPs was studied in detail and is shown in Figure 5.4.  
The characteristic FTIR peaks of the amine groups have been identified in detail. The 
asymmetric and symmetric deformation modes of amine groups due to the surface adsorbed 
APTES molecules have been observed at 1610 and 1510 cm-1 respectively. These two peaks 
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originate from the interaction between the acidic silanol group on the nanosurface and basic 
amino group of the APTES.   
 
Figure 5.3.  (a) The FTIR signature of the aminated NP (suspended in toluene) for various 
reaction times for the 900-1200 cm-1 region is described to show the conjugation of APTES 
on the nanosurface, and (b) based on that, a diagram is presented to depict the APTES 
deposition as a function of reaction time. 
The deformation modes of amine groups at 1575 and 1493 cm-1, which appear due to the 
hydrogen bond formation by the amine group presumably with atmospheric carbon dioxide, 
increase with the time of APTES incubation and show significantly higher density in the 12 
h aminated NPs, with the 1575 cm-1 band showing a more significant increase. The physical 
nature of the interaction is evident from the ω(CH3) mode, i.e. the –CH3 wagging mode of 
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the APTES backbone at 1300cm-1. The two distinct peaks at 1440 and 1390 cm-1 represent 
the asymmetric and symmetric deformation mode for the methyl (-CH3) groups from the 
ethoxy group (-OCH2CH3) of the APTES indicating the incompleteness of the hydrolysis.    
 
Figure 5.4.  The FTIR signature of the aminated NP (suspended in toluene) for various 
reaction times for the 1200-1800 cm-1 region is described to show the evolution of various 
populations of amine peaks. 
 
5.5.3 Antibody conjugation and bioassay performance  
The optimum reaction time for NP surface amine-silanization has been validated by 
assaying the antibody conjugation efficiency of the aminated NPs. The anti-CD41-NP 
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conjugates prepared with NPs of reported functionalization durations were incubated with 
platelet-adsorbed microtitre plate wells and characterized for their conjugation efficiency as 
a function of the fluorescence intensity (of the conjugated dye NIR664) at 694nm upon 
excitation at 660nm. 
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Figure 5.5 A plot of NP fluorescence at 694nm (excited at 660nm) versus amine-silanization 
time is shown for a plate based direct binding assay that reports the binding between 
surface attached IgG and anti-IgG conjugated with the aminated NP.  
  
The dependence of antibody binding on the ordering of the amine layer deposited on NP is 
depicted in Figure 5.5 shows. The plot of fluorescence intensity vs. time of amine-
silanization for the NPs shows an increase of the intensity up to 3 h reaction time followed 
by a steady decrease for longer times. Therefore the maximum antibody attachment occurred 
on the NPs having the 3 h amine-silanization. This shows the importance of monolayer of 
functional groups on a nanosurface for biomolecular conjugation. 
For the 5 and 12 h amine-silanization sample, the multiple layering of cross linked APTES 
poses a marked inhibition for antibody attachment compared to the 3 h data. Firstly, during 
the longer time of amine-silanization reaction it is likely that the primary amine group of the 
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nanosurface bound APTES molecule can interact with the hydroxyl group of unbound 
APTES molecule via hydrogen bonding. Furthermore, the reverse interaction, i.e. hydrogen 
bond formation between the hydroxyl group of the surface bound APTES molecule and the 
primary amine group of a nearby unbound APTES molecule can significantly limit the 
number of free primary amine groups in spite of the longer extent of APTES exposure. In 
addition to that, the steric hindrance posed by the bulky amine layer composed of a cross-
linking-driven mesh structure is likely to restrict the antibody attachment.  
The optimum antibody-NP conjugate that was obtained from various characterization 
strategies performed was also characterized by visualizing under SEM (Figure 5.6) and 
confocal microscopy (Figure 5.6 d, e) for its specificity of labelling, distribution across the 
platelet and imaging performance. The data obtained indicate a highly non-homogeneous 
distribution of the conjugates across the platelet surface particularly along the periphery 
where the distribution of CD41 is reported to be dense. However, the agglomeration was 
found prominent in few instances, suggesting a poly-dispersed conjugate population. Further 
work is under investigation in order to obtain better poly-dispersity. On the contrary, 
conjugates were found highly specific to platelets as indicated in the confocal micrographs 
(Figure 5.6 d, e). 
5.6 Conclusion 
This work has successfully demonstrated the optimization of functionalization of Si NP and, 
most importantly, the use of FL and FCS to monitor the surface modification process of 
silica NPs in conjunction with conventional techniques like zeta potentiometry and FTIR 
spectroscopy. An optimum reaction time of 3 h was found suitable to functionalize Si NP 
with APTES. This could be a generic regimen for all types of silane, as the underlying 
chemistry of silanization will remain the same. However, other contributing factors such as 
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the chemistry involved with functional groups of silanes like amine, thiol or carboxy may 
have some impact. Further experimentation is required to solve the surface-associated 
agglomeration of conjugates in order to improve dispersion of these NP conjugates in 
solution. 
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Figure 5.6 Scanning electron micrographs illustrating (a) a platelet; (b) and (c) the 
interaction of anti-CD41-NP conjugates of the same stock with the platelet. The strong 
agglomeration tendency as depicted in ‘c’ micrographs indicates that further optimization 
of the conjugates is required to improve the solubility and dispersion in optimized PBS 
strength and pH. (d, e) A confocal micrograph of platelet imaging tendency of the NP- anti-
CD41 antibody conjugates. Horizontally, upper panel depicts the control NPs conjugated to 
mouse IgG that is not targeted for CD41, whereas, the lower panel illustrates the anti-
CD41-conjugated NPs, which are specifically labeling the platelet. Vertically, left, central 
and right panels correspond to imaging in the red and green component channels in order 
to abnegate the auto-fluorescence of platelets. 
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Chapter 6 
Analysis and reduction of process-induced 
aggregation of NIR-664 dye-doped silica 
nanoparticles 
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6.1 Abstract 
NIR664 dye-doped silica nanoparticles (Si NP) were intended to be employed for probing 
platelets under various physiological conditions. However, aggregation was observed in 
aminopropyltriethoxy silane (APTES)-functionalized NPs after optimization of silanization 
conditions as described in Chapter 5. Therefore, aggregation susceptibility as a function of 
zeta potential was studied for unfunctionalized, amine and carboxy-functionalized NPs 
under various physico-chemical conditions such as nature of the solvent, ionic strength of 
the dispersion medium and pH. In addition, impact of antibody cross-linking with the 
functionalized NPs was also analysed. A consistent relation was obtained for salt strength 
and pH of the solvent. However, zeta potential of the antibody-cross-linked NPs was highly 
variable without any chemical or physical surface blocking. Conversely, no significant 
improvement could be registered even after chemical blocking with ethylenediamine (EDA) 
followed by physical blocking with BSA. 
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6.2 Introduction 
Nanoparticles (NPs) in the form of homogenous solutions have numerous applications in the 
field of biomedical diagnostics and therapeutics [1-3]. However, the tendency of 
nanoparticles to aggregate has imposed restrictions to their applications in solvent [2, 4]. 
This aggregation is governed by multiple factors and most critical are the chemical and 
physical nature of these NPs. In a given system the stability of bare (unfunctionalized) NPs 
is predicted as a function of overall charge (Figure 6.1), which is an inherent property of the 
nanoparticle, such that the higher the charge the more stable and dispersed will be the 
system [5].  
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Figure 6.1 Representation of charge distribution along various planes surrounding the NP 
and origin of zeta potential. Adapted from Somasundaram et al. (2009) [5]. 
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The chemistry and surface properties of nanoparticles are affected by the surrounding 
chemical environment. Therefore, the overall charge-based stability might be compromised 
resulting in NP aggregation. Many novel surface modification strategies have been 
developed that claimed to minimize the aggregation behavior of NPs [4, 6-9]. Conversely, 
there are various interactions that prevail in the functionalized nanoparticles. Examples of 
such interactions could be inter-nanoparticle hydrogen bonding, hydrophobicity of the 
nanoparticle core, bipolar interface (shear plane; Figure 6.1) and others [10]. We speculate 
that the nanoparticle functionalization also introduces multivalency to the existing 
interactions by replicating the total number of reactive chemical species on the surface of 
nanoparticles. This aggregation model becomes more complicated when proteins are 
captured on the functionalized nanoparticles by chemical methods. A native antibody 
(model protein), which is not chemically modified, has multiple amine and carboxyl groups 
on its surface. Therefore, an antibody activated for either of these functional groups will 
have multiple activated sites, which increases the possibility of an antibody interacting with 
multiple nanoparticles. This could result in large aggregates of antibody-nanoparticle 
conjugates. In addition, this aggregation pattern will be more complicated if the activated 
antibodies react with other such antibodies prior to reacting with the functionalized 
nanoparticles in a multiple-nanoparticle binding behavior [10]. 
This study attempts to develop a better understanding of the aggregation behavior of the 
NIR664 dye-doped silica nanoparticles having an average size of 95 ± 5 nm with the final 
aim of using these nanoparticles for probing platelet surface markers [11]. Bare and 
functionalized (carboxy and amine) nanoparticles were subjected to different physical 
environments i.e. pH and ionic strengths of phosphate buffer. The effect of antibody 
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crosslinking with the amine and carboxy-functionalized nanoparticles was also analyzed 
along with assessing the effect of physical and chemical surface blocking of the antibody 
conjugated nanoparticles. Further, an attempt was also made to reduce the heterogeneity in 
the size distribution of antibody-nanoparticle conjugates by gradual centrifugation. A 
method was attempted for separating out the aggregates from other antibody-conjugated 
nanoparticles as a function of centrifugal force and time.  
6.3 Materials  
NIR664 (1.6 mg), 1-hexanol (99%), Mercaptopropyltri-ethoxy silane (MPTES), Triton X-
100, cyclohexane,  hexanol, tetraethoxy silane, ammonium hydroxide (NH4OH), absolute 
ethanol (EtOH), aminopropylotriethoxy silane (APTES) and anti-CD41 antibody were 
procured from Sigma Aldrich, Blessington, Co. Wicklow, Ireland. PBS (sachet), 1-ethyl-3-
[3-dimethylaminopropyl]carbodiimide hydrochloride (EDC), N-hydroxysulfosuccinimide 
(SNHS) and bovine serum albumin (BSA) were obtained from Thermo Fisher Ireland.   
6.4 Methods 
6.4.1 Defining aggregation tendency in terms of zeta potential 
There is no direct measurement of nanoparticle aggregation. However, by measuring the 
surface charge properties and the nature of surface functional groups, the stability of the 
nanoparticle core could be predicted. This is a highly probabilistic approach that could have 
strong variability associated with it. 
Therefore, zeta potential was employed as an indicative marker for the stability of the NPs. 
Zeta potential is the interfacial voltage or difference in the electrical potential of the solvent 
medium in bulk phase (dispersion media) that is interacting/ attached to the surface of 
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dispersed NPs. This is an absolute property associated with a given colloidal system. NP 
stability, on the basis of zeta potential, is defined as in Table 6.1 [12].  
Table 6.1 Stability characteristics of colloidal particles as a function of zeta potential 
Zeta potential (mv) Stability characteristics 
± 10 Highly instable (rapid aggregation) 
± 10-30 Instable (slow flocculation) 
± 30-40 Moderate stability (high solvent dependence) 
± 40-60 Stable 
Above ± 60 Highly stable 
 
6.4.2 Nanoparticle functionalization 
Prior to functionalization, NIR664 dye-doped silica nanoparticles were centrifuged and dried 
under a stream of nitrogen to evaporate any traces of solvent (ethanol). Afterwards, 
nanoparticles were weighted and a concentration of 20 mg/mL was prepared in the desired 
solvent as will be described. The optimization of silane-mediated functionalization of 
NIR664 dye-doped silica nanoparticles has already been reported from this laboratory [11]. 
6.4.2.1 Functionalization with amino-silane 
NPs were functionalized according to the protocol described (Chapter 5, section 5.4.2, page 
150). NPs, at a concentration described previously, were incubated in a solution of 3-
aminopropyltriethoxy silane (APTES) (2% (v/v) in 90% (v/v) ethanol with deionized water) 
for 3 h. The functionalized NPs were washed five times with ethanol by repeated 
centrifugation. Functionalized nanoparticles obtained after the last wash were stored in 
ethanol for further analysis.  
6.4.2.2 Functionalization with carboxy-silane 
Nanoparticle stock was dissolved in deionized water because of the insolubility of carboxy 
silane in ethanol. Similar to amine functionalization, the dispersed nanoparticles were 
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incubated with carboxyl silane (2% (v/v)) for a period of three hours. These nanoparticles 
were also processed accordingly and were stored in ethanol.   
6.4.3 Storage stability 
6.4.3.1 Effect of solvent 
Bare, amine and carboxy-functionalized NPs were incubated in DIW and ethanol along with 
three different saline strengths of PBS (viz. 1, 10 and 100mM), pH 7.2. These solvents were 
selected on the basis of their use in the preparatory phases of the NPs and antibody-NP 
adducts.  
6.4.3.2 Effect of NP incubation at different pHs  
In order to study the effect of pH, bare and functionalized (amino and carboxy) NPs were 
incubated in DIW at pH 4, 7 and 10. The zeta potential was recorded after 24h of sample 
incubation. 
6.4.3.3 Effect of antibody cross-linking strategy and surface blocking methods  
In order to assess the effect of antibody immobilization strategy and surface blocking 
method of the antibody-conjugated NPs on their storage stability, two different schemes 
namely carboxy silane and amine silane-based functionalization, were performed (Figure 
6.2). Functionalized NPs were subjected to antibody conjugation.  
6.4.3.3.1 Amine surface blocking strategy for antibody-cross-linked-amine-
functionalized NP adducts 
Three different surface blocking strategies were employed for this study. Those were (i) 
physical blocking of surface with 1% (w/v) BSA in 1mM PBS, pH 7.2, (ii) chemical 
blocking of EDC-activated anti-CD41 antibody with ethylenediamine (EDA), and (iii) 
chemical blocking with EDA followed by surface blocking with BSA. The anti-CD41 
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antibody (900 µL of 15 µg/mL diluted in optimized buffer strength of PBS (pH 7.2) was 
incubated with a 100 µL pre-mixed solution of EDC (4 mg/mL) and SNHS (11 mg/mL) for 
15 min at 37 oC. The resulting EDC-activated antibody solution was added to the APTES-
functionalized NPs (15 mg/mL), suspended in optimized buffer strength of PBS (pH 7.2) 
and incubated for 1 h at RT with continuous mild stirring. This antibody-conjugated NP 
solution was then washed five times with optimized buffer strength of PBS, pH 7.2, by 
repeated centrifugation (750 X g). Afterwards, the antibody-NP adduct was dispersed in 
optimized buffer strength of PBS, pH 7.2. 
The prepared solution of antibody-conjugated NP was then incubated with 1% (w/v) BSA in 
PBS for 2h with continuous mild stirring. This solution was then washed as described and 
stored for further study. However, for chemical blocking experiments, after allowing cross-
linking of EDC-activated antibody with NPs for 10 min, 10 µL of EDA diluted in four 
different molar concentrations (viz. 50, 10, 0.1 and 0mM) was added to the reaction mixture. 
This reaction solution was allowed to further cross-link for 1h with continuous mild stirring 
followed by washing (centrifugation at 750 X g). A fraction of EDA-blocked solution was 
stored for further analysis; whereas, the other fraction was incubated with 1% (w/v) BSA as 
per the description.  
6.4.3.3.2 Carboxy surface blocking strategy for antibody-cross-linked-carboxy-
functionalized NP adducts 
Similarly, all the three described surface blocking strategies were also employed for 
carboxy-functionalized NPs. Those were physical blocking of surface with 1% (w/v) BSA in 
optimized buffer strength of PBS, pH 7.2, chemical blocking of EDC-activated carboxy-NPs 
with ethylenediamine (EDA), and chemical blocking with EDA followed by surface 
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blocking with BSA. The carboxy groups on the functionalized NPs (1.8 mL of 15 mg/mL) 
were activated by incubating with 200 µL EDC (4 mg/mL) and SNHS (11 mg/mL) for 15 
min at RT with continuous mild stirring. The EDC-activated nanoparticles were centrifuged 
at 750 X g for 15 min in order to remove any unreacted excess EDC. These EDC-activated 
NPs were reconstituted in optimized buffer strength of PBS, pH 7.4 and anti-CD41 antibody 
(900 µL of 15 µg/mL) was added to it and incubated for 1 h at RT with continuous mild 
stirring. This antibody-conjugated NP solution was then washed with PBS (optimized buffer 
strength), pH 7.2, for five times by repeated centrifugation (750 X g). Afterwards, the 
antibody-NP adduct was dispersed in optimized buffer strength of PBS, pH 7.2. 
The prepared solution of antibody-conjugated NP was then incubated with 1% (w/v) BSA in 
PBS for 2h with continuous mild stirring. This solution was then washed as described and 
stored for further study. However, for chemical blocking experiments, after allowing cross-
linking of EDC-activated NPs with antibody for 10 min, 10 µL of EDA diluted in four 
different molar concentrations (viz. 50, 10, 0.1 and 0mM) was added to the reaction mixture. 
This reaction solution was allowed to further cross-link for 1h with continuous mild stirring 
followed by washing (centrifugation at 750 X g). A fraction of EDA-blocked solution was 
stored for further analysis; whereas, the other fraction was incubated with 1% (w/v) BSA as 
per the description.  
6.4.4 Characterization of NP stability using Surface charge (zeta potential) 
measurement 
Zeta potential for the aminated samples was measured by a Beckman Coulter Instrument by 
using the flow cell. The averages obtained from three measurement sets were analyzed by 
the DelsaNano software in the result section where each measurement was the average of 50 
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individual measurements performed at various positions (10 measurements each in 5 
positions) in the flow cell that is set as default. 
6.5 Results and Discussion 
Stability of a colloidal system is described according to the DLVO theory [5]. According to 
this theory the stability of a colloidal system is dependent on the extent of attractive van der 
Waals and repulsive electrical double layer forces. These two forces predominantly govern 
the intermolecular interactions of NPs in Brownian motion. Therefore, the higher the double 
layer forces the better will be the dispersion of NPs in the colloid. Unfunctionalized Si NPs 
have a net negative charge of -35 to -60 mV, which indicates that strong repulsive double 
layer forces are significantly higher in comparison to the van der Waals interaction. 
Therefore, the unfunctionalized NPs are highly stable. In addition, size of the NPs is also a 
critical parameter in governing their stability. NPs having a smaller size have lower surface 
area to charge ratio, which indicates that high amount of charge is distributed over a smaller 
double-layer, indicating better dispersion and stability. NPs employed in this study are 
moderately sized (~ 95 nm) and therefore these have a moderate stability as also indicated 
by their zeta potential (~ -35 mV). However, after functionalizing a NP with carboxy or 
amine groups, the surface charge distribution is significantly changed. This causes a 
disruption of the pre-existing double layer forces. In this study, the effects of various factors 
that NPs are exposed to, during various preparatory phases, are assessed to determine their 
stability as a function of their respective zeta potentials.  
6.5.1 Effect of solvent  
The nature of a solvent governs the strength of double layer forces at the interface of solvent 
and NP [13-15]. The zeta potential obtained for NPs incubated in DIW, ethanol and three 
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saline strengths of PBS, pH 7.2 is shown in Figure 6.2.  The zeta potential obtained for 
unfunctionalized NPs suspended in DIW and ethanol was not significantly different; 
whereas, a significant shift toward positive scale was obtained for all the samples incubated 
in PBS, regardless of the salt concentration. The rationale to this significant increase in the 
zeta potential of the Si NP samples in PBS may be the disruption of the double layer at the 
interface due to the presence of additional salt-induced charges [16]. 
Following the concept of planes (i.e. shear and stern planes) in the measurements of zeta 
potential, the charge density around the NP changes the inter-molecular distance. An 
exponential decrease in the charge away from the shear plane is the critical parameter which 
is important in the NP stability, where the shear plane is the NP environment around it 
which interacts with the solvent. Debye double layer thickness (an inverse of the exponential 
charge decrease) is the space that holds the ‘shear’ plane. It is a function of available salt 
concentration/ ion strength of the given solution, such that with increasing salt concentration 
the double layer thickness decreases until the double layer repulsive forces are overcome by 
van der Waals attractive forces, resulting in aggregation (salting out effect) [17]. To this 
effect, a positive shift in zeta at increasing salt concentrations of PBS could also be justified. 
In addition to the double layer interaction behavior of the bare NPs, stability of the 
functionalized NPs is governed by the nature of the surface functional groups, as evident 
from the results obtained for amine and carboxy-functionalized NPs (Figure 6.2). A 
decrease in the zeta was registered for amine-functionalized NPs suspended in the solvents 
in the order of DIW, ethanol, PBS 1mM, PBS 10mM and PBS 100mM. However, the 
decrease was insignificant for DIW and ethanol dispersed NPs, where ethanol (polarity 
index: 5.2) is less polar than water (polarity index: 9) [18]. Functionalization of highly  
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 Figure 6.2 Zeta potential of unfunctionalized, and carboxy and amine functionalized NPs 
as a function of nature of (a) solvent and (b) ionic strength of phosphate buffered saline. 
There was no significant effect on zeta potentials of NPs in DIW (polarity index: 9) and 
ethanol (polarity index: 5.2); whereas considerable decrease in zeta was registered for 
samples incubated in PBS. Zeta potential was found to have an inverse relation with the 
ionic strength of the dispersion media. DIW is de-ionized water; SiNP is silica nanoparticle 
followed the nature of functionalization as suffix. Amine and carboxy represents the 
respective functional groups on SiNP. 
 
negative Si NPs with amino silane induces two basic changes in the composition of the NP. 
These are, decreasing the net negative charge of the NP core by engaging most of its 
pendant ‘OH’ groups and increasing its size by 5.6Å (for a monolayer). This results in a 
decreased ‘stern’ capacity of functionalized NPs where, ‘stern’ capacity is the amount of 
charge that can be adsorbed on the negative NP core, which migrates with the particle in the 
solvent. In addition, the possible role of hydrogen bonding between the hydrogen of amines 
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and oxygen of the unreacted hydroxyl groups of NPs could not be excluded in aggregation. 
Therefore, theoretically, the amine-functionalized NP should be unstable. The results 
obtained with zeta potential suggested the same for amine-functionalized NPs and 
flocculation could be observed even at a zeta of +29 mV. In addition, it is possible that 
functionalized NPs are actually a mixture of functionalized, partially and completely 
unfunctionalized NPs. Therefore, it may be speculated that this mixed colloid, which 
possesses all the abilities to induce aggregation, might be the plausible reason of NP 
instability.  
Conversely, a shift in zeta potential further towards the negative scale for the carboxy 
functionalized NPs dispersed in DIW, ethanol and PBS (1mM ionic strength) was obtained. 
However, this negative shift was insignificant. The most negative zeta obtained with PBS, 
pH 7.2 might be the effect of pH (Figure 6.3), which is more basic than DIW and ethanol. 
However, the effect of salt concentration on carboxy-functionalized NPs was similar to the 
PBS dispersed amine-NPs.  
Also, 1mM PBS, pH 7.2 was found to be a suitable replacement as a dispersion medium for 
DIW and ethanol for antibody conjugation and storage.  
6.5.2 Effect of pH 
The zeta potential values of bare Si NP (pI 5.8) samples incubated in DIW at different pH, 
i.e. 5, 7 and 10, suggest that negative charge on the unfunctionalized NPs in solution was 
increasing with the increasing pH (Figure 6.3).  
The rationale for this behaviour could be that with stronger alkaline dispersion medium the 
number of hydroxyl groups in the solution and on the surface might increase [19, 20]. These 
findings are consistent with the reports claiming to study the effect of various pH on the bare 
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Si NPs [21, 22]. In addition these results suggest that there is an inverse relation between the 
charge on NPs and pH of the dispersion medium. However, aminated NP samples with a net 
‘+’ charge were found to be moderately stable (slow flocculation zone) at an acidic pH. 
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Figure 6.3 Zeta potential of unfunctionalized, carboxy and amine functionalized NPs as a 
function of pH. There was a significant decrease/ negative shift in zeta for unfunctionalized 
NPs (SiNPunf) along with the increase in the alkalinity of the dispersion media. Similarly, 
carboxy and amine-functionalized NPs followed the decreasing trend with increasing 
alkalinity of the medium. Zeta potential was found to have an inverse relation with the alkali 
strength in the dispersion media. DIW is de-ionized water; SiNP is silica nanoparticle 
followed the nature of functionalization as suffix; amine and carboxy represents the 
respective functional groups on SiNP. 
 
The zeta potential of aminated NPs decreases with increasing alkalinity of the solvent. The 
rationale is that the number of hydroxyl ions is significantly higher which could efficiently 
disrupt the orderly arrangement of ‘+’ surface charge. Conversely, when pH decreases, the 
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number of charged amine species will be higher in accordance of their respective pI values 
resulting in an ordered inter-particle repulsion that might contribute to the stability of 
aminated Si NPs under acidic conditions. Similarly, the net charge on the carboxy-
functionalized NPs was also found to decrease more toward the basic pH. It could be simply 
explained as a function of number of hydroxyl groups present in the solvent. With increasing 
alkalinity, the number of hydroxyl groups significantly increases. This results in increased 
ionization of carboxy groups to carboxyl ions. This ionization increases the total negative 
charge inducing an ordered distribution of negative charge in the system, increasing the 
repulsive forces and overall stability of the system. However, there are reports that claim the 
possibility of the self-assembly of carboxy and amine silane-functionalized NPs due to 
intermolecular interactions of various carboxyl and amine groups [23, 24] implying that 
even at moderate zeta potentials these NPs are susceptible to flocculation. 
6.5.3 Effect of antibody crosslinking  
It was hypothesized that a typical IgG antibody possessing multiple carboxy (approx. 37) 
and amine groups (approx. 80) (Entrez protein seq: AAA02914) could react with multiple 
antibodies and multiple NPs (Section 6.2) in an uncontrolled manner that could result in big 
aggregates of (antibody)n-(NP)n. Therefore, apart from non-covalent interaction-induced 
flocculation, the biggest challenge toward generating well dispersed antibody-NP adducts is 
to perform the covalent reaction in a controlled manner in order to minimize multimerization 
of the single NP and antibodies (individual) covalently bound to its surface. Several 
chemical and physical blocking experiments were performed. Chemical blocking was based 
upon blocking of EDC-activated carboxy groups on either antibody or NPs with 
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ethylenediamine (EDA). The activated carboxy groups were blocked with different molar 
concentrations of EDA with or without subsequent BSA blocking (physical). 
The results obtained (Figure 6.4) showed that there was no EDA concentration dependence 
in either amine or carboxy functionalized NPs.  
In the case of amine functionalized NPs, there was a decrease in the zeta potential (shift 
towards negative axis) for all the antibody-conjugated samples with EDA-based blocking 
with or without BSA. A plausible reason for this decrease could be the addition of protein 
(antibody) that might change the slipping plane of the NPs. In addition, the interaction of 
antibody with the NPs in the solution, which is a mixture of functionalized and 
unfunctionalized NPs, could have decreased the overall surface charge as their respective 
zeta potentials were found to be in the instability zone of the negative axis [8]. However, the 
decrease in zeta potential was comparatively more in the case of blocking with EDA in 
conjunction with BSA, which is an amine-rich globular protein. There could only be one 
plausible explanation for this increase in the negative charge with BSA-blocking. Each 
molecule of BSA has 89 primary free amines and 98 free carboxyl groups [25]. Considering 
that NPs are positively charged, if BSA blocks the surface with hydrophobic, ionic and van 
der Waals interactions then there will be a decrease in overall negative charge due to the 
reduction in the number of free carboxyl groups on BSA. However, as evident from Figure 
6.4, the overall negative charge has increased following the BSA-blocking. Therefore, it 
may be proposed that the BSA coating on the surface might be as a result of non-ionic and 
non-covalent interactions, as a result of which there is significantly high number of free 
carboxyl groups of BSA on the surface resulting in an overall negative charge [8, 26]. 
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Figure 6.4 Effect of antibody cross-linking and surface blocking strategies on their 
respective zeta potentials. Zeta potential registered for (a) EDA-based blocking of the EDC-
activated carboxy groups, and (b) EDA-based blocking in tandem with physical blocking of 
the surface with BSA. There was no correlation between antibody conjugation strategies and 
their respective zeta potentials. EDA is ethylenediamine and B is BSA. The prefix with EDA 
and BSA represents their molar and weight percent concentrations, respectively. SiNP 
followed by suffix amine and carboxy represents silica NPs with respective 
functionalization. 
It was proposed prior to the experiments that addition of EDA should reduce the aggregation 
induced by uncontrolled cross-linking. However, for carboxyl NPs the ‘charge reversal’ due 
to the blocking of carboxyl groups (negative) with EDA (positive) increased the zeta 
potential towards the positive axis. This positive shift of zeta was not significant enough to 
induce a stable positive charge. Moreover, this increase in zeta resulted in decreasing the 
stability of carboxy NPs. The anomalous charge imparting behaviour obtained for BSA-
based blocking of amine-functionalized NPs was also observed for carboxy NPs. BSA-based 
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blocking of the surface was found to impart a positive shift in zeta unlike in amine NPs 
where a negative shift was obtained. 
A visible flocculation in all the antibody conjugates was observed. It is important to mention 
here is that the aggregation behaviour of protein-conjugated NPs is very complex and it is a 
challenging task to design a model for analysing the nature of aggregation and forces that 
are playing crucial role in aggregation. There are many variables in antibody-NP conjugates 
that increase the possibilities of aggregation in these samples (Figure 6.5). Considering 
EDA and BSA blocking as an efficient method for minimizing aggregation due to covalent 
cross-linking of many antibody-NPs complexes, the potential participants in these 
aggregation events could be non-covalent interaction of proteins with other proteins or 
functional groups of NPs and vice versa. In addition, EDA, which is a homobifunctional 
blocker, could bind to two antibodies or NPs at the same time, one from each of its ends. 
This EDA-mediated cross-linking of antibodies and NPs with each other could result in a 
big complex of antibody-NP conjugates. However, EDA is a small molecule and steric 
hindrance created by the charge at the interphase and NP size could interfere with EDA-
mediated cross-linking. Conversely, it is also important to mention that EDA is a prominent 
chelating agent and a precursor to polymers such as dendrimer polyamidoamine (PAMAM). 
Therefore, its potential role in crosslinking-mediated NP aggregation might not be neglected 
and further studies are required to understand the behaviour obtained with EDA and BSA-
based surface blocking. In addition, the role of various colloid dispersants should also be 
studied.  
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6.6 Conclusions 
A stability profile of the functionalized and unfunctionalized Si NPs employed for designing 
platelet diagnostics was generated as a function of dispersion media (solvent), salt  
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Figure 6.5 A hypothetical model depicting various possible interactions that may have 
crucial role in nanoparticle aggregation. However, their individual roles in aggregation are 
not known. The main type of interactions that were speculated to play some role are (i) ionic 
and hydrophobic interactions along with hydrogen bonding between functional groups of an 
antibody (conjugated to a nanoparticle) with other nanoparticle; (ii) binding of 
nanoparticles to self-cross-linked antibodies (many antibodies cross-linked during the 
process of EDC activation); and, (iii) interaction of functionalized and bare nanoparticles 
with each other. The positively charged nanoparticles are amine functionalized; whereas, 
negatively charged nanoparticles are bare or partially functionalized. 
 
concentration and pH of the solvent. A correlation was obtained between zeta potential-ionic 
strength and zeta potential-pH, as expected. However, for the stability profiling of these NPs 
after antibody conjugation and surface blocking with EDA and BSA, a clear relationship 
could not be established between zeta and conjugation strategies employed. This could 
imply to the complex nature of aggregation and involvement of various type of ionic, non-
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ionic-non-covalent and covalent interactions in the underlying mechanisms of aggregate 
formation. And, it is a scientific challenge to model such a complex physical process. The 
choice of chemical blocker was also critical. EDA is reactive from both of its terminals and 
possibility of its reaction to two NPs from its each end may not be overlooked. Therefore, in 
further studies ethanolamine has been chosen as a chemical blocker. In addition further 
complex analysis should be performed in order to obtain a relevant information that could be 
employed to devise an efficient NP-based platelet diagnostics. 
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Chapter 7 
Conclusions and future work 
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7.1 Conclusions 
A generic strategy was required that could be employed to activate a wide range of solid support 
materials to increase stability of oxidized surface with a higher degree of homogeneity. 
Therefore, a surface modification strategy was successfully developed and optimized using 
potassium hydroxide and oxygen-plasma treatment-based surface activation followed by amino-
terminal silane-based functionalization. The developed method can also be performed using 
silanes with carboxy- or epoxy-functionalities because the basic functionalization chemistry of 
the silane remains the same irrespective of the terminal functional groups present on it. This 
creates many practical applications of the surface activation and functionalization strategy 
described in this thesis such as (a) development of high sensitivity immunoassays on various 
polymeric and metallic supports as demonstrated in this thesis, and (b) development of 
customized biosensor surfaces for potential label-free detection along with microarray and 
microfluidic platforms. 
This strategy was employed to modify a range of polymeric surfaces, such as polystyrene, 
polymethylmethacrylate, cellulose acetate, poly carbonate and polycyclo-olefins. A high 
sensitivity immunoassay was developed and optimized using HFA as the model antigen system. 
The sensitivity of this immunoassay was 38 pg/mL, which was eight to ten-fold more sensitive 
than conventional immunoassays (based on adsorption of the antibody on the surface). The same 
strategy was later employed to develop several commercially relevant immunoassays for 
proprietary analytes of Bristol Myers Squibb, Syracuse, NY, USA. 
The potential of the developed strategy could be realized as the technology was transferred to 
Bristol Myers Squibb, and VTT, a leading Finnish research institute. In addition, this strategy 
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was employed for functionalizing other polymer-based bioanalytical platforms for microarray 
and fluorescence assay developments with fluorocap. 
In the course of this research understanding of several important processes was analyzed and 
developed. The most important is determination of the loss of analyte during sample preparation, 
which is often overlooked in routine analysis. Minimizing such losses is an important issue 
because it could have significant effects on the overall immune/bioassay performance. A model 
describing the nature of analyte loss was developed, which was very useful in predicting the 
nature of such losses and calculating their amounts. However, this model has certain limitations 
and is strictly based upon the model situation examined. Therefore, many additional parameters 
may have to be considered. Adsorption and loss of conformation of analyte were predominant 
factors contributing to the loss of analyte. BSA-based pre-treatment of sample tubes was 
developed to minimize such effects. This pre-treatment step significantly lessens these losses. In 
addition, the impact of storing temperature was also established as a contributing factor to such 
losses and it was found that storage at 4 oC reduces these losses. Therefore, it is suggested that 
sample preparation be performed in pretreated tubes and, when required, they should be stored at 
4 oC. 
The other major area was the assessment and modelling of the various possibilities of 
aggregation of silica nanoparticles following chemical functionalization. However, this model 
has significant limitations as it was strictly based upon the assumption that crosslinking might 
have a significant role in aggregation of these NPs along with other non-covalent (van der Waals 
forces) and ionic interactions. Various factors, such as self-interaction of unfunctionalized and 
functionalized silican nanoparticles, self-conjugation of silica nanoparticles after chemical 
activation, antibody-antibody interactions in the antibody-conjugated silica nanoparticles, and 
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the tendency of an antibody to conjugate to many nanoparticles were identified as contributing 
parameters in silica nanoparticle aggregation. Further studies are ongoing to other contributing 
parameters. In addition, with optimum antibody conjugation strategies, these NPs could prove to 
be efficient probes for a range of biological systems. Their high probing efficiency (~ 95%) and 
specificity (~ 100%) was demonstrated with anti-CD41 antibody-conjugated NPs for detecting 
CD41 surface marker on the platelets. 
Therefore, this research contributes significantly to understanding the various basic parameters 
for enhancing the sensitivities and probing the efficiencies of immobilized antibody systems and 
could have tremendous influence on the bioassay performance. In addition, the strategies 
developed could be employed to generate commercially relevant immunoassays. 
7.2 Future work 
Further development of the research described in this thesis should involve the following issues 
7.2.1 Sorting NPs as a function of their charge using a self-developed NP sorter 
Functionalization of NPs is a method with partial efficiency and only a certain percentage of the 
actual mass of NPs is grafted with desired functional groups. It was speculated that a mixed 
population of NPs might be the most significant reason for aggregation of the functionalized NPs 
(without antibody conjugation), which have a zeta potential in the range of moderate stability. 
Therefore, a prototype should be designed for separating out NPs on the basis of their net charge. 
This will allow study of the charge-based aggregation behavior of these dye-doped NPs. 
However, this sorter will only be useful for amine functionalized NPs, which have a net ‘+’ 
charge and could be separated using the electric field migration property of NPs. 
 
 
192 
 
7.2.2 Replacing ethylenediamine (EDA) with ethanolamine (EA) 
EDA is a homobifunctional blocker having amine at both the terminals. Initially, EDA was 
selected for quenching the activated carboxy-groups due to its high reactivity. However, it was 
later realized that due to the presence of two amino groups (bivalency) on EDA this could also 
be involved in aggregation as a result of binding two NPs or antibodies in a cascade fashion. 
Therefore, EDA will be replaced by EA for future studies despite its low reactivity toward 
carboxyl groups in comparison to EDA. 
7.2.3 Gradual centrifugation as an aggregate sorting procedure 
Aggregation in protein-conjugated NPs is inevitable under the current experimental conditions. 
Therefore, a gradual centrifugation model will also be employed in tandem with the above 
strategies. This model is based on subjecting the antibody-conjugated NPs as a function of (i) 
centrifugal force, and (ii) time of centrifugation. It is anticipated from this model that aggregates 
will be removed from the solvent medium according to their sizes and a much more 
homogeneous and dispersed solution of antibody-conjugated NPs could be obtained. 
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Development of a High Sensitivity Rapid Sandwich
ELISA Procedure and Its Comparison with the
Conventional Approach
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A highly sensitive and rapid sandwich enzyme-linked
immunosorbent assay (ELISA) procedure was developed
for the detection of human fetuin A/AHSG (r2-HS-
glycoprotein), a specific biomarker for hepatocellular
carcinoma and atherosclerosis. Anti-human fetuin A
antibody was immobilized on aminopropyltriethoxysilane-
mediated amine-functionalized microtiter plates using
1-ethyl-3-[3-dimethylaminopropyl]carbodiimide hydro-
chloride and N-hydroxysulfosuccinimide-based heterobi-
functional cross-linking. The analytical sensitivity of the
developed assay was 39 pg/mL, compared to 625 pg/
mL for the conventional assay. The generic nature of the
developed procedure was demonstrated by performing
human fetuin A assays on different polymeric matrixes,
i.e., polystyrene, poly(methyl methacrylate), and polycy-
clo-olefin (Zeonex), in a modified microtiter plate format.
Thus, the newly developed procedure has considerable
advantages over the existing method.
Conventional enzyme-linked immunosorbent assay (ELISA)
procedures have been followed for decades for the detection of
analytes of importance in industrial, healthcare, and academic
research. However, improvement on existing ELISA technologies
are continuously attempted by many groups.1,2 We report the
development of a high-sensitivity ELISA-based assay for human
fetuin A (HFA), with lower detection limits and a higher sensitivity
than commercially available assays. The biological importance of
HFA, a member of the cystatin superfamily, which is commonly
present in the cortical plate of the immature cerebral cortex and
hemopoietic matrix of bone marrow, is discussed elsewhere.3-10
There are many commercially available ELISA kits for fetuin A,
which are listed in Supplementary Table 1, Supporting Informa-
tion. The assay was demonstrated on different commercially
relevant solid supports. The developed ELISA is better than the
conventional procedure in terms of greatly reduced overall assay
duration, higher sensitivity, and greater reproducibility.
HFA was taken as the model assay system to demonstrate the
utility of our developed ELISA procedure since all the assay
components were commercially available in kit form. This enabled
us to do robust and highly precise comparison of the developed
ELISA with the commercially existing conventional ELISA pro-
cedures, as the same assay components were used under the same
conditions. The developed procedure can be employed on any
commercially relevant substrate. Therefore, this approach of
immobilizing antibody on chemically modified solid supports
(Figure 1) has potential applications in many other assays and
formats.
EXPERIMENTAL SECTION
Plate Preparation, Amine-Functionalization with Silane,
and Cross-Linking Carboxyl Groups of Anti-HFA Antibody
to the Amino Groups of the Surface of Microtiter Plate Wells.
Each well of the 96-well plate was treated with 100 µL of absolute
ethanol for 5 min at 37 °C and washed five times with 300 µL of
deionized water (DIW). Subsequently, each well was treated with
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100 µL of 1.0% (w/v) KOH at 37 °C for 10 min followed by five
washings with 300 µL of DIW. The KOH-treated wells were then
functionalized with amino groups by incubation with 100 µL of
2% (v/v) aminopropyltriethoxysilane (APTES) per well at 80 °C
for 1 h inside a vacuum-desiccator, in order to achieve maximum
silanization. The reaction mechanism following the KOH activation
and APTES-based surface functionalization involves mild oxidation
followed by a hydrolytic APTES polymerization on the oxidized
surface through its alkoxy groups.11,12 The desiccator was
equilibrated to room temperature for 20 min. The amine-func-
tionalized plate was subsequently washed five times with 300 µL
of DIW in order to remove excess unbound 3-APTES from the
surface. Afterward, the anti-HFA/AHSG (R2-HS-glycoprotein; 990
µL of 4 µg/mL) was incubated with 10 µL of a premixed solution
of 1-ethyl-3-[3-dimethylaminopropyl]carbodiimide hydrochloride
(EDC) (4 mg/mL) and N-hydroxysulfosuccinimide (SNHS) (11
mg/mL) for 15 min at 37 °C. The resulting EDC cross-linked anti-
HFA/AHSG antibody solution was added to each of the function-
alized wells (100 µL) and incubated for 1 h at 37 °C. The anti-
HFA/AHSG-coated wells were then washed five times with 300
µL of PBS. The methodology pertaining to the conventional assay
is described in detail in the Supporting Information methods
section.
ELISA on Anti-HFA/AHSG Antibody-Immobilized Micro-
titer Plates. Plates with covalent and passively immobilized anti-
HFA antibody were blocked with 1% (v/v) BSA diluted in 0.1 M
phosphate buffered saline (PBS), pH 7.4, for 30 min at 37 °C and
subsequently washed five times with 300 µL of PBS. Varying
concentrations of HFA/AHSG (from 4.8 pg/mL to 20 ng/mL)
were prepared in 0.1 M PBS, pH 7.4, and 100 µL of each of these
concentrations were incubated in the antibody-coated plates for
1 h at 37 °C and, subsequently washed five times with PBS. One
hundred microliters of biotinylated anti-HFA/AHSG detection
antibody (200 ng/mL) was added and incubated for 1 h at 37 °C
followed by five PBS washes. HRP-conjugated streptavidin (100
µL per well), at a dilution of 1:200, was added and then incubated
for 20 min at 37 °C followed by five washes with PBS. The 3,3′,5,5′-
tetramethylbenzidine (TMB) substrate was subsequently added
(as per the manufacturer’s recommendations), and the reaction
was stopped after 20 min by addition of 50 µL of 1N H2SO4. The
absorbance was recorded at a primary wavelength of 450 nm
with a reference wavelength of 540 nm. The dual wavelength
system of absorbance measurement in 96-well plates is de-
signed to eliminate or greatly reduce the optical imperfections
at the well-to-well level.
All the experiments were carried out in triplicate. The control
for this study was 0 ng/mL HFA in 0.1 M PBS, pH 7.4, and the
absorbance of the control was subtracted from all the assay values.
The respective analytical sensitivity (detection limit) of the assay
was determined where analytical sensitivity was calculated using
the formula [mean absorbance of blank +3σ (standard deviation
of the blank)]. Additionally, data sets obtained from the modified
Figure 1. Schematic of the developed sandwich ELISA procedure for the HFA/AHSG assay. Plate functionalization was performed by treatment
with 1% (w/v) KOH and then silanization with 2% (v/v) APTES. KOH oxidizes the organic moiety of the polymer generating a carbonyl (-CO)
or a hydroxyl (-OH) group according to the nature of the polymer. The alkoxy groups of APTES subsequently react with the carbonyl or hydroxyl
groups of the surface in a hydrolysis-dependent reaction.11,12 Anti-HFA/AHSG antibody was then captured using EDC and sulfo-NHS chemistry
on the aminated 96-well plate, where the EDC-SNHS was used in a ratio of 1:100 with the antibody. The EDC-SNHS-activated antibody molecules
were then immobilized on the aminated ELISA plate, where a bond was formed between amine groups on the plate and the activated carboxyl
groups of the antibody.
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and conventional ELISA were analyzed using standard curve
analysis of Sigma Plot software, version 11.0.
RESULTS AND DISCUSSION
The range of detection of HFA/AHSG for the developed ELISA
(Figure 2) was 9-20 pg/mL (r2 ) 0.99). An analytical sensitivity
of 39 pg/mL was recorded for developed ELISA, where
analytical sensitivity was calculated using the formula [average
absorbance of the blank + 3(SDblank)]. Assay variability
parameters for this high-sensitivity assay for HFA are described
in Table 1, where intraday assay variability was calculated from
5 repeats performed on a single day, and interday assay variability
was calculated from three repeats performed on three different
days in triplicate. The percentage recovery for lower concentra-
tions (4.88-625 pg/mL) was 50-80% while for higher concentra-
tions (1.2-20 ng/mL) it was 75-100%. The percentage recovery
was calculated as the obtained value/expected value × 100.
The half-effective concentration (EC50) obtained from the
dose-response curve,13 which is a measure of analyte-ligand
interaction, was found to be on an average of 3.3 ng/mL. The
EC50 for all the assay repeats was found to be in the range of
3-3.5 ng/mL. A lower EC50 (3.3 ng/mL), which was obtained
for the developed ELISA, suggests a strong interaction between
HFA and anti-HFA antibody. This interaction behavior is
attributed to the significant increase in the total amount of
immobilized antibody achieved using the covalent immobiliza-
tion strategy, which increased the availability of anti-HFA
antibody per HFA molecule, thus increasing the resultant HFA
capture on the well surface.
Conversely, EC50 for the conventional ELISA format was 23
ng/mL, (r2 ) 0.99), which was significantly higher than the
developed ELISA. This suggests a less sensitive conventional
assay (Supplementary Table 2, Supporting Information). The
most important factor that may be attributed to the enhanced
sensitivity of the modified assay is the covalent immobilization of
the anti-HFA/AHSG capture antibody since the covalently cross-
linked antibodies should not leach out during the assay procedure
in comparison to the use of passively adsorbed antibodies, where
leaching may occur more easily.
Performance of the developed sandwich ELISA procedure was
compared with the conventional protocols (Figure 2), both
involving passively adsorbed antibody on normal unmodified
microtiter plates (one performed using the modified protocol and
the other as per the manufacturer’s recommendations). All the
assays were performed simultaneously on the same day under
same set of conditions in order to minimize variability, where
variability was reported as percentage coefficient of variation (%
CV) (Table 1).
The technique employed here for chemically modifying the
polymeric surface was developed and standardized by our group,
and a standard EDC-based cross-linking strategy was deployed
to immobilize anti-HFA/AHSG antibody. The developed sandwich
ELISA procedure decreased the overall assay duration from 20
to 6 h, which is more than a 3-fold decrease. Thus, the reported
procedure is a rapid ELISA format having the additional benefit
of being generic in nature, i.e., it can be used with sandwich
ELISAs on different polymeric matrixes for a range of different
analytes. Hence, using the surface modification technique reported
here, it is possible to develop rapid and high sensitivity assays
on various categories of solid supports including those that are
chemically inert.
To the best of our knowledge, this developed ELISA procedure
is the most sensitive assay reported for the detection of HFA/
AHSG (Supplementary Table 1, Supporting Information), which
is based on the comparison between different commercially
available ELISA kits for HFA. The sensitivity of the assay
developed by our group may be attributed to the use of mono-
clonal antibody at the capture stage, which was covalently
immobilized on the surface, and a polyclonal antibody to detect
the antigen. The covalently cross-linked monoclonal antibodies
that are used as capture antibodies in this study were found to
capture significantly higher amounts of HFA, which has improved
the detection limit and the overall assay sensitivity of the
developed ELISA procedure in comparison to the conventional
format. However, the commercially available ELISA kits, as
described in Supplementary Table 1 (Supporting Information),
have different capture and detection antibody combinations, which
(13) Armbruster, D. A.; Schwarzhoff, R. H.; Hubster, E. C.; Liserio, M. K. Clin.
Chem. 1993, 39, 2137–2146.
Figure 2. Comparative analysis of developed sandwich ELISA (black
circles) with the conventional format. Anti-human fetuin A (anti-HFA)
antibody was covalently bound to the amine-modified surface in the
developed ELISA, whereas antibody adsorbed on the unmodified
surface was used in the conventional assay format. The conventional
assay was performed with the manufacturer-recommended protocol
(white circles) and the protocol developed in this study (inverted
triangle). The error bars represents standard deviations.
Table 1. Comparison of Assay Performance
Parameters (Precision and Sensitivity) for
Conventional and Developed ELISAsa
intraday precision
range (CV %),
(n ) 5)
interday precision
range (CV %),
(n ) 3)
sensitivity
(pg/mL)
developed ELISA 2.4-10.4 1.7-17.6 39
conventional ELISA 4.7-17.4 3.6-20.0 624
a Intraday precision was calculated from the five repeats (n ) 5) of
the same assay on a single day but at different times, while interday
precision was calculated from assay repeats on three different days (n
) 3). All the assays were carried out in triplicate. Analytical sensitivity
was calculated using the formula [average absorbance of the blank +
3(SDblank)].
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may be a factor in their reduced sensitivities.14 The sensitivity
and specificity of any immunoassay is dependent on the antigen
capture efficiency of an antibody which is subsequently governed
by the nature of antibody15,16 and accounts for the different assay
sensitivities of the commercially available kits employing different
type of antibodies that are monoclonal or polyclonal at the capture
stage in ELISA.
Three different types of commercially relevant substrates,
polystyrene (PS) (hydrophobic), polymethyl methacrylate (PMMA)
(hydrophilic), and cyclo-olefin polymer (Zeonex) (inert), were
used in the modified microtiter plate format. The HFA assay was
performed on these matrixes in the modified microtiter plate
format. The HFA assays performed on different solid substrates
could not be directly compared because of their different thick-
nesses. Theoretically, the optical path length contributes toward
the absorbance (A). Therefore, a thick solid support increases
the path length and, hence, significantly changes the absorbance.
However, the generic nature of the developed ELISA procedure
was successfully demonstrated (Figure 3). The HFA assay
performed on the Zeonex support, which is an inert cyclic poly
olefin derivative, had an analytical sensitivity of 19.5 pg/mL, while
for the assay performed on PS and PMMA, it was 78 pg/mL. The
analytical sensitivities for the HFA assay and the dose-response,
which determines the slope-dependent linearity range of the assay,
of HFA-anti-HFA for all the three solid supports used in this study
suggests that this modified protocol increases the overall assay
sensitivity and is not confined to the nature of the solid support
used for capturing antibody.
CONCLUSIONS
A rapid sandwich ELISA procedure was developed for the
highly sensitive detection of HFA/AHSG. It was based on the
covalent immobilization of anti-HFA capture antibody on a
3-APTES-functionalized microtiter plate. The developed ELISA has
comparatively better analytical sensitivity (39 pg/mL) and less
variability in interday and intraday assay repeats than the
conventional format, which has an analytical sensitivity of 624 pg/
mL. The surface chemistry developed for this study is generic
and can be employed to activate polymer matrixes irrespective of
their chemical nature as demonstrated on PS (hydrophobic),
PMMA (hydrophilic), and polycyclo-olefin (inert). Therefore, this
strategy can also be used for rapid assay development on various
commercially relevant substrates and the screening of substrates
for particular biosensor/diagnostic applications.
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Figure 3. Performance of the developed ELISA on different solid
support matrixes. Three categories of the solid support were chosen
on the basis of their chemical properties, namely polystyrene (PS)
which is hydrophobic (white circles); polymethyl methacrylate (PMMA),
a hydrophilic polymer (black circles); and polycyclo-olefin polymer,
trade name Zeonex, which is a neutral matrix (inverted black
triangles). The error bars represent standard deviations.
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IntroDuctIon
ELISA is a widely used technique and continuous efforts are being 
made to substantially improve its various applications1,2. Adsorption 
on microtiter plate wells is a commonly used antibody immobiliza-
tion procedure for ELISAs; however, this strategy has drawbacks 
associated with loss of antibody functionality, nonuniform distri-
bution of antibody molecules on the surface, poor signal-to-noise 
ratio, leaching and protein exchange3–6. In addition, antibody can 
only be physisorbed on chemically active hydrophilic and hydro-
phobic surfaces. Amine-terminated silanes, such as 3-aminopro-
pyltriethoxysilane (APTES), are commonly used for amination of 
metallic supports for different biosensor applications, and there 
are also reports on silane-based modification of microtiter plate 
wells7,8. However, these methods use harsh procedures for surface 
activation, e.g., oxidation of the polymeric surface with strong oxi-
dizing agents, such as sulfuric and nitric acid, in order to generate 
pendant nucleophilic (hydroxyl or nitro) functional groups. These 
groups covalently react with the alkoxy groups of silane generating 
self-assembled layers, but can interfere with the functionality of the 
target biomolecules if traces remain on the modified surfaces9,10.
We describe a rapid and high-sensitivity immunoassay procedure 
that uses covalently immobilized capture antibody on an amino-
silane-functionalized microtiter plate11. The basic idea of developing 
a chemically active surface for rapid ELISA-based immunoassay was 
conceived as an approach for accelerated analysis. The surface acti-
vation, which is the primary requirement for silane-based function-
alization, was achieved by exposing the desired polymeric surface 
to KOH12–14 (1% (wt/vol)) in conjunction with an O
2
 plasma15–21. 
This activation procedure induces carbonyl (-CO) and hydroxyl 
(-OH) groups on the solid matrix, depending on the nature of the 
polymer14–18. These nucleophilic centers on the polymeric surface 
attract electrophilic alkoxy pockets of APTES, generating silanol 
bonds (-O-Si-; Fig. 1)14,16. The developed method was demonstrated 
using human fetuin A (HFA) as a model antigen system.
The analytical advantages of the approach described in this 
paper were clearly demonstrated in comparison to conven-
tional methods11. Reported techniques using wet methods7 have 
certain drawbacks such as generation of a nonspecific pool of 
oxygen-containing chemical species9 and uncontrolled surface 
 roughness10,22. However, the use of plasma enables considerable 
control of these aspects. Therefore, our method uses chemical 
activation using a mild oxidation agent (low KOH concentration) 
followed by O
2
 plasma treatment, enabling the utilization of 
the combined effects of wet and plasma treatment. It also effi-
ciently increases control over the surface roughness as the acid-
based activation is completely replaced by a milder agent, thereby 
 permitting milder functionalization of the surface and covalent 
 crosslinking of antibodies by means of their carboxyl groups. The 
control over surface roughness in the developed procedure enables 
the homogeneous distribution of antibody over the surface, result-
ing in enhancement of analyte detection sensitivity23, whereas harsh 
chemical activation generates a non-homogeneous functional layer 
on the surface with associated non-homogeneous antibody dis-
tribution. This could also result in antibody trapping/non-avail-
ability for binding in the closely packed network, hence lessening 
accessibility for the analyte. However, the use of chemicals such as 
APTES and EDC (1-ethyl-3-(3-dimethylaminopropyl)-carbodiim-
ide hydrochloride) introduces additional biosafety requirements, 
and the need for more sophisticated instrumentation and facilities 
may also be a restriction.
The described method has enabled us to develop immunoassays 
on multiple substrates, including inert polymers, either in the same 
or in separate microtiter plates18,19,24. The method has potential 
applications in various biosensor-based formats. We have used the 
approach, and modifications thereof, for the development of chemi-
luminescence, surface plasmon resonance and fluorescence-based 
microarray assays for highly stable agarose-based chromatographic 
resins, and it could also be used in methods for screening anti-
body phage-display libraries (C.K.D., S.K.V. and R.O., unpublished 
observations). One potential limitation of the approach may be the 
need for specific conditions and instrumentation for silanization. 
Multisubstrate-compatible ELISA procedures for 
rapid and high-sensitivity immunoassays
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this protocol describes an improved and optimized approach to develop rapid and high-sensitivity elIsas by covalently 
immobilizing antibody on chemically modified polymeric surfaces. the method involves initial surface activation with KoH and 
an o2 plasma, and then amine functionalization with 3-aminopropyltriethoxysilane. the second step requires covalent antibody 
immobilization on the aminated surface, followed by elIsa. the elIsa procedure developed is 16-fold more sensitive than 
established methods. this protocol could be used generally as a quantitative analytical approach to perform high-sensitivity and 
rapid assays in clinical situations, and would provide a faster approach to screen phage-displayed libraries in antibody development 
facilities. the antibody immobilization procedure is of ~3 h duration and facilitates rapid elIsas. this method can be used to 
perform assays on a wide range of commercially relevant solid support matrices (including those that are chemically inert) with 
various biosensor formats.
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Nevertheless, silane functionalization can be performed at room 
temperature (RT; ~25 °C) in a fume hood, thereby obviating the 
need for use of a vacuum pump and an oven. The use of this alter-
native approach will certainly affect various analytical parameters 
such as limit of detection (LOD) and effective concentration for 
half-maximum response (EC
50
), but the performance may still be 
better than the conventional method, particularly when the silani-
zation time is increased.
Experimental design
Silanization. Silanization requires a vacuum desiccator and oven. 
The oven should be preset to 80 °C for at least 20 min for tempera-
ture equilibration, and vacuum should then be applied. It is advan-
tageous to equilibrate the desiccator before generating the vacuum. 
Various parameters such as APTES concentration and silanization 
time were also optimized in this study (Supplementary Fig. 1). The 
characterization of APTES functionalization was monitored with 
Fourier transform infrared (FTIR) spectroscopy (Supplementary 
Fig. 2). The silane has a marked tendency for multimerization, 
as it contains both nucleophilic and electrophilic centers. This 
makes the duration of silanization a critical parameter, as forma-
tion of randomized multilayers of silane can occur over extended 
time periods. This will eventually result in random antibody 
capture, which will directly affect overall immunoassay perform-
ance. Reports suggest that APTES forms multilayers after 3 h of 
incubation25,26. Therefore, we fully optimized our protocol, both 
for the duration of silanization and the concentration of APTES 
used (Supplementary Fig. 1).
Immunoassay optimization. In immunoassay development, all 
the components were commercially obtained as lyophilized samples 
and were checked for quality of performance before use. A number 
of process controls relevant to the reported procedure were included 
to optimize the ELISA and are shown in Supplementary Figure 3. 
Process controls included were also designed to test the cross-
reactivity of kit components. HFA (standard positive control) and 
standards were supplied with the kit. The relevant analyte (fetuin 
for this study) obtained from various sources and additional con-
trol biomolecules that may present cross-reactivity challenges, such 
as human fetuin B in the assay developed for HFA, must also be 
used as controls. In this study, 1% (vol/vol) BSA in 0.1 M PBS was 
used as a blank. Different HFA dilutions were prepared and sub-
jected to ELISA in the developed and conventional assay formats in 
order to define various analytical parameters. In addition, a number 
of assay dilutions were selected such that the lowest and highest 
concentrations followed the sigmoidal curve and were required to 
have at least five concentrations in the linear range on the standard 
curve. An irrelevant analyte, such as albumin, was routinely used 
as a negative control.
Result analysis. The EC
50
 (ref. 26) is the half-maximal effective 
concentration of antigen/ligand that induces 50% of the maximum 
detectable signal on the linear working range of an assay. Therefore, 
EC
50
 provides quantitative details of the analyte detection ability of 
an assay. Theoretically, it could be calculated by using four- or five-
parameter curve fitting equations27. Most of the analysis systems 
determine the value of EC
50
 using four-parameter logistic-based 
Substrate Step 1: EtOH treatment, 5 min at RT Step 4: 2% (vol/vol) APTES, 1 h at 80 °C
            in vacuum desiccatorStep 2: 1% (wt/vol) KOH, 10 min at RT
Step 13: SA-HRP incubation, 20 min at RT
Step 12: Detection of antibody (enzyme labeled), 1 h at 37 °C
Step 11:
Antigen incubation,
1 h at 37 °C
Steps 7 and 8: Incubate for 15 min at RT
Step 9: 
Incubate for
1 h at 37 °C
Step 10: 1% (vol/vol) BSA incubation, 30 min at 37 °C
BSA
Assay procedure, 3 h 30 min
EDC/SNHS +
Step 3: O2- plasma, 3 min
OH/CO OH/CO OH/CO
NH2
NH2
COOH
C=O C=O
HN HNNH2
C=O C=O
HN HNNH2
NH2NH2
NH2
Si
Si
RH, CO2, H2OOR OR OR
NH2
Si
OR O O
R
OR OO
Figure 1 | Schematic representation of the optimized surface modification and antibody immobilization strategy. The method involves 1% (wt/vol) KOH 
treatment that generates OH/CO groups on the polymeric surfaces, depending on their chemical nature; this facilitates the reaction of amine-terminal silane 
(APTES). Antibody was conjugated to the amino groups of the functionalized surface. These steps were followed with a standardized ELISA procedure with 
optimized blocking, washing and incubation steps. SA-HRP, streptavidin-HRP; SNHS, SulfoNHS.
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standard curve analysis. We have used SigmaPlot 11.0 software 
to analyze the various parameters such as EC
50
 and Hill slope 
(Supplementary Fig. 4).
LOD or assay sensitivity is the ability of the assay to detect the 
lowest possible analyte concentration present in the solution. There 
are many stringent ways to calculate LOD28. However, the most 
common and widely used method to determine LOD is signal of 
blank ± 3 s.d. The procedure for the calculation of LOD is given in 
the Supplementary Methods section.
Microtiter plate assembly to develop assays on different poly-
meric supports. The design and assembly of microtiter plates with 
different solid supports is summarized in Supplementary Figure 5. 
A patterned, double-sided, pressure-sensitive adhesive was designed 
and developed such that the hole pattern at the bottom of microtiter 
plate corresponds to that on the adhesive. This adhesive was applied 
to the pre-blocked bottomless microtiter plates and the desired 
polymeric support was then attached. Afterward, pressure was 
applied with a press. More details about this strategy can be found 
in Vashist et al.24 and also in Supplementary Figure 5. Microtiter 
plates prepared using the described method differ from the com-
mercially available plates in having a different polymeric solid 
support. Therefore, these plates can be used in the PROCEDURE in 
the same manner as that of commercial microtiter plates.
MaterIals
REAGENTS
Anti-HRP antibody (Sigma-Aldrich, cat. no. P2419-2ML)
HRP (Sigma-Aldrich, cat. no. P8375)
Human fetuin A ELISA kit (R&D Systems, cat. no. DY1184e) ! cautIon 
Store the reconstituted antibody and antigen at 4 °C only if they are to be 
used within 2 months, otherwise, aliquot out and store at  − 80 °C for up 
to 6 months. The kit contains mouse anti-HFA capture antibody (720 µg 
ml − 1); HFA/α-2-HS glycoprotein (AHSG) (90 ng ml − 1); biotin-labeled goat 
anti-HFA detection antibody; and HRP-conjugated streptavidin ! cautIon 
Streptavidin is light-sensitive. Store in the dark.
Blocker BSA in PBS (10×, pH 7.4, 10% (wt/vol); Thermo Scientific,  
cat. no. 37525)  crItIcal Filter before use to remove microbial  
contamination. This is critical for surface blocking.
Absolute ethanol (Sigma-Aldrich, cat. no. 02856) ! cautIon It is highly 
flammable. Keep the container tightly closed. Keep away from sources of 
ignition. Alcohol vapors may be harmful to soft tissues such as the eyes or 
the respiratory tract. Use in a safety cabinet or a fume cupboard.
Sulfuric acid (H
2
SO
4
; Sigma-Aldrich, cat. no. 339741) ! cautIon It is 
strongly corrosive and an irritant. Avoid contact with any part of the body. 
Wear suitable protective clothing and safety glasses during handling. Handle 
in a safety cabinet or a fume cupboard. In case of skin contamination, wash 
immediately with acid neutralizers and seek medical advice immediately.
KOH pellets (99.99%, semiconductor grade; Sigma-Aldrich, cat. no. 
306568) ! cautIon It can cause severe burns. Avoid contact with skin  
and eyes. Wear appropriate protection and handle in a safety cabinet.  
 crItIcal The concentration of KOH must be exactly 1% (wt/vol) in 
autoclaved deionized water (DIW, 18 Ω). It can affect the surface properties 
and can affect antibody immobilization.
3-Aminopropyltriethoxysilane (3-APTES; Sigma-Aldrich, cat. no. A3684)  
! cautIon It is a skin and eye irritant. It is potentially toxic to the kidneys. 
 crItIcal Prepare in autoclaved DIW (18 Ω; see REAGENT SETUP).
BupH phosphate-buffered saline (PBS) packs (0.1 M sodium phosphate  
and 0.15 M sodium chloride (pH 7.2); Thermo Scientific, cat. no. 18372)  
! cautIon Avoid inhaling the powder.  crItIcal Prepare in autoclaved 
DIW (18 Ω; see REAGENT SETUP).
BupH MES-buffered saline packs (0.1 M MES (2-(N-morpholino)ethane 
sulfonic acid), 0.9% (wt/vol) sodium chloride (pH 4.7); Thermo Scientific, 
cat. no. 28390) ! cautIon Avoid inhalation.  crItIcal Prepare in  
autoclaved DIW (18 Ω; see REAGENT SETUP).
1-Ethyl-3-(3-dimethylaminopropyl)-carbodiimide hydrochloride (EDC; 
Thermo Scientific, cat. no. 22981) ! cautIon It is an irritant. Handle inside 
a fume cupboard. EDC is hygroscopic, absorbs moisture and may lose  
activity. Equilibrate to RT before opening the container  crItIcal Store  
at recommended temperature ( − 20 °C). Reconstitute in 0.1 M MES  
(pH 4.7; see REAGENT SETUP).
Sulfo-N-hydroxysuccinimide (SulfoNHS; Thermo Scientific, cat. no. 24525) 
 crItIcal Store at the recommended temperature (4 °C). Reconstitute in 
0.1 M MES (pH 4.7; see REAGENT SETUP).
TMB substrate kit (Thermo Scientific, cat. no. 34021). The kit contains 
TMB solution (0.4 g l − 1) ! cautIon It is a skin, eye and lung irritant. In case 
•
•
•
•
•
•
•
•
•
•
•
•
•
of skin contact, wash with plenty of water  crItIcal TMB to peroxide 
ratio is critical for color development. Maintain it in the ratio 1:1; peroxide 
solution (containing 0.02% (vol/vol) H
2
O
2
 in citric acid buffer; Thermo 
Scientific) ! cautIon It is a strong oxidizing agent. It is harmful if  
swallowed and also poses severe risk of damage to eyes. Rinse immediately 
with plenty of water in case of contact and seek medical attention. Wear 
suitable protection and work in safety cabinet or fume cupboard.
Deionized water (18 Ω, DIW)
EQUIPMENT
Freezer ( − 70 °C, operating range  − 60 to  − 80 °C; New Brunswick)
Refrigerator (2–8 °C; Future)
ELISA plate reader (Tecan)
Mini incubator (Labnet)
Harrick plasma cleaner (Harrick Plasma; model number PDC-002)
PVC fume cupboard (Chemflow range; CSC)
Nunc microwell 96-well polystyrene plates (flat bottom (non-treated), 
sterile; Sigma-Aldrich, cat. no. P7491)
PMMA (Poly(methyl methylacrylate)) polycarbonate, cellulose acetate  
polymer (in the form of 1-mm-thick sheets) and zeonex polymer  
(1.5-mm-thick slides; Microfluidic ChipShop)
Desiccator with vacuum control nozzle (Lennox)
Vacuum source
Eppendorf microtubes (1.5 ml; Sigma-Aldrich, cat. no. Z 606340)
SigmaPlot software bundle version 11.0 from Systat for detailed assay analysis
REAGENT SETUP
PBS Each sachet (BupH phosphate-buffered saline (PBS) packs) contains  
0.1 M phosphate and 0.15 M NaCl and yields a volume of 500 ml in the pH 
range 6.8–7.4. Add a sachet to 100 ml of autoclaved DIW and dissolve.  
Finally, adjust the volume up to 500 ml. This can be stored at RT for 2 weeks.  
Check pH before use.
MES Each sachet (BupH MES-buffered saline packs) contains 0.1 M MES 
and 0.9% (wt/wt) NaCl and yields a volume of 500 ml at pH 4.7. Add a sachet 
to 100 ml of autoclaved DIW and dissolve. Adjust the final volume up to  
500 ml. Check the pH and adjust it to 4.7 if necessary. This can be stored at 
RT for 2 weeks. Check pH before use.
APTES The solution is supplied at 99% purity. Reconstitute in autoclaved 
DIW to produce an effective 2% (vol/vol) solution. Prepare a fresh solution 
for each functionalization.
EDC Each pack contains 25 g EDC. Reconstitute in 0.1 M MES buffer (pH 4.7), 
at a concentration of 8 mg ml − 1. Mix it with equal volumes of sulfoNHS solution  
(22 mg ml − 1). Aliquots can be stored effectively for 6 months at  − 20 °C.
SulfoNHS Each pack contains 5 g sulfoNHS. Reconstitute in 0.1 M MES  
(pH 4.7), at a concentration of 22 mg ml − 1. Mix with equal volumes of EDC 
(8 mg ml − 1). Aliquots can be stored effectively for 6 months at  − 20 °C.
H
2
SO
4
 The concentrated solution is 37 N. Add 2.7 ml of 37 N H
2
SO
4
 to  
97.3 ml of DIW to produce a 1 N solution. Reaction of acid and water is  
exothermic; therefore, acid should always be added to water. This solution 
can be stored indefinitely at RT.
•
•
•
•
•
•
•
•
•
•
•
•
•
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proceDure
surface activation and amine functionalization ● tIMInG ~1 h 30 min
1| Incubate the surface of the plate well with 100 µl of absolute ethanol for 5 min and wash extensively with DIW (minimum 
five times with 300 µl DIW per well). Washing can also be performed with an automatic plate washer or squeeze bottles.
2| Incubate the surface of the plate well with 100 µl of 1% (wt/vol) KOH in DIW for 10 min and wash extensively with DIW 
(as described in Step 1).
 crItIcal step KOH treatment should not be longer than the optimized time, because it may cause strong aberrations in 
the surface and may change the surface properties.
3| Treat the KOH-activated surface with O2 plasma in the plasma cleaner set at a plasma strength of 29.6 W. The total input 
power of the instrument is 200 W. Vacuum pump with a pump speed of 0.83 ft3 min − 1 was used to generate a pressure of 
0.27 mbar. Monitor the process of plasma development in the chamber.
 crItIcal step Flush the plasma cabinet with O2 to generate an oxidizing environment. Keep the vacuum pump switched 
on during the whole process. The duration of plasma treatment (3 min) is critical.
? trouBlesHootInG
4| Incubate the plasma-oxidized plate well surface with 100 µl of 2% (vol/vol) APTES in DIW.
 crItIcal step Place the APTES-added plates in the desiccator and create vacuum. Incubate the vacuum desiccator  
at 80 °C for 1 h.
5| Equilibrate the desiccator to RT after incubation.
! cautIon Open the desiccator in a fume cupboard to avoid APTES fumes. Use a fume cupboard and wear protective clothing 
and safety glasses.
 crItIcal step Equilibrating the desiccator stops the APTES vaporization and enhances the uniformity of functionalization.
? trouBlesHootInG
6| Wash the APTES-modified plate well surface extensively five times with DIW (as described in Step 1).
antibody immobilization ● tIMInG ~1 h
7| Dissolve 0.4 mg of EDC and 1.1 mg of sulfoNHS in 100 µl of 0.1 M MES (pH 4.7).
 crItIcal step The ratio of EDC and sulfoNHS is important for optimal cross-linking. Use the recommended ratios of EDC 
and sulfoNHS or optimize this ratio.
? trouBlesHootInG
8| Incubate 990 µl of the antibody to be immobilized with 10 µl of EDC-sulfoNHS solution for 15 min at RT.
9| Incubate the activated antibody in the APTES-modified plate well surface for 1 h at 37 °C and wash five times with  
300 µl of 0.1 M PBS (pH 7.4).
? trouBlesHootInG
elIsa ● tIMInG ~3 h 30 min (sandwich format)
10| To carry out the HFA ELISA (sandwich format), block the antibody-immobilized surface with 300 µl of 1% (vol/vol) BSA 
for 30 min at 37 °C; follow this by five washings with PBS, as described in Step 9.
 crItIcal step Use filtered BSA or filter the BSA solution before use to remove any microbial or other contaminants.
? trouBlesHootInG
11| Add 100 µl of HFA (range from 4.8 pg ml − 1 to 20 ng ml − 1) in triplicate to BSA-blocked wells and incubate for 1 h at  
37 °C; follow with five PBS washings, as described in Step 9.
? trouBlesHootInG
12| Incubate 100 µl of biotin-conjugated detection antibody in each of the antigen-captured wells for 1 h at 37 °C,  
and follow by five PBS washings, as described in Step 9.
? trouBlesHootInG
13| Add 100 µl of streptavidin-HRP conjugate and incubate for 20 min; follow with five PBS washings, as described in Step 9.
? trouBlesHootInG
14| Add 100 µl of TMB-H2O2 mixture to each of these wells and incubate for 20 min at RT to develop color.
? trouBlesHootInG
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15| Stop the enzyme-substrate reaction with addition of 50 µl of 1 N H2SO4 to each well.
16| Record the absorbance at a primary wavelength of 450 nm and secondary wavelength of 540 nm in the Tecan ELISA 
plate scanner.
 crItIcal step Determine the absorbance within 10 min of stopping the enzyme-substrate reaction.
? trouBlesHootInG
Troubleshooting advice can be found in table 1.
● tIMInG
Steps 1–6, Surface activation: ~1 h 30 min
Steps 7–9, Antibody immobilization: ~1 h
Steps 10–16, Sandwich format: ~3 h 30 min
antIcIpateD results
The developed procedure was demonstrated using HFA as the antigen. With this improved method, a 16-fold increase in 
assay sensitivity was achieved (Fig. 2) in comparison with the conventional assay format. The analytical sensitivity of the 
developed sandwich ELISA procedure was 39 pg ml − 1, with an EC50 of 3 ng ml
 − 1, whereas the sensitivity and EC50 of the 
taBle 1 | Troubleshooting table.
step problem possible reason solution
3 No violet color High O2 content in the chamber Restart the plasma etching procedure. 
Flush less O2 into the chamber
5 No color development in the  
enzyme-substrate reaction of the 
ELISA procedure, whereas the  
passively adsorbed control plate 
developed color
Characterize with FTIR spectroscopy  
to determine whether there is any  
characteristic amine peaks. If not, then  
APTES may be degraded (hydrolyzed).  
If yes, proceed to next troubleshooting step
Use a different batch of APTES
7 Same as in Step 5 Check as in Step 5; if the problem is not 
resolved after replacing APTES, then the EDC 
may be degraded/hydrolyzed
Use a new EDC stock. If the problem  
still persists, check the next trouble-
shooting step
9, 11, 12 No color development in the  
enzyme-substrate reaction of the 
ELISA procedure
Capture or detection antibody and/ or  
antigen may have lost functionality
Proteins, such as antibodies or many 
antigens, are highly susceptible to  
temperature or storage conditions.  
Avoid repeated freeze-thaw cycles 
and store appropriately
10 High background Check quality of BSA Use different BSA stock and make up 
fresh solution in PBS
13 No color development in the  
enzyme-substrate reaction of 
 the ELISA procedure
Degraded streptavidin Streptavidin should be stored in the 
dark. Reconstitute fresh solution and 
store in the dark
14 Same as in Step 13 TMB or H2O2 may be degraded Use fresh TMB and/or H2O2 solution
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Figure 2 | Assay performance with the developed and conventional  
ELISA procedure. A concentration range of HFA/AHSG (0–20,000 pg ml − 1)  
was subjected to ELISA on different plates with either covalently 
immobilized or passively adsorbed antibody. The results shown are the 
mean ± s.d. The EC50 represents the concentration of the analyte/ligand 
that generates 50% of the maximum signal obtained in the linear working 
range on a standard curve. This is also known as half-maximum effective 
concentration. The LOD is the minimum amount of the analyte that is 
detected when the analyte is subjected to an assay. % CV denotes the 
variability in measuring a specific analyte concentration in a given 
number of assay repeats.
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444 | VOL.6 NO.4 | 2011 | nature protocols
 conventional assay were 625 pg ml − 1 and 23 ng ml − 1, respec-
tively. The working/dynamic range for the developed sandwich 
ELISA was 10–20,000 pg ml − 1, whereas for conventional assay it 
was 150–20,000 pg ml − 1 (ref. 11). This was mainly because of the higher retention rate of the covalently immobilized anti-
body, whereas the physisorbed antibody in conventional assays could leach out or be lost because of protein exchanges3–6.  
Another advantage of this strategy is the long-term storage stability of the capture antibody-coated microtiter plates, which 
can be useful for the development of commercial diagnostics. The developed protocol also enables the utilization of  
a number of different solid support matrices, irrespective of their chemical nature, as depicted in Figure 3. The developed 
procedure was demonstrated by performing ELISA on different polymeric matrices, such as cellulose acetate, polystyrene, 
PMMA and polycyclo-olefin (Zeonex), in a modified microtiter plate format11,24. Thus, the newly developed procedure has  
considerable advantages over the existing procedure, which will enable this protocol to find wide applications as an  
analytical tool in industrial, clinical and research settings.
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Figure 3 | The performance of the developed procedure on a range of 
polymeric solid support matrices. The assay was performed at a HFA 
concentration of 1.25 ng ml − 1 and a comparison was made. CA, PC, PMMA, PS 
and ZnX correspond to signals obtained for the assays performed on amine-
functionalized cellulose acetate, polycarbonate, polymethyl methacrylate, 
polystyrene and zeonex, respectively. The suffix ‘-ads’ after the polymer 
abbreviation (on x axis) corresponds to the assay performed with antibody 
adsorbed on the respective unmodified polymeric matrix, e.g., CA-ads 
corresponds to signal obtained for the assay performed with antibody 
adsorbed on unmodified cellulose acetate polymer.
Note: Supplementary information is available via the HTML version of this article.
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tube surfaces and/or altered immunogenicity†
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DOI: 10.1039/c0an00689kThe non-specific loss of protein analytes can have a major effect on assay results particularly where the
concentrations of such analytes are extremely low and the matrix is complex. This report assesses how
the protein incubated in sample tubes may be lost due to adsorption. Use of proteins, such as bovine
serum albumin (BSA), may be used to pre-treat tubes to reduce such losses. However, such losses may
also be associated with structural perturbations leading to changes in immunogenicity (as a result of
alterations in specific epitope-related conformations). This can lead to erroneous results or lack of
comparability with a range of methodologies such as the bicinchoninic protein assay and
immunoassays or when surface plasmon resonance (SPR)-based approaches are used. A model system
to evaluate these phenomena is proposed.Introduction
Analytical techniques such as surface plasmon resonance (SPR)
and enzyme-linked immunosorbent assay (ELISA) may involve
sample preparation1–5 and long incubation periods of analyte in
sample tubes. Thus, there is a possibility of analyte loss due to
non-specific binding to matrix-associated interferants or
adsorption of protein molecules onto the surface of the tubes or
onto devices used in the preparation procedure.6–14 This may
result in a low analyte recovery and/or a considerable decrease in
the signal obtained with specific techniques (e.g. antibody-based
methods such as ELISA). Therefore, it is critically important to
prevent such analyte loss, particularly for the antigens that are
present at very low concentrations (such as cardiac troponins,
tumor biomarkers or cytokines).15 The use of relevant controls
and standards can be used to compensate for some losses due to
this phenomenon. However, it can have very significant effects if
the technique or assay used is no longer able to detect the lowaCentre for Bioanalytical Sciences (CBAS), National Centre for Sensor
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1406 | Analyst, 2011, 136, 1406–1411levels of the analyte present, due to the amount lost in the pre-
analysis steps.
This report describes analyte losses both as a function of
duration of incubation and due to the chemical nature of the tube
material. The model analytes employed for this study were
human fetuin A (HFA) and HRP-labeled mouse IgG. Analyte
loss was characterized by comparative analysis of sampling
performed in tubes that were either treated with blocking
proteins such as BSA or were used without any prior treatment
(untreated). Known quantities of the analyte were incubated in
BSA-treated and untreated tubes made of polypropylene (PP)
and low protein-adsorbing chrome-coated glass (GT) (custom-
ized for SPR studies) for 0, 0.5 and 12 h. The analyte loss was
characterized as a function of decrease in absorbance obtained
with the bicinchoninic acid (BCA) assay (which is a direct
method for calculation of total protein concentration in solution
and hence, to quantitate protein recovery). After confirming
protein analyte loss with the BCA assay, enzyme-linked immu-
noassay (ELIA) and surface plasmon resonance (SPR) were
employed to determine the apparent concentration of the tar-
geted analytes. Our findings indicated that in immunoassay-
based analyses the reduction in concentration may be due to
a combination of losses associated with non-specific adsorption
and structural changes that may result in altered epitope
conformation leading to reduced immunogenicity.Experimental
Materials
1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC), sulfo-
N-hydroxysuccinimide (SNHS), phosphate buffered saline (PBS,
0.1 M, pH 7.4), 2-(N-morpholino)ethanesulfonic acid (MES,This journal is ª The Royal Society of Chemistry 2011
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View OnlinepH 4.7), tetramethylbenzidine (TMB) substrate kit, BCA assay
kit and bovine serum albumin (BSA) were purchased from
Fischer Scientific (Ireland), Ballycoolin, Dublin, Ireland. HRP-
labeled mouse IgG, goat anti-mouse IgG, potassium hydroxide
(KOH), 3-APTES, absolute ethanol, Nunc 96-well polystyrene
plates (P7491) and Eppendorf polypropylene (PP) microtubes
were obtained from Sigma-Aldrich, Tallaght, Dublin, Ireland.
SIA gold chips (BR-1004-05) and glass vials (BR-1002-09) were
obtained from GE Healthcare, Buckinghamshire, HP7 9NA,
UK. Human fetuin A/AHSG duoset kit, with all human fetuin A
assay components, was procured from R&D Systems Europe,
Abingdon, Oxon, UK. The kit consisted of the capture anti-
human fetuin A/AHSG (anti-HFA) antibody from mouse,
human fetuin A/AHSG standard, biotinylated goat anti-HFA
detection antibody and streptavidin–HRP. All the assay
components were reconstituted in 0.15 M PBS, pH 7.4, with 1%
(w/v) BSA. All buffers and solutions were prepared using Milli-Q
deionised water (DIW). The dilution of BSA was made in 0.15 M
PBS, pH 7.4, whereas KOH and 3-APTES were diluted in DIW.
EDC and SNHS were reconstituted in 0.1 M MES buffer,
pH 4.7.
Tube-blocking
Polypropylene (PP) and glass (GT) tubes were treated with 1%
(w/v) BSA for 30 min followed by extensive washing with PBS
(0.15 M, pH 7.4; Sigma-Aldrich, Ireland). The tubes were dried
under nitrogen (N2).
Sampling
HFA (0–20 000 pg mL1) and HRP-labeled mouse IgG
(0–1210 ng mL1) were reconstituted in 0.15 M PBS, pH 7.4. All
samples were incubated in BSA-treated and untreated tubes (PP
and GT) for 0, 0.5 and 12 h at room temperature (RT). Addi-
tionally, HFA was also incubated in BSA (1% (w/v))-treated and
untreated tubes at 4 C for analysis essential to quantify the
contribution of sample incubation conditions to the altered
immunogenicity. ‘Blank’ controls for this study had zero analyte
concentration and were incubated for 0 h in blocked PP and GT
tubes. These controls also facilitate the detection of any BSA
leaching into solution from the tube surfaces following blocking.
Analytical
ELIA was performed over the stated concentration range of
analytes for all sets of sampling, whereas the BCA and SPR
assays were performed at concentrations of 10 ng mL1 and
300 ng mL1 for HFA and HRP-labeled mouse IgG, respectively.
The BCA assay, performed according to the manufacturer’s
instructions, was used to determine the HFA recovery in the
samples incubated for different durations. ELIA was performed
with covalently immobilized anti-HFA antibody, as previously
described.16 The microtiter plate wells were activated using 1%
(w/v) KOH. The amine-functionalization was performed with
3-aminopropyltriethoxy silane (APTES). The anti-HFA anti-
body was conjugated to the aminated surface via EDC chemistry.
For SPR (Biacore 3000) analysis each flow-cell of the amine-
activated gold chip had approximately 5000 response units of
anti-HFA antibody immobilised, using EDC chemistry. TheThis journal is ª The Royal Society of Chemistry 2011sample buffer (HEPES, pH 7.0) was passed over all the flow-cells
serving as a blank. Four different concentrations of HFA
(1.25–10 ng mL1) in two sets were incubated in BSA-treated and
untreated tubes and were then subjected to SPR analysis. The
corresponding control values were deducted from each signal
value. The absorbance and RU signals obtained for ELIA and
SPR were analysed and reported as the % analyte loss, where the
% signal loss for each set of experiment was calculated as a loss
relative to the 0 h sampling performed in blocked (B) tubes and
discussed in detail in the Theory and analysis section. Similarly,
goat anti-mouse IgG was immobilized on the chip and
HRP-labeled mouse IgG was assayed at a concentration of
300 ng mL1 (concentration just above the EC50 value). SPR was
performed on all samples that were used in the BCA assay and
ELIA.Theory and analysis
The model developed is an attempt to capture key elements that
can impinge on the accuracy and potential sensitivity of an assay
and to suggest approaches that may help to quantitate and
minimise the sample loss. It is also the case that there are inherent
limitations in the analytical methods used but the model attempts
to take these into consideration.
The model describing various theoretical considerations is
presented in Fig. 1. The model follows the sequence of events
according to the ‘A–B’ rule, where the contributing factors are
calculated by deducting individual fractions at each step from the
total. All the calculations performed with the results obtained
from BCA, ELIA and SPR were based on an assumption that
there was no significant analyte loss for the samples incubated in
blocked tubes for 0 h incubation. The difference in signals
obtained for samples incubated for various durations in blocked
and unblocked tubes with respect to those in blocked tubes at 0 h
quantifies the adsorption-based analyte loss (%DS). This is
summarized as eqn (1).
%DS ¼ [1  (St/S0h B)]  100 (1)
where St: signal obtained for the HFA or HRP-labeled mouse
IgG samples at a given incubation time and S0h B: signal obtained
for the HFA or HRP-labeled mouse IgG sample incubated in
BSA-treated tubes at 0 h incubation (equivalent to 100% signal).
The loss was expressed as the relative percentage signal loss
(Table 1, marked with *), where the signal corresponds to the
absorbance (for ELIA-based analysis) or response units (for
SPR-based analysis) for each set of sampling performed in either
PP or GT tubes.
Similarly, the signal loss contributed by the reduced analyte
immunogenicity (%DSimmunogenicity-associated) was calculated as
the difference in signals obtained with the samples incubated for
12 h in blocked tubes at RT with respect to those in blocked tubes
for 12 h at 4 C. This is shown in eqn (2). This assumption was
based on the fact that when protein molecules in solution are
adsorbed onto surfaces, their conformation may become more
unstable and a loss of structural integrity can occur.17–21 There
may also be aggregation-dependant activity loss where the
aggregation may either be due to solvent22,23 or temperature
effects.24 Additionally, an increase in protein adsorption occursAnalyst, 2011, 136, 1406–1411 | 1407
Fig. 1 This model is designed to illustrate that the losses in the analyte (e.g. HFA) concentration, as determined by antibody-based methods, result from
a combination of both adsorption on the tube surfaces and loss of the conformation-related immunogenicity and that these increase over the time of
incubation and also are temperature dependent.
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View Onlinein the temperature range 20–40 C. However, at lower temper-
atures there is a significant reduction in adsorption.25,26
For this study, the analyte samples were incubated in the BSA-
treated tubes under two conditions: (a) at RT and (b) at 4 C with
the same experimental set-up. The percentage fraction of the
signal loss relative to the samples incubated at 4 C for 12 h was
calculated using the following eqn (2)
%DSimmunogenicity-associated ¼ [1  (S12h RT B/S12h 4 C B)]  100 (2)
where S12h RT: signal of the HFA or HRP-labeled mouse IgG
samples incubated for 12 h at RT and S12h 4 C B: signal of theTable 1 Determination of the total HFA loss due to non-specific adsorption
Incubation time/h Sample tube
Percentag
to sample
time in blo
ELIA
0 RT BSA-treated PP 0
Untreated PP 7
0.5 RT BSA-treated PP 11
Untreated PP 23
12 RT BSA-treated PP 34 (24**)
Untreated PP 65 (49**)
12 (4 C) BSA-treated PP 24***
Untreated PP 48***
a * The percentage signal loss for each set of HFA samples at a defined incuba
performed at 0 h incubation. ** The fraction of the total signal loss contributed
The percentage signal loss obtained for sampling performed at 12 h in BSA-tr
to the immunogenicity loss (marked with ** in Table 2) corresponds closely w
treated and untreated tubes at 4 C for 12 h. This indicates that the immunoge
C. b PP stands for polypropylene tubes. c r2 is the coefficient of determinat
confidence) represents the level of significance between the analysis perform
this study were calculated using SigmaPlot software version 11.0.
1408 | Analyst, 2011, 136, 1406–1411corresponding sample incubated for 12 h at 4 C in BSA-treated
tubes (equivalent to the estimate of the signal loss contributed
mainly by adsorption in blocked tubes only).
This fraction, as exemplified by eqn (2), corresponds to losses
associated with the altered immunogenicity in samples due to
longer incubations. However, the total analyte loss (eqn (1)) for
12 h incubation at RT is consisted of two different loss frac-
tions corresponding to adsorption and the altered immunoge-
nicity. Therefore, in order to obtain how much the
compromized immunogenicity (eqn (2); Table 2, marked
with **) contributes toward the total signal loss we have
devised eqn (3).and the conformation-related immunogenicity changesa
e signal loss* relative
s of 0 h incubation
cked tubes
Correlation studies
BCA BCA vs. ELIA
0 BSA-treated PPb, r2c ¼ 1.00 (p ¼
0.76) and untreated PP, r2 ¼ 0.78
(p ¼ 0.48)
5
2
7
24
30
9
24
tion time was calculated using eqn (1). The control for this used blocking
by adsorption-based non-specific losses and calculated using eqn (4). ***
eated and untreated tubes (**) after deducting the fraction corresponding
ith the percentage signal loss obtained for the samples incubated in BSA-
nicity-related losses in HFA samples were minimized for incubations at 4
ion of the techniques used for cross-validation and the p-value (at 95%
ed with both the experimental approaches used. The r2 and p-values for
This journal is ª The Royal Society of Chemistry 2011
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View Online%(DS/DSimmunogenicity-associated) ¼ [(Bn)(An)] (3)
where Bn: the altered immunogenicity-associated loss
(%DSimmunogenicity-associated) for ‘n’ h of incubation at RT, An: the
total signal loss (%DS) in the samples for the corresponding
incubation time (as calculated using eqn (1)).
Similarly, the adsorption-associated analyte loss can be
obtained by deducting the altered immunogenicity fraction (eqn
(3)) from the total analyte loss corresponding to 100% loss (eqn
(1)). The percentage fraction of the total signal loss corre-
sponding to the loss due to non-specific adsorption (Table 1,
marked with **) was calculated using eqn (4),
[(100  Bn)An] (4)
Furthermore, these equations are explained in detail with an
example in the Theory and analysis section of the ESI†.
Moreover, the immunogenicity-associated loss in untreated
tubes could also be determined by eqn (5) (Table 2). A
comparison of samples incubated in untreated tubes for 12 h at
RT with the samples in untreated tubes for 12 h at 4 C is
informative (eqn (5), Table 2). The fractions corresponding to
loss due to adsorption and immunogenicity are listed in Table 1.Fig. 2 Analysis of the protein analyte (HFA) loss due to non-specific
adsorption and the conformation-related immunogenicity as a function
of percentage signal loss. The BCA assay was employed initially to
quantify the HFA loss (initial concentration (C0) of 10 ng mL
1) in the
BSA-treated (B) and untreated (U) sample tubes (the numerical value
before B and U corresponds to the time of incubation in hours). The
findings of the BCA assay were cross-validated to immunoassay formats
with a sandwich ELIA and SPR. The ‘12B 4’ and ‘12U 4’ correspond to
the 12 h incubation of HFA performed at 4 C in BSA-treated and
untreated tubes, respectively. Error bars represent the standard devia-
tion. The % loss was expressed relative to the signal obtained for samples
incubated in blocked tubes at 0 h incubation (equivalent to 100% signal)
and was calculated using eqn (1).Results and discussions
Evaluation of the protein loss in unblocked PP tubes
The loss of HFA (initial concentration (C0) ¼ 10 ng mL1) and
HRP-labeled mouse IgG (initial concentration (C0) ¼ 300 ng
mL1) over the time was quantified by the BCA assay (Fig. 2).
The relative loss was calculated as a difference between the initial
(C0) and recovered (CT) concentrations of the analyte in solution
[C0CT]. The analyte loss obtained with the BCA assay was also
compared and correlated with SPR and ELIA (Fig. 2, Table 1
and Fig. S1a and c, ESI†). However, the analyte loss shown with
the BCA assay was considerably lower than that found with SPR
and ELIA.
This difference in loss calculated using the BCA assay with
respect to ELIA and SPR is due to the nature of the analytical
approach. BCA measures the total protein content in the solu-
tion and does not distinguish the conformationally compromised
analyte from its active form. Therefore only the protein loss
attributed to adsorption is accountable in the case of BCA assay.
However, ELIA and SPR are highly sensitive approaches andTable 2 Determination of the immunogenicity-associated loss for HFA sam
In BSA-treate
%DSimmunogenicity-associated 30*
Immunogenicity-associated loss as
a % of the total loss
10**
a * The calculations pertaining to the immunogenicity-associated analyte loss
mentioned in eqn (5). %DSimmunogenicity-associated in untreated tubes ¼ [{1 
determines the compromised immunogenicity-associated loss in untreated
duration at 4 C and RT. This comparison will provide the losses due to t
unblocked tubes. Fraction ‘[{1  (S12h U RT/S12h U 4 C)}]’ in eqn (5) corresp
the fraction ‘{1  (S12h B RT/S12h U RT)}’ corresponds to adsorption losses.
altered immunogenicity-associated losses in untreated tubes. ** Contribution
calculated using eqn (3).
This journal is ª The Royal Society of Chemistry 2011losses due to both adsorption and the analyte conformation
changes are detectable. This results in a higher % signal loss due
to analyte loss. There was no significant loss obtained with the
BCA assay for the samples incubated in untreated tubes for 0 h
and 0.5 h. Whereas, a consistent increase in the percentage loss
was obtained with ELIA and SPR as a function of the increasing
incubation time.
The protein loss was higher in GT tubes in comparison to PP
tubes (Fig. S2, ESI†). This differential analyte loss behaviour was
attributed to the chemical nature of the tube material used. The
data obtained for HFA were validated with a HRP-labeled
mouse IgG-based two component system (Fig. S3, ESI†). Similar
results were obtained with the HRP-labeled mouse IgG and were
in accordance with the previous reports on the loss of immuno-
globulin from the solution.27 However, HFA (59 kDa) isples incubated in BSA-treated and untreated tubes for 12 h at 4 Ca
d tubes (eqn (2)) In untreated tubes (eqn (5))
28*
18**
were performed using either eqn (2), or the modified version of eqn (2), as
(S12h U RT/S12h U 4 C)}]  [{1  (S12h B RT/S12h U RT)}]  100 eqn (5)
tubes by comparing samples incubated in untreated tubes for a 12 h
he altered immunogenicity by deducting adsorption-associated losses in
onds to the loss due to the altered immunogenicity and adsorption but
Therefore, by deducting adsorption losses from the earlier will give the
of %DSimmunogenicity-associated toward total signal loss (Table 1, **) was
Analyst, 2011, 136, 1406–1411 | 1409
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View Onlinea relatively smaller molecule in comparison to the HRP-labeled
mouse IgG molecule (194 kDa). This significant size difference
between HFA and the mouse IgG–HRP conjugate significantly
changes the adsorption behaviour although the loss behaviour
follows the same pattern for both analytes.Effect of tube-blocking on the protein analyte loss
The tube surface was treated with 1% (w/v) bovine serum
albumin (BSA), which is a routine blocking agent for various
immunoassays. Tubes were incubated with 1% (w/v) BSA for
30 min followed by washing with 0.15 M PBS, pH 7.4, and dried
under N2.
The percentage signal loss (protein analyte loss) in the blocked
tubes was analyzed using the same procedure as described
previously for the untreated tubes. A comparative analysis was
made for the analyte loss obtained for test samples incubation in
BSA-treated and untreated tubes over a 12 h incubation period
(Fig. 2).
A significant decrease (p # 0.05) in the amount of protein loss
was achieved by blocking the tubes with 1% (w/v) BSA.
However, it is advisable to optimize the surface blocking as
a function of BSA concentrations and tube-treatment times for
all types of polymers as the adsorption kinetics of the blocking
proteins are dependent on the chemical nature of the surface to
be treated.
The tube treatment significantly improved the available
antigen concentration in solution and, hence, various analytical
features of the assays (Table S1, ESI†). However, while a certain
amount of analyte loss was observed in the BSA-treated tubes
with 12 h incubation, it was significantly less (p # 0.05), in
comparison to the untreated tubes (Fig. S1a–d, ESI†). This
signal loss in blocked tubes may be due to the nature of BSA,
which has a tendency to bind reversibly to a variety of potential
analytes, thus developing a dynamic interaction between the
BSA adsorbed on the tube surface and the free analyte in
solution.28,29
The effect of tube-blocking was also analyzed in a direct assay
format by incubating HRP-labeled mouse IgG in the untreated
and BSA-treated tubes, and assaying with immobilized goat anti-
mouse IgG (Fig. S3, ESI†). The results obtained were found to
correspond to those with HFA.Evaluation of the contribution of the HFA fraction with
conformation-related impaired immunogenicity
The loss of protein activity as a result of conformational changes
on solid–liquid interfaces29–32 or due to molecular flattening/
spreading33 has already been demonstrated. However, analysis of
protein losses due to these phenomena and their effects on the
bio/immunoassay performance have not been reported. It was
shown that adsorption may be a potential source of conforma-
tional stress on protein molecules, which may result in
a compromized immunogenicity. Therefore, in this study an
attempt was made to assess the contribution of the immunoge-
nicity loss to the loss of signal in samples incubated for 12 h at
room temperature. This fraction of signal loss was quantified by
calculating the difference in the signals obtained for samples
incubated in BSA-treated and untreated tubes at room1410 | Analyst, 2011, 136, 1406–1411temperature and comparing them with samples incubated in
BSA-treated tubes at 4 C using eqn (2). These calculations were
initially based upon previous reports stating that the conforma-
tion-associated activity of a protein is retained at lower temper-
atures in the order of 4 C > RT > 37 C.34–38 Therefore, the
signal loss contributed by the fraction of HFA with the impaired
immunogenicity will be minimal for the samples incubated in
BSA-blocked tubes at 4 C. There was a substantial signal loss
due to this phenomenon, which was significantly greater in the
samples incubated in untreated tubes. As claimed in many
studies29–33 the compromised immunogenicity loss may be
a result of the conformational stress/change induced either by
solid–liquid interface or by molecular spreading of proteins in
physisorbed systems that increases over the period of incubation.
The adsorption-associated loss (%DSadsorption) obtained for
samples incubated at RT and the total loss (%DS) in samples
incubated at 4 C for 12 h were equivalent (p # 0.001) (Tables 1
and 2). These findings justify our assumption that there were
significant reductions in the losses due to the impaired immu-
nogenicity of the HFA samples incubated at 4 C for a duration
of 12 h. One explanation may be that the kinetics of proteins in
solution reduces significantly at lower temperatures. Therefore,
with less movements in the solution, the probability of analyte
interactions with the surface is also reduced.
The results obtained indicate that epitope-conformation
changes and related immunogenicity alterations contribute
significantly to the apparent loss of analytes during sample
preparation and processing, and may be significantly minimized
by using BSA-blocked tubes at 4 C.Evaluation of the signal loss due to the nature of tube material
The dependence of the protein loss on the chemical composition
of the sample tubes (PP and glass (GT)) was analyzed. The %
signal losses obtained for HFA sampling in BSA-treated and
untreated PP tubes were significantly lower than the corre-
sponding values obtained in GT tubes even though GT tubes
were customized for low protein adsorption. This protein
adsorption behaviour strongly supports the previous reports,
where hydrophilic self-assembled monolayers (SAMs) were
found to be more active in terms of protein adsorption than
hydrophobic SAMs.10,39,40 A similar finding was also reported for
silica-based nanoparticulate material.41 However, the BSA-
treatment significantly reduced the analyte losses due to non-
specific adsorption in both type of tubes (Fig. S4, ESI†).
Therefore, the use of pre-treated sample tubes significantly
reduced analyte losses and this is of major significance to
generate accurate assay results, minimise the loss of analytes and
leads to a greater reproducibility in immunoassays based on
different assay/biosensor formats.Conclusions
In the design of any assay involving protein analytes it is
necessary to carefully select the tubes used and it may be neces-
sary to pre-treat (block) them to minimise losses due to non-
specific adsorption or alterations in the immunogenicity. Careful
selection of temperature is also required. It is advisable to opti-
mise these parameters in relation to each protein studied.This journal is ª The Royal Society of Chemistry 2011
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View OnlineA model approach was developed to assist in the rationale
understanding of the issues involved.
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This Article addresses the important issue of the characterization of surface functional groups for optical bioassay
applications. We use a model system consisting of spherical dye-doped silica nanoparticles (NPs) that have been func-
tionalized with amine groups whereby the encapsulated cyanine-based near-infrared dye fluorescence acts as a probe of
the NP surface environment. This facilitates the identification of the optimum deposition parameters for the formation
of a stable ordered amine monolayer and also elucidates the functionalization profile of the amine-silanization process.
Specifically, we use a novel approach where the techniques of fluorescence correlation spectroscopy (FCS) and fluores-
cence lifetimemeasurement (FL) are used in conjunctionwith themore conventional analytical techniques of zeta poten-
tial measurement and Fourier transfer infrared spectroscopy (FTIR). The dynamics of the ordering of the amine layer in
different stages of the reaction have been characterized by FTIR, FL, and FCS. The results indicate an optimum reac-
tion time for the formation of a stable amine layer, which is optimized for further biomolecular conjugation, whereas
extended reaction times lead to a disordered cross-linked layer. The results have been validated using an immunoglob-
ulin (IgG) plate-based direct binding assay where the maximum number of IgG-conjugated aminated NPs were
captured by immobilized anti-IgG antibodies for theNP sample corresponding to the optimized amine-silanization con-
dition. Importantly, these results point to the potential of FCS and FL as useful analytical tools in diverse fields such as
characterization of surface functionalization.
1. Introduction
The use of fluorescence-based nanoparticles (NPs) as high
brightness labels in the field of nanobiophotonics has potential in
the broad area of clinical diagnostics.1 The essential criteria to
construct an efficient high brightness label involves the tuning of
primarily twomajor properties (i) the brightness and (ii) the target
specificity. The latter, which is the focus of this Article, is achieved
by functionalizing2 the NP with appropriate surface chemistry,
which facilitates the conjugation of the relevant biomolecule, for
example, an antibody in the case of NP-based immunosensing.3,4
For this attachment, several surface functionalization strategies
are available such as amine-silanization,5 thiol-silanization,6 and
epoxylation.7 Optimum conjugation requires a well-ordered sur-
face,8 which enables conjugationof the antibodywith proper func-
tional conformation so as to avoid steric hindrance of binding to
the target antigen.
Silica NPs have advantages such as high brightness compared
with single dye molecule probes, tunability of size, ease of surface
functionalization, and relative biocompatibility. These properties
are advantageous to design efficient bioassays with decreased limit
of detection (LOD)9 as well as the use of the NPs as cellular
probes.10 There are two main approaches to the synthesis of
highly fluorescent silica NPs, the St€ober sol-gel process,11 and
the reverse microemulsion12 approach, which is the approach
used here.
Standard conjugation strategies normally involve covalent linker-
based attachment chemistry. The approach used here involves an
amine functionalization strategy using aminopropyl triethoxy
silane (APTES).13 The availability of free hydroxyl groups on the
silica surface facilitates the surface functionalization of the NP.
The ability of silanes such as APTES to form siloxane bonds by
reacting with the silanol hydroxyl groups, makes them useful in
silica functionalization. In this work, to achieve a homogeneous,
ordered amine surface layer, we adopted an APTES-based self-
assembly approach.
Techniques like ellipsometry,14,15 contact-angle goniometry,15
andX-ray photoelectron spectroscopy16 are useful tomeasure the
amine layer thickness on a flat surface, more popularly on the
glass surface15-17 or siliconwafers,17 but these techniques fall short
*Corresponding author. E-mail: Colette.McDonagh@dcu.ie.
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for NP-based systems because of the very small thickness of the
amine layer15,17 on theNP surface comparedwith theNPdiameter.
This significantly limits the detection by the aforesaid methods.
Another important technique, FTIR, has also been used18,19 to
elucidate the dynamics of APTES-based amine layer growth on a
planar silica surface, but the dynamics aswell as the time course of
the reaction on the nanosurface have not yet been reported in
detail to our knowledge. In thisArticle, we have not only extended
the study of the amine-silanization profile to the nanosurface of
dye-doped silica NPs but also introduced fluorescence lifetime
(FL)20 and fluorescence correlation spectroscopy (FCS)21,22 to
complement the conventionally used techniques for NPs like zeta
potential measurement and FTIR to construct a complete reac-
tion profile for the surface amine-silanization of the NPs. The
advantage of fluorescence-based techniques lies in high sensitivity
detection. In our system, the near-infrared dye, 4,5-benzo-50-
(iodoacetaminomethyl)-10,3,3,30,30-pentamethyl-1-(4-sulfobutyl)-
indodicarbocyanine (NIR664), has been covalently encapsulated
in the silica NPs by the microemulsion method. The cyanine-
based dyes are very efficient sensors of chemical environment
because of their strong fluorescence response to the hydrophobic-
ity of the immediate microenvironment23 that actually alters the
equilibrium between themonomer and aggregate states of the dye,
having distinct absorption peaks at 665 and 615 nm, respectively.
While encapsulated inside a NP, the dye is distributed in two dis-
tinct populations, and thus any significant alteration at the imme-
diate microenvironment of the dye doped NP can be sensed by
this dynamic equilibrium.Hence,wehave applied the fluorescence-
based techniques of FCS and FL measurement to probe the
behavior of the dye under the influence of the immediate micro-
environment of the aminated NP surface. The dual component
FL behavior of the dye in the NP has recently been reported by
our group, which describes smaller (say t1) and larger (say t2)
components as representative for the core fraction and a more
solvent accessible, that is, a peripheral fraction.24 This has been
used here as a useful tool for characterizing the surface function-
alization.
Regarding FCS, several parameters have been reported to be
critical in describing some key biomolecular reactions by various
groups. Flomenbom et al. have reported on the stretching of fluo-
rescence correlation decay to elucidate a protease activity.25 Kohl
et al. also used fluorescence cross-correlation to determine pro-
tease activity and presented relative cross-correlation as an inter-
esting tool to investigate the reaction kinetics.26 Later, Prakash
et al. addressed the fluctuation of enzymatic catalysis by using the
autocorrelation function (ACF).27 Recently, protein folding dy-
namics has been addressed by FCS.28 Of late, the important
application of this versatile technique in the field of nanoprobe
characterization has been published by theWiesner group,29 who
have shown the FCS signatures of dye within a NP. We have
extended the application of this technique to probe the surface
functionalization of theNP, in particular, to elucidate the detailed
structure of the amine functional layer as a function of APTES
exposure.
A key achievement of this work is the use of multiple charac-
terization techniques, including somenovel approaches, to achieve
an optimized ordered amine layer. The model system used is a
dye-doped silica NP where the dye fluorescence is sensitive to the
NP surface environment. This enables the use of novel techniques
such as FL and FCS, in combination with FTIR and other tech-
niques, tomonitor the growth and conformation of amine groups
on the surface.
2. Experimental Section
2.1. Synthesis of Dye-Doped NPs.NIR664 (1.6 mg, Sigma
Aldrich) solubilized in 1-hexanol (Sigma Aldrich) was reacted
with 1 μL of mercaptopropyl triethoxy silane (MPTES, Sigma
Aldrich) in a nitrogen atmosphere with constant stirring at room
temperature for 3 to 4 h. The iodoacetamide part drives the reac-
tion by interacting with the thiol group to form covalent conjuga-
tion. For the particle synthesis, we prepared a microemulsion by
mixing 3.78 g Triton X-100 (Sigma Aldrich), 15 mL of cyclohex-
ane (SigmaAldrich), 1.6 mL of hexanol (SigmaAldrich), 2 mL of
the conjugated dye, and 0.96 mL of Milli-Q water by stirring for
5 min. After the microemulsion was formed, 200 μL of TEOS
(Sigma Aldrich) was added to it and stirred for 30 min. Then,
120μLofNH4OH(SigmaAldrich)was added to start the alkaline
hydrolysis for 24 h. Then, a further 150 μL of TEOSwas added to
the reaction mixture to make a compact silica shell at the exterior
of theNP. Itwas thenwashed four timeswith ethyl alcohol (Sigma
Aldrich) in 9000 rpm for 25 min and finally resuspended in ethyl
alcohol. The TEM picture of the ∼80 nm NP can be found in
Figure s1 of the Supporting Information.
2.2. Amine-Silanization of the NPs. The kinetics study was
performed to study silanizationbehavior ofAPTES (SigmaAldrich,
Ireland) onNPs. Silanizationwas performedwith 2% (v/v) APTES
prepared in absolute ethanol in a set of five different time points
viz. 1, 2, 3, 5, and 12 h, considering nonfunctionalized NP as the
control for this study (0 h). Each sample set was fed with a starter
batch ofNP sample at a concentration of 6mg/mL.Additionally,
a set of NP functionalization with various amine concentrations
was performed to find out the optimum working amine concen-
tration. These NPs were subjected to 0.5, 1, 2, and 3%APTES in
absolute ethanol for the optimized period from the previous set of
experiments again with reference to nonfunctionalizedNPs as the
control (0% APTES).
2.3. Thiol-Silanization of the NPs. For comparison, NPs
from the same batch were modified with 2% (v/v) thiol-terminal
mercaptopropyltrimethoxysilane (MPTMS) under similar condi-
tions for the same time period at which amine-silanization ofNPs
was performed. The extent of thiol-silanizationwas checked spec-
trophotometrically by using Ellman’s reagent (Thermo Fischer,
Dublin, Ireland; see Figure s2 of Supporting Information for
details).
Assay Details. Aminated NPs were conjugated to mouse IgG
by using conventional linker chemistry for attaching mouse IgG.
NPs (10 mg/mL) were incubated with 4% (v/v) APTES over five
different durations, that is, 1, 2, 3, 5, and 12 h. The NP-APTES
solution was continuously stirred for corresponding durations.
Each set of NP-APTES solution was subjected to centrifugation
(15 000 rpm) wash with absolute ethanol five times and finally
with 0.01M PBS (pH 7.4). The mouse IgG (990 μL of 3 μg/mL in
0.1M PBS, pH 7.4; Sigma Aldrich, Ireland) was incubated with a
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10 μL premixed solution of 1-ethyl-3-[3-dimethylaminopropyl]-
carbodiimide hydrochloride (EDC; Thermo Fischer, previously
Pierce) (4mg/mL) andN-hydroxysulfosuccinimide (SNHS;Thermo
Fischer) (11 mg/mL) for 15 min at 37 C. The resulting EDC-
activated IgG solution was added to the APTES-functionalized
NPs, suspended in 0.01M PBS (pH 7.4), and incubated for 1 h at
RT. The IgG-conjugatedNP solution was washed five times with
0.01MPBSpH7.4.The goat anti-IgG (10μg/mL; SigmaAldrich)
was physisorbed in the microtiter plate wells by incubating for 2 h
at 37 C. Afterward, the plate wells were washed five times with
0.1M PBS (pH 7.4) and blocked for 30min with 1% (v/v) bovine
serum albumin (BSA; Thermo Fischer) in 0.1M PBS, pH 7.4 at
37 C. The plate was subjected to a wash with PBS five times. The
IgG-conjugated NPs were incubated in the corresponding anti-
IgG immobilized plate wells and incubated for 1 h at 37 C, fol-
lowed by five PBS washes. The fluorescence was recorded with
Tecan (GmBH, Austria). A 96-well plate was used to incubate
goat antimouse IgG on its surface. Unbound anti-IgG was
washed away. IgG-conjugated NPs of equal concentrations
were added to the anti-IgG plate (in triplicate). After 30 min,
the unbound NPs were washed away. The plate was excited at
660 nm and was read at 690 nm.
2.4. Characterization of the Aminated Nanoparticles.
ZetaPotentialMeasurement.The zeta potential for the aminated
sampleswasmeasuredbyaBeckmanCoulter Instrumentbyusing
the flow cell. The average obtained from three measurement sets
was analyzed by the DelsaNano software in the Results and
Discussion section, where each measurement was the average of
50 individual measurements performed at various positions
(10 measurements each in 5 positions) in the flow cell that is set as
default.
FTIR Study. Liquid FT-IR (Thermo Nicolet Corporation,
Madison,WI) was used to characterize the chemical nature of the
functionalization on NPs. NPs were resuspended in two sets, one
in absolute ethanol and the other in toluene at a concentration of
2mg/mL for bothof the cases.Thiswas done to assess the effect of
the solvent-based environment on the FT-IR spectral analysis.
The functionalized samples from each set were subjected to FT-
IR, and transmittance (%T) was recorded.Themeasurementswere
baseline-corrected with corresponding solvents. All of these sam-
ples were later analyzed using various peaks in the transmission
spectra.
Measuring FL and FCS.FLandFCSmeasurementswere per-
formed on aMicroTime 200 inverse time-resolved fluorescence
microscope (MT200, PicoQuant, Berlin, Germany). The micro-
scope body comprised amodified Olympus IX71 equipped with a
60 water immersion lens (UPlanSApo 60 1.2 water/CC1.48,
Olympus). Sample illumination was achieved using a horizontally
polarized 640 nm pulsed diode laser (LDH-P-C640, PicoQuant)
operated at 20 MHz. For FL and FCS, a pulsed laser is used to
provide the fluorescence excitation, and the detection was per-
formed on two different time scales. The shorter time scale is the
picosecond-to-nanosecond one, where the distance between the
exciting laser pulses and the photondetection events is taggedwith
time, whereas the larger time scale of detection is in the range of
hundreds of nanoseconds to seconds. The FL is calculated from
the decay of the photon intensity. The absolute arrival time re-
corded for the detected photons is used for calculating the ACF.
However, the ACF function is inversely proportional to the num-
ber of particles in the illumination volume. Fluorescence was sep-
arated from excitation using a 535/640 nm dichroic filter (z532/
635rpc, AHF/Chroma) and passed through a 690/70M emission
filter (HQ690/70M, AHF/Chroma). NP suspensions were placed
on cleanedmicroscope coverslips (Sigma) beforemounting on the
microscope stage. Objective correction collar settings were opti-
mized for minimum sample illumination volumes with maximum
detection levels, and all NP lifetime recordings were performed
20μmabove the coverslip surfacewith a recording timeof 120 s per
sample. Emitted light passed through a polarization independent
50/50 beam splitter (Olympus) and focused onto two single-
photon avalanche detectors (SPADs, Micro Photon Devices).
Illumination was maintained at 0.2 μW at the detectors for all
samples.More than 10000 counts were recorded for each sample,
and the resulting lifetime histograms were tail-fit immediately to
correct for the influence of the machine response function using
double exponential fits. Data were recorded in the time-tagged,
time-resolved format (TTTR) format that enabled both lifetime
and FCS to be performed on the same data set. All data were
analyzed using SymPhoTime (PicoQuant).
Theoritical Aspects of the Correlation Study. The fluores-
cence ACF is denoted by Ga in eq 1, where Ia is the fluorescence
intensity from channel 1, τ is the time delay, and the brackets
(<>) represent the time average (of time t) of the bracketed term.
GaðτÞ ¼ < IaðtÞIaðtþ τÞ >
< IaðtÞ >< IaðtÞ > ð1Þ
However, the ACF performed on the solution has been ob-
served to include the instrument response function (IRF) at the
beginning of the time scale contributed by both channels 1 and 2.
To compensate for the effect of the IRF, the intensities fromchan-
nels 1 and 2 have been cross-correlated, and the cross-correlation
function (CCF), denoted byGab, is defined in eq 2,where Ia and Ib
are the fluorescence intensities of channels 1 and 2, respectively,
and the other terms are the same as those in eq 1. Significant im-
provement of the correlation function is obtained after theACF is
replaced by the CCF, where the CCF acts as a filter for the IRF.
For our fluorescence correlation study, CCF has been performed
and discussed below.
GabðτÞ ¼ < IaðtÞIbðtþ τÞ >
< IaðtÞ >< IbðtÞ > ð2Þ
Another important advantage of CCF in the application field
lies in its ability to quantify the processmore accurately as the am-
plitude of the CCF is proportional to the fluorophore concentra-
tion, which can be estimated by applying eq 3, where Veff is the
effective volume. To equilibrate different sets of aminated NPs,
we have normalized the fluorophore concentration by dividing the
amplitude of CCF by the amplitude of the ACF for the channel
having a smaller fluorophore count. This is referred to as the rel-
ative cross-correlation factor to channel ‘a’ (CCra), as shown in
eq 4.26 For theACF calculation, the channel having a lower count
is chosen over its high counting counterpart. The choice is so
because the photon counts, which correlate with the number of
fluorophores in the confocal volume,may suffer significantly from
fluorescence quenching for a very highconcentrationof the fluoro-
phore, leading to inaccurate concentration parameters.
< Cab >¼ Gabð0Þ
VeffGað0ÞGbð0Þ ð3Þ
CCra ¼ < Cab >
< Ca >
¼ Gabð0Þ
Gað0Þ ð4Þ
A reaction like surface amine-silanization that manipulates the
immediate microenvironment of the nanosurface significantly af-
fects the FCS decay by introducing relaxation to the decay time.
In this system of reacting molecules, the reaction system is com-
posedof two primary components, theNP surface and hydrolyzed
APTES.During the initial stages of this reaction, the nanosurface
is considered tobenonhomogeneousbecauseof the incompleteness
of the reaction leading to a variety of distributions of surface-
attached APTES molecules on the NPs. This heterogeneous dis-
tributionof surface-attachedAPTES is sensedas adisorderedmicro-
environment by the chemically sensitive monomer-aggregate
equilibrium of the encapsulated dye, slowing down the correla-
tion decay. It leads to the hypothesis that the decrease in the
decay constant can be utilized to monitor the whole reaction with
18128 DOI: 10.1021/la103212d Langmuir 2010, 26(23), 18125–18134
Article Roy et al.
reference to the initial state (i.e., reaction at time 0) with re-
spect to the ordering phenomena of thewhole system. The param-
eter Rcor is introduced to correlate the decay constants, as shown
in eq 5, where R0 and Rt are the decay constants at time 0 and
t (hours), respectively. Hence, the parameter Rcor works as a cor-
relator between the state of the reaction at time, t, and the initial
state of a reaction.
Rcor ¼ R0-RtR0 ð5Þ
Other Characterization Techniques. For UV-visible spec-
troscopy, aCary 50 scanUV-visible spectrophotometer (Varian)
was used. For fluorescence spectroscopy, a Fluoromax spectro-
photometer was used. Regarding TEM measurement, a Hitachi
7000 transmission electron microscope was operated at 100 kV.
Image capture was performed digitally by a Megaview 2 CCD
camera.Weprepared specimens byputting adropof the ethanolic
solutions of the NPs on a Formvar carbon-coated copper grid
(Agar Scientific).
3. Results and Discussion
3.1. Zeta Potential Measurement to Measure Surface
Charge. During the amine-silanization reaction of the NPs by
APTES, the negatively charged hydroxyl groups are replaced by
the positively charged amine groups (Figure 1). This charge tran-
sition on the nanosurface can effectively be measured with zeta
potential measurement. The zeta potential results are shown in
Figure 2a. The unmodifiedNP shows an average zeta potential of
-35.8 mV. The NP sample collected after 1 h of incubation with
APTES shows a sharp increase of the zeta potential value to
-8.1 mV. It continues to increase until it reaches saturation at 3 h
with amuchhigher positive value of>35mV signifying the stable
depositionof the amine groupall over the surface of theNPs.Addi-
tionally, the high numerical value of the zeta potential demon-
strates the solvent stability of the NPs. However, although this
technique is straightforward enough to report the effective depo-
sition of the positively charged amine groups on the negatively
charged silica nanosurface, the finer details of the APTES depo-
sition and the formation of the aminemonolayer and cross-linked
super structures cannot be elucidated. The reason for that is
attributed to the fact that upon reaching a critical value of the zeta
potential (here, the saturation value), any further conjugation of
APTES to the nanosurface is involved in either cross-linking or
intermolecular hydrogen bonding engaging the primary amine
groups with -OH groups (nanosurface silanol group or -OH
groups of surface-attached APTES molecules), thus limiting a
further increase in positive zeta potential value.
3.2. FTIRMeasurement Demonstrates Amine Function-
alization. FTIRhas been performed in two solvents, ethanol and
toluene, to investigate two different aspects of the silica nano-
surface. In ethanol, the emphasis is given toward the replacement
kinetics of the silanol (Si-OH) group by the amine group as a
Figure 1. Cartoondepicting the amine-silanization reactionwith theTEM image of the aminatedNPhaving size bar of 100 and 20nm length
for the left and right images, respectively.
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result of the siloxane bond formation and deposition of the
protonated amine group on the nanosurface. In the toluene envi-
ronment, however, the fine structure of the surface-stabilized
amine groups has been studied to make a detailed account of the
whole process because there is no interference from the -OH
groups of the ethanol. First, in the presence of ethanol, the overall
amine-silanization process was studied by following the gradual
disappearance of the surface siloxane (Si-OH) bond and the cor-
responding appearance of the amine group for theNPs suspended
in ethanol. Both the hydroxyl and amine groups are closely placed
Figure 2. (a) Plot of incubation time for APTES with aminated NP suspension versus the zeta potential. (b) FTIR spectra for the same
samples where the inset shows peak shift versus time of amine-silanization.
Figure 3. (a) FTIR signature of the aminatedNP (suspended in toluene) for various reaction times for the 900-1200 cm-1 region is described
to show the conjugation ofAPTESon the nanosurface. (b) Based on that a cartoon is presented to depict theAPTES deposition as a function
of reaction time.
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at the far end of the FTIR spectrum from 3300 to 3600 cm-1,
signified by a broad peak in this region, but there was a significant
kinetic effect to monitor the amine-silanization by assessing the
shift of the peak value of the broad peak from 3350 to 3337 cm-1,
as observed in Figure 2b. When this value of the wavenumber for
the corresponding peakswas plotted against the time ofNPs incu-
bation with APTES, time kinetics was obtained, showing satura-
tion after 3 h, which is shown in the inset of Figure 2b. Therefore,
like the zeta potential measurement, FTIR indicates saturation
kinetics after 3 h of reaction.
FTIR studies performed on theNPs suspended in toluene have
shown several fine structures arising from the amine groups at-
tached to the nanosurface and the attachment between the silica
surface and the APTES moiety. The FTIR spectrum has been
divided into two major parts to analyze the kinetics; the first seg-
ment to be discussed is the region between 1200 and 1800 cm-1,
which deals with various responses from the amine groups, and
the second region spans from 900 to 1200 cm-1, which mainly
deals with the covalent attachment of the silica surface with the
APTES. Figure 3a shows the response of the 900 to 1200 cm-1
region. It shows that the Si-Obonds began forming from the first
hour of reaction from the 1110 cm-1 peak, but the effective con-
jugation has started from the second hour of the reactionwith the
appearance of the conjugation peaks like Si-O-Si at 1030 cm-1
and ethoxy group (-OCH2CH3) at 1080 cm-1. Looking at the
reaction steps of the amine-silanization given in the cartoon in
Figure 3b, it is evident that the first step is the conjugation of sur-
face-OH group with the hydrolyzed APTES, which is followed
by Si-O-Si bond formation between surface-attached APTES
molecules to form the amine monolayer. This agrees well with the
data. It can be seen that the rate of Si-O-Si peak formation is
much higher up to the third hour. For theNPswith higherAPTES
Figure 4. FTIRsignature of the aminatedNP (suspended in toluene) for various reaction times for the 1200-1800 cm-1 region isdescribed to
show the evolution of various populations of amine peaks.
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incubation time (i.e., 5 and 12 h), there is a steep increase in the
ethoxy group (-OCH2CH3) at 1080 cm-1 signifying incomplete
hydrolysis of APTES and significant increase in siloxane groups
(Si-O-Si) at 1110 cm-1, implying cross-linking between the sur-
face bound and free APTES leading to multiple inhomogeneous
layers of amine groups on the nanosurface. In addition, the broad
shoulder starting from 1125 cm-1 signifies the polymerized or
physically adsorbedAPTES on the nanosurface that is very prom-
inent in the 12 h incubation sample. A cartoon based on these
detailed features during theamine-silanization process is presented
in Figure 3b.
To study the detailed amine group kinetics during this amine-
silanization reaction, we studied the 1200 to 1800 cm-1 spectrum
of the aminated NPs in detail, which is shown in Figure 4. The
characteristic FTIR peaks of the amine groups have been identi-
fied in detail. The asymmetric and symmetric deformation modes
of amine groups due to the surface-adsorbed APTES molecules
have been observed at 1610 and 1510 cm-1, respectively. These
two peaks originate from the interaction between the acidic silanol
group on the nanosurface and basic amino group of the APTES.
The deformation modes of amine groups at 1575 and 1493 cm-1,
which appear because of the hydrogen bond formation by the
amine group presumably with atmospheric carbon dioxide, in-
crease with the time of APTES incubation and show significantly
higher density in the 12 h aminatedNPs, with the 1575 cm-1 band
showing a more significant increase. The physical nature of the
interaction is evident from the ω(CH3) mode, that is, the -CH3
wagging mode of the APTES backbone at 1300 cm-1. The two
distinct peaks at 1440 and 1390 cm-1 represent the asymmetric
and symmetric deformation mode for the methyl (-CH3) groups
from the ethoxy group (-OCH2CH3) of the APTES, indicating
the incompleteness of the hydrolysis.
3.3. Fluorescence Lifetime Studies of the Aminated NP
Surface.NIR664-dopedNPs show two distinct FLs correspond-
ing to the solvent-insensitive core fraction of the conjugated dye
located in the NP interior and the solvent-accessible dye popula-
tion located near the nanosurface. The smaller component of the
FL (denoted as t1) represents the core fraction, and the large frac-
tion (denoted as t2) represents the solvent accessible fraction. The
values of the t1 and t2 for the unmodified NPs are 0.534 and
0.967 ns, respectively. Figure 5a shows the behavior of both com-
ponents of theFLswith the time of amine-silanization. These data
show that both lifetime components reach a maximum at 3 h of
reaction and then drop for longer times (The normalized TCSPC
data can be observed inFigure s3 of the Supporting Information).
This behavior is attributed to the efficient sensing of the chemical
microenvironment by the entrapped dye.23,24 The intensity decay
of the fluorophore is sensitive to the dye environment, in this case
the deposition of the ordered amine layer on the NP surface.
The amine monolayer formation that takes place in 3 to 4 h
of amine-silanization is correlated to the peak of the FL trend
in Figure 5a, whereas the decrease in the FL on the higher
time scale denotes the deterioration of layer coherence due to
the secondary cross-linking between the amine monolayer with
the unbound APTES, slowing the intensity decay and resulting
in the decrease in the FL.
This FL technique has been extended to evaluate its potential
to estimate the extent of amine-silanization on the nanosurface.
NPs were functionalized with different APTES concentrations,
as described in the Experimental Section, for 3 h to achieve a
monolayer distribution of the amine groups. Then, they were
tested byFLmeasurement. The result, demonstrated inFigure 5b,
shows the dependence of the FL on the APTES concentration.
It clearly shows that both lifetimes (t1 and t2) sense the surface
microenvironment and there is a linear relationship between
lifetime and APTES concentration.
To test the universality of this technique, we have also tested it
on thiolated NPs. NPs with different extents of thiol-silanization
have shown some dependency of the FL on the MPTES concen-
tration (results can be found in the Supporting Information),
but the linear fit was not as good as that for the aminated NPs
(Figure s4 in Supporting Information). This difference in dye sen-
sitivity with various surface functionalization chemistries can be
explained by the chemical stability of the functional group. Thiol
(-SH) groups are much more prone to aerial oxidation to form
disulfide linkage (-S-S-) between surface-attached or unbound
MPTESmolecules,making the thiolmonolayer irregular and less-
ordered comparedwith themuchmore stable aminemonolayer.30
3.4. FCS Study of the Aminated NPs. The cross-corrello-
grams of the NPs in the various stages of the amine-silanization
reaction were calculated by cross-correlating the ACFs obtained
fromboth channels, as described in theExperimental Section.The
CCFwas further normalized to nullify the concentration effect,
that is, the number of fluorophores present in the confocal volume.
Figure 5. (a) Dependence of FL on the duration of amine-silani-
zation reaction and (b) the dependence of the FLs (smaller and
higher component in left and right panel, respectively) of aminated
NPs on the reacting APTES concentration.
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The normalized correllogram for the NPs, shown in Figure 6, is
categorized in two timewindows relating to the different stages of
amine-silanization; Figure 6a shows the correllogram from 0 to
3 h, and Figure 6b shows the same for higher reaction times, that
is, 5 and 12 h.HereFigure 6a represents the formation of the amine
monolayer and Figure 6b shows the secondary cross-linking phe-
nomenon between surface-attached and unbound APTES. which
was previously discussed. The decay time of this cross-corrello-
gram is strongly correlated with the ordering of the APTESmole-
cules on theNP surface. The unboundNP (at time 0 h) is themost
ordered state characterized by homogenously populated sila-
nol (Si-OH) groups throughout the surface. At the start of the
reaction, the system gets the maximum disordered configuration
after 1 h when very few APTES molecules are chemically bound
to the surface, and some of them are physically adsorbed as
unhydrolyzed APTES molecules. There is a 35 times increase in
theCCFdecay time from20 to 700ms for the first hour of reaction.
This significantly high decay time reflects the nonhomogeneity of
the immediate surface environment due to the incompleteness of
the reaction,which is effectively sensed by the dynamicmonomer-
aggregate equilibriumof the encapsulateddye.This smaller extent
of reactivity during the first hour mark also fits well with the
FTIR results discussed earlier. In the second hour of the reac-
tion, the CCF decay time decreased to 200 ms, and in the third
hour, it decreases to 35ms, which is very close to that of the initial
state. Therefore, the maximum stabilization during amine-
silanization is achieved during the ordered monolayer formation,
which gives a decay time closest to the initial state. On the higher
time scale, shown in Figure 6b, the decay time increases again
to as high as 500 ms for both 5 and 12 h. This increment shows
the reappearance of the disordered state signifying the forma-
tion of secondary cross-linking between surface-attachedAPTES
with the free APTESmolecule. It is also important to note that
the maximum of the FL versus reaction time curve (Figure 2c)
was observed during the orderedmonolayer formation, where the
chemical-ordering-driven alteration of the microenvironment is
sensed efficiently by the entrapped dye population. While inves-
tigating the basic principle behind the sensing method, it has been
found that the surface functionalization drives the monomer-
aggregate equilibrium of NIR664 more toward the aggregate
state, which is evident from the absorption spectra of the NPs
(Figure s5 in Supporting Information).
Further analysis of the CCF data can give even more informa-
tion about the reaction states of the amine-silanization pathway.
The normalizedCCFs (Gn(t)) were fittedwith a single exponential
decay (in aR2 range of 0.93 to 0.99),whereR is the decay constant.
The variation of these decay constants for different fitting con-
ditions is given in Table 1. At the start of the reaction, the value of
R decreases sharply in the first hour and returns to a maximum at
3 h before further decreasing at longer times. Importantly, the
bulk deposition of the amine layer after 12 h is indicated by the
emergence of a biexponential fit with both pre-exponential factors
(shown in Table 1) having positive values indicating two distinct
chemicalmicroenvironments effectively sensed by the fluorophore.
However, it canbehypothesized that the ratioof the two exponents
is probably a function of the ratio of the thickness of amine layer
and NP radius.
A comparative study between amplitudes of ACF and CCF
was carried out to probe the stabilization of the amine layer on the
nanosurface. Figure 7a gives the profiles of ACF and CCF in
different stages of amine-silanization. The degree of similarity of
the amplitudes of these two correlations is indicative of the overall
order of the system. The correllogram in the first hour shows a
large difference of the amplitude between the two correlation
decays, indicating a lesser extent of stable monolayer formation.
As described in the Experimental Section, this stabilization of the
amine layer on the nanosurface has been examined with the var-
iation of normalized cross-correlation amplitude (CCra) with time
on a scale where fully unbound and completely stable layers are
set as 0 and 1, respectively. The first hour of amine-silanization
shows a very lowvalueofCCra (just over 2%).This value increases
Figure 6. Normalized fluorescence cross correllogram for aminated NPs is shown in two panels, (a) the 0-3 h kinetics and (b) 5-12 h
observations with respect to 0 and 3 h CCFs.
Table 1. Decay Constants of the Normalized CCFs for Aminated
NP Samples
time of
amine-silanization
reaction (h)
single
exponential fit
Gn(t) = ae-Rt
biexponential fit
Gn(t) = ae-Rt þ be-βt
a R a R b β
0 1.004 0.2647 -1.248 1.392 2.25 0.1875
1 0.72 0.0048 -0.007 0.006 0.72 0.0048
2 0.9959 0.0467 1.036 0.0467 -0.04 0.047
3 1.006 0.1639 -4.757 0.1639 5.76 0.1379
5 0.9837 0.0232 0.985 0.0230 -0.0012 0.007
12 0.9897 0.0157 0.969 0.0157 0.0198 0.0163
DOI: 10.1021/la103212d 18133Langmuir 2010, 26(23), 18125–18134
Roy et al. Article
significantly in the second hour. The maximum is reached at∼3 h
before decreasing at higher time scales. This stabilization land-
scape, as shown in Figure 7b, denotes the formation of the stable
monolayer of surface-attached APTES molecule up to 3 h, fol-
lowed by destabilizing secondary cross-linking by surface-bound
and free APTES molecules at longer times.
This monolayer formation and secondary cross-linking-driven
multipleAPTES layer has been constructed by designing the reac-
tion coordinate based on the correlation between the single expo-
nential decay constant for different stages of amine-silanization
with that of the initial reaction stage, as described in eq 5. In
Figure 8, a spline was generated on the basis of a hypothesis pre-
sented in the Experimental Section with the experimental Rcor
values to form a close approximation to the energy landscape for
the amine-silanization reaction onNP surface.Hence, theminima
and the maxima of the curve represent the most ordered and dis-
ordered states of the reaction, respectively. Here the two max-
imumpoints, that is, in a very early stage (∼1 h) and in later stages
(∼12 h), represent the most disordered states of the reaction be-
cause of the heterogeneously distributed nanosurface-attached
APTESmolecules for the former and formationof secondarybulky
amine layers via cross-linking and H-bonding for the latter. The
minimum of the curve during the reaction occurs after 3 h of reac-
tion time denoting the amine monolayer formation, the most
ordered state during the reaction having the minimum distance
with the initial stage in the reaction coordinate.
Figure 7. Plots ofACFandCCF for each set of aminatedNPs have been presented (a) and the dependence ofCCra on the amine-silanization
time is presented to construct the reaction profile (b).
18134 DOI: 10.1021/la103212d Langmuir 2010, 26(23), 18125–18134
Article Roy et al.
3.5. Direct Binding Immunoassay. The optimum reaction
time for NP surface amine-silanization has been validated by as-
saying the antibody conjugation efficiency of the aminated NPs.
As described in the Experimental Section, the binding between
anti-IgG-and IgG-conjugatedaminatedNPwas studiedbymeasur-
ing the fluorescence intensity (of the conjugated dye NIR664) at
700 nmupon excitation at 660 nm.Figure 9 shows the dependence
of antibody binding on the ordering of the amine layer deposited
on theNP.The plot of fluorescence intensity versus time of amine-
silanization for theNPs shows an increase in the intensity up to 3 h
reaction time, followed by a steady decrease for longer times.
Therefore, the maximum antibody attachment occurred on the
NPs having the 3 h amine-silanization.This shows the importance
of an ordered monolayer of functional groups on a nanosurface
for biomolecular conjugation. For the 5 and 12 h amine-silaniza-
tion sample, the multiple layering of cross-linked APTES poses a
marked inhibition for antibody attachment comparedwith the 3 h
data. First, during the longer time of amine-silanization reaction,
it is likely that the primary amine group of the nanosurface-bound
APTES molecule can interact with the hydroxyl group of un-
boundAPTESmolecule via hydrogen bonding. Furthermore, the
reverse interaction, that is, hydrogen bond formation between the
hydroxyl group of the surface bound APTES molecule and the
primary amine group of a nearby unboundAPTESmolecule, can
significantly limit the number of free primary amine groups
despite the longer extent of APTES exposure. In addition to that,
the steric hindrance posed by the bulky amine layer composedof a
cross-linking driven mesh structure is likely to restrict the anti-
body attachment.
4. Conclusions
In this work, we have successfully demonstrated the applica-
tion of FL and FCS to monitor the surface-modification process
of silica NPs as well as optimized the surface layer structure for
efficient conjugation of biomolecules. Conventional techniques
like zeta potentiometry and FTIR spectroscopy can indicate the
bulk amine group deposition and the altered chemical signatures
on the nanosurface, respectively. The FTIR analysis identified an
optimum time of 3 h for the formation of anordered aminemono-
layer and the formation of a disordered secondary APTES cross-
linked layer at longer reaction times. The superior sensitivity of
fluorescence, in particular, FLs, coupled to the sensitivity of the
encapsulated dye to the NP surface environment, facilitated the
elucidation of the details of the amine-silanization reaction and
the evolution of the amine layer structure in different stages of the
reaction. This is manifested as a variation in FL value as a func-
tion of amine-silanization reaction time, which, in agreement with
the FTIRanalysis, indicates an optimum reaction time of 3 h. The
power of FCS as a novel probe of functional layer structure has
also been demonstrated. Analysis of both the normalized CCF
function, Gab, and the relative cross-correlation factor, CCra,
indicates an optimum amine-silanization reaction time of 3 h in
agreement with the FL analysis. Furthermore, an in-depth anal-
ysis of the FCS decay constant variation further validated the
above conclusions. Finally, a direct binding assay was carried out
that indicated that maximum antibody-antigen binding occurs
on the ordered amine monolayer corresponding to 3 h of reaction
time. Thiswork clearly demonstrates the potential ofFLandFCS
to complement and supplement other more conventional char-
acterization techniques toward the elucidation of nanosurface
functional layer structure and kinetics.
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Figure 8. Construction of a reaction profile for the nanosurface
amine-silanization on the basis of chemical ordering, described by
the correlation parameter Rcor that measures the correlation dis-
tance between different states of the reaction and the initial state.
Figure 9. Plot of NP fluorescence at 700 nm (excited at 660 nm)
versus amine-silanization time is shown for a plate-based direct
binding assay that reports the binding between surface attached
IgG and anti-IgG conjugated with the aminated NP.
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View Online / Journal Homepage / Table of Contents for this issueEffect of antibody immobilization strategies on the analytical performance of
a surface plasmon resonance-based immunoassay†
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DOI: 10.1039/c1an15325kAntibody immobilization strategies (random, covalent, orientated and combinations of each) were
examined to determine their performance in a surface plasmon resonance-based immunoassay using
human fetuin A (HFA) as the model antigen system. The random antibody immobilization strategy
selected was based on passive adsorption of anti-HFA antibody on 3-aminopropyltriethoxysilane
(APTES)-functionalized gold (Au) chips. The covalent strategy employed covalent crosslinking of anti-
HFA antibody on APTES-functionalized chips using 1-ethyl-3-[3-dimethylaminopropyl]carbodiimide
(EDC) and sulfo-N-hydroxysuccinimide (SNHS). The orientation strategy used passive adsorption of
protein A (PrA) on Au chips, with subsequent binding of the anti-HFA antibody in an orientated
fashion via its fragment crystallisable (Fc) region. In the covalent-orientated strategy, PrA was first
bound covalently, to the surface, which in turn, then binds the anti-HFA antibody in an orientated
manner. Finally, in the most widely used strategy, covalent binding of anti-HFA antibody to
carboxymethyldextran (CM5-dextran) was employed. This immobilization strategy gave the highest
anti-HFA antibody immobilization density, whereas the highest HFA response was obtained with the
covalent-orientated immobilization strategy. Therefore, the covalent-orientated strategy was the best
for SPR-based HFA immunoassay and can detect 0.6–20.0 ng/mL of HFA in less than 10 min.Introduction
Immunoassays based on the immobilization of antibodies on
a substrate have been widely used in different biosensing or
bioanalytical techniques for the detection of specific antigens.
Surface plasmon resonance (SPR)-based immunosensors are
‘real-time’ and ‘label-free’ rapid assay formats that provide
highly useful information on biomolecular interactions1,2 and
provide highly reproducible immunoassays.
The immobilization of antibodies on sensor chips plays a very
important role in the analytical performance of a SPR-based
immunoassay. The affinity, orientation and stability of the
antibodies are often affected by the immobilization strategyaCentre for Bioanalytical Sciences (CBAS), National Centre for Sensor
Research, Dublin City University, Dublin 9, Ireland. E-mail: richard.
okennedy@dcu.ie; Fax: +353 1 700 5412; Tel: +353 1 700 7810
bBristol-Myers Squibb (BMS), Swords Laboratories, Watery Lane,
Swords, Co. Dublin, Ireland
cApplied Biochemistry Group, School of Biotechnology, Dublin City
University, Dublin 9, Ireland
dBiomedical Diagnostics Institute (BDI), Dublin City University, Dublin 9,
Ireland
† Electronic supplementary information (ESI) available. See DOI:
10.1039/c1an15325k
‡ Current Address: NUSNNI-NanoCore, National University of
Singapore, T-Lab Level 11, 5A Engineering Drive 1, Singapore 117580
x These authors contributed equally
This journal is ª The Royal Society of Chemistry 2011employed.3,4 In addition, the size of the antibodies/fragments
used and their surface distribution and the size of the analyte are
of significance in relation to the minimization of steric hindrance,
which may affect the immunoassay performance. Antibodies
present in the solution phase have three dimensional freedom of
movement and maintain their native structure. Immobilization
of antibodies at an interface restricts their freedom of movement
and may impact on their three dimensional conformation.5
Therefore, a critical understanding of the interactions between
macromolecular receptor and ligand is important.5
A large number of chemistries are available for immobilizing
antibodies on biosensor surfaces, however, those introducing
orientation6 and maintaining native antibody conformation7 are
of major importance. CM5-dextran is often used where the
antibody is linked via its amine groups to the EDC-NHS-acti-
vated carboxyl groups of CM5 by heterobifunctional cross-
linking and this chemistry leads to a high density of antibody
immobilization. However, immobilization using this strategy can
result in interference with the antigen detection capability if the
antibody is inadvertently captured via amine groups of or adja-
cent to the antigen binding site.8
In another format, poly-histidine tagged antibodies are bound
to nitriloacetic acid (NTA)-modified surfaces. However, prob-
lems may arise from the strong non-specific adsorption of other
metal-binding proteins to the poly-histidine tag and continuous
leaching of the bound ligand.9,10 Biotin-avidin systems have alsoAnalyst, 2011, 136, 4431–4436 | 4431
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View Onlinebeen used for immobilization in SPR assays. Streptavidin-coated
SPR chips are preferred for the site-directed immobilization of
biotinylated antibodies. This strategy introduces steric freedom
along with site-directed orientation. However, as with other
proteins, immobilization of streptavidin on the surface may
introduce conformational-stress that may reduce its binding
affinity for biotin. This can also occur with other physical
parameters such as temperature.11 Conversely, strategies
employing thiols, which can be immobilized on the gold surface
with high-affinity and without any prior surface modification,
provide strong site-directed orientation. This strategy is useful if
the antibody naturally has free thiol groups. However, if the thiol
group is introduced chemically, involving reaction with the
antibody’s amine groups, then this can affect activity.
A high degree of orientation for the capture antibody on
a sensor surface can be attained with a sub-layer of proteins such
as protein A or protein G.12 These proteins are specific for
binding the Fc region of the antibodies, which keeps the frag-
ment antigen-binding (Fab) region free for antigen binding thus
obviating the need of any chemical modification of the antibody.
However, randomly immobilized Fc-binding protein molecules
may affect the orientation of antibody to some degree but this is
significantly lower in comparison to the degree of orientation
actually achieved. Nevertheless, due to steric considerations,
a maximum of two antibodies may only be accommodated by
each of these protein binding molecules.7 Drawbacks associated
with random immobilization and the introduction of confor-
mational strain will not affect, to a significant degree, the anti-
body molecules captured on the sub-layer of Fc-binding proteins.
Moreover, Fc-binding protein-antibody interaction is generally
regenerative.13
The present study is aimed at determining the effect of
various antibody immobilization strategies, i.e. random, orien-
tated, covalent, covalent-orientated and covalent-CM5-dextran
on a SPR-based immunoassay for HFA. Recently we reported
a multi-substrate compatible novel antibody immobilization
strategy,14 which is based on the APTES functionalization of
the surface and the covalent binding of antibodies to it by EDC-
SNHS heterobifunctional crosslinking. Various optimization
parameters associated to APTES functionalization of the Au
chip are described in the supplementary section Figure S1 &
S2.† The same strategy was employed for SPR immunoassays
and the schematic representation of the strategy is depicted in
Fig. 1. An alternate covalent-orientated strategy was also
devised by introducing an additional step in the covalent
strategy, where PrA was initially bound covalently and anti-
HFA antibody was immobilized, thereafter, in an orientated
manner. The random strategy employed the passive adsorption
of anti-HFA antibody on APTES-functionalized chips, whereas
the orientated strategy used the passive adsorption of PrA on
SIA Au chips followed by the orientated immobilization of anti-
HFA antibody. The covalent-CM5-dextran strategy employed
the covalent binding of amino groups of anti-HFA antibody to
the carboxyl groups of CM5-dextran using EDC-SNHS. Each
strategy was compared on the basis of their SPR immunoassay
performance, anti-HFA antibody immobilization density and
mass-density of captured HFA. This study provides an insight
as to how antibody orientation strategy may influence immu-
noassay performance.4432 | Analyst, 2011, 136, 4431–4436Materials and methods
Reagents and materials
EDC, SNHS and 2-(N-morpholino)ethane sulfonic acid (MES,
pH 4.7) were purchased fromThermo Scientific. 3-APTES (purity
98%, w/v), 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
(HEPES), Tween 20, H2O2 (30%, v/v), H2SO4 (97.5%, v/v),
ethylenediaminetetraacetic acid (EDTA), NaCl and protein A
(soluble, Cowan strain, recombinant, expressed in Escherichia
coli) were procured form Sigma-Aldrich, Singapore. The human
Fetuin A/AHSG kit with all the necessary components was
obtained fromR&DSystems Inc., USA.All buffers and solutions
were preparedwith 18MUMilli-Q ultrapure water (UPW) filtered
through a 2-mmfilter. Surface PlasmonResonancewas performed
on BIAcore 3000 purchased from GE Healthcare, Uppsala,
Sweden. The SIA kit (BR-1004-05) containing SPR Au chips,
carboxymethyl dextran (CMD)-functionalized Au chips, and
ethanolamine hydrochloride (1M, pH 8.5) were purchased from
GE Healthcare, London, U.K.
The SPR Au chip was assembled according to the instructions
supplied by the manufacturer. HEPES-buffered saline (HBS)
buffer (10mM) pH 7.4, (running buffer for BIAcore) was made
up, filtered through 0.2mm Millipore filter paper and degassed
overnight in order to remove any air bubbles, which may cause
interference with SPR analysis. All the sample dilutions were
made in the running buffer (10mM HBS, pH 7.4). The dilutions
of HFA were made in BSA-preblocked glass vials, prepared by
incubating with 1% (w/v) BSA for 30 min, to minimize the sample
loss due to non-specific adsorption on sample tube surfaces and/
or effects due to altered immunogenicity.15Surface cleaning of SIA Au chip and APTES functionalization
The Au chip was cleaned with piranha etch [60 mL of H2SO4
(97.5%, v/v): 30 mL of H2O2 (30%, v/v)] for two minutes followed
by extensive washing. Piranha treatment oxidizes the gold
surface, as evident by the contact angle, which is 9.3. When the
piranha-treated chips are washed with deionized water, the water
molecules get strongly adsorbed on the surface thereby gener-
ating ‘hydroxyl’ groups,16,17 as evident by the increase in contact
angle to 28–32.
The chip was then incubated with 100 mL of 2% (v/v) APTES
for one hr at room temperature (RT) in a fume hood followed by
five washes with UPW. Following this, different immobilization
strategies were applied.EDC activation of anti-HFA antibody
Anti-HFA antibody (990mL of 100 mg/ml in HBS) was incubated
at room temperature for 15 min with 10 mL of cross-linking
solution containing EDC (4 mg/mL) and sulfo-NHS (11 mg/mL)
in 0.1 MMES buffer, pH 4.7. The procedure led to the activation
of carboxyl groups on the anti-HFA antibody with EDC. The
EDC-activated anti-HFA antibody was captured on the APTES-
functionalized Au chip (previously described) for the covalent
immobilization strategy.
Similarly, PrA was also activated with EDC and captured on
the APTES-functionalized Au chip surface for the orientated
strategy.This journal is ª The Royal Society of Chemistry 2011
Fig. 1 Schematic representation of various immobilization strategies employed for the SPR-based HFA immunoassay. PrA is protein A.
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View OnlineImmobilization of anti-HFA antibody
For the random antibody non-covalent immobilization strategy,
50 mL of anti-HFA antibody (100 mg/mL) was injected over all
the four flow cells of an APTES-functionalized Au chip at a flow
rate of 10 mL/min and the baseline was allowed to stabilize. BSA
(20 mL of 1% (w/v)) was subsequently used for blocking.
For the covalent immobilization strategy, 50 mL of EDC-
activated antibody (100 mg/mL) was injected over all the four
flow cells of an APTES-functionalized Au chip, and BSA was
used for blocking as previously described.
For orientated immobilization strategy, 50 ml of protein A
(100 mg/mL) was injected over the four flow cells of the piranha-
treated Au chip at a flow rate of 10 mL/min. Twenty microliters of
1% (w/v) BSA was then injected for blocking. After baseline
stabilization, 50 mL of anti-HFA antibody (100 mg/mL) diluted in
10 mMHBS, pH 7.4, was injected over all the flow cells at a flow
rate of 10 mL/min.
For the covalent-orientated immobilization strategy, 50 ml of
EDC-activated PrA was injected over all four flow cells of an
APTES-functionalized Au chip at a flow rate of 10 mL/min. TheThis journal is ª The Royal Society of Chemistry 2011chip was blocked with BSA, as previously described, followed by
the addition of anti-HFA antibody.Covalent-CM5-dextran immobilization strategy
A CM5 dextran-functionalized Au chip was docked into BIA-
core 3000 and primed. Pre-concentration studies were performed
in order to obtain the optimum pH of the sodium acetate buffer
for use with anti-HFA antibody immobilization (pH range of
4.0–5.0). Further activation was performed at a pH of 4.2
(optimum). Afterwards, the CM5-dextran chip was activated by
injecting a 50 mL solution containing 200 mg of EDC and 550 mg
of SNHS in 0.1M MES buffer, pH 4.7, through all the flow cells
at a flow rate of 10 mL/min. Thereafter, the procedure employed
for the random immobilization strategy was used, with the
exception that blocking was initially performed with 20 mL of 1M
ethanolamine hydrochloride, pH 8.5, followed by 20 mL of 1%
(w/v) BSA. Ethanolamine hydrochloride (1M), pH 8.5, blocks
the unreacted ester groups in the CM5-dextran matrix, while
BSA blocks the non-specific binding sites on the chip surface.Analyst, 2011, 136, 4431–4436 | 4433
Fig. 2 Change in response units caused by anti-HFA antibody immo-
bilization when various antibody immobilization strategies were used for
the SPR-based HFA immunoassay. Error bars represent standard devi-
ation obtained from the nine repeats for each sample. Cov means
covalent.
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View OnlineHFA-detection
Fifty microlitres of the dilution buffer (10mM HBS, pH 7.4) was
passed through all the flow cells before HFA capture and the
resultant changes in the SPR response units (RU) for each of the
four flow cells were recorded. Fifty microlitres of HFA at six
different dilutions (0.6, 1.2, 2.5, 5.0, 10.0 and 20.0 ng/mL) were
then passed through the flow cells. Subsequently, the RU values
obtained for the blanks were subtracted from the RU values
obtained for captured HFA of the corresponding flow cells.
All the experiments pertaining to different immobilization
strategies were repeated nine times and the standard deviation
was calculated. The SPR-based HFA detection curves were
plotted with SigmaPlot software, version 11.2 based on a four
parameter logistic (eqn (1)). The analytical parameters such as
EC50 and Hillslope, generated by the software analysis report,
were then used to evaluate the analytical performance18 of SPR
immunoassays with the various antibody immobilization
strategies.
y ¼ min + (max  min)/[1 + (x/EC50)(Hillslope)] (1)
Results and discussion
Comparison of antibody immobilization strategies on basis of
anti-HFA antibody immobilization density
The development of the APTES-functionalization of Au chips,
used for various antibody immobilization strategies in this study,
was optimized for APTES concentration, APTES functionali-
zation time and APTES density (Supplementary Fig. S1 and S2).
The effect of employing various antibody immobilization
strategies in a SPR immunoassay was initially observed by
determining the immobilization density of anti-HFA antibody
on the SPR chip. The highest and lowest anti-HFA antibody
immobilization densities, as shown in Table 1, were obtained
with covalent-CM5-dextran immobilization and random
immobilization strategies, respectively. The anti-HFA antibody
immobilization densities were found in the decreasing order of
covalent-CM5-dextran > covalent > covalent-orientated >
orientated > random strategies (Fig. 2). The immobilizationTable 1 Determination of molecular densities of immobilized anti-HFA an
formats, based on various antibody immobilization strategies, were employed
Antibody
Immobilization
Strategy
Immobilization of anti-HFA antibody
DRU
Mass densityb
(ng/cm2)
Molecular Den
(molecules/cm2)
Random 816.0  11.7 81.6  1.2 3.3  1011
Covalent 1536.0  10.4 153.6  1.0 6.1  1011
Orientated 1112.0  9.6 111.2  1.0 4.4  1011
Covalent-orientated 1457.0  8.8 145.7  1.0 5.8  1011
Covalent-CM5-dextran 1728.0  12.4 172.8  1.2 6.9  1011
a DRU: Change in resonance units (RU) caused by binding. b Calculated usi
c Calculated by [Mass density (ng/cm2)/Molecular weight (in ng)]. Molecula
respectively. In order to calculate molecular weight in SI units, the conversio
anti-HFA antibody and HFA are 24.9  1011ng and 7.0  1011ng, respe
HFA i.e. the concentration just above the EC50.
4434 | Analyst, 2011, 136, 4431–4436densities were calculated using a conversion factor i.e. 1 ng/mm2
of biomolecule corresponds to a change of 1000 RU.19–21 The
lowest antibody immobilization density in the random immobi-
lization strategy was attributed to the irregular and uncontrolled
binding of the antibody over the surface mainly by electrostatic
and hydrophobic interactions.21 Additionally, many other
factors, such as molecular spreading and inter-molecular inter-
actions, may affect the immobilization-density of adsorbed
antibodies at the interface,19,22 which, in turn, determines the
functionality of adsorbed antibodies.22 However, the introduc-
tion of PrA molecules enables the orientated immobilization of
antibodies in a site-directed fashion. The anti-HFA immobili-
zation density of the orientated immobilization strategy was
greater than that of the random immobilization strategy as PrA
binds very strongly to the Au surface, which is the main reason
that it has been used extensively for biosensing applications in
various biosensor formats.
The capture ratio of 1 : 1 for anti-HFA antibody bound to
PrA is in line with previous findings, which state that one PrA
molecule can bind to a maximum of two antibody molecules
based on conformational and intermolecular restrictions.23tibody and detected amount of HFA when different SPR immunoassay
a
HFAd
sityc
DRU
Mass densityb
(ng/cm2)
Molecular Densityc
(molecules/cm2)
EC50
(ng/mL)
63.0  16 6.3  1.6 (0.9  0.2)  1011 5.7
149.0  9.6 14.9  1.0 (2.1  0.1)  1011 3.8
113.0  10.5 11.3  1.0 (1.6  0.1)  1011 4.0
194.0  9.5 19.4  1.0 (2.8  0.1)  1011 3.7
138.0  10.4 13.8  1.0 (1.9  0.1)  1011 4.1
ng the commonly used conversion factor i.e. 1000 RU ¼ 100 ng/cm2.13,14
r weight of anti-HFA antibody and HFA were 150 kDa and 43.5 kDa,
n factor 1 kDa ¼ 1000 Da ¼ 1000 g was used. The molecular weight of
ctively. d Calculations were performed for the detection of 5 ng/mL of
This journal is ª The Royal Society of Chemistry 2011
Fig. 3 Change in response units caused by HFA detection at 5 ng/mL
when various antibody immobilization strategies were used for the SPR-
based HFA immunoassay. Error bars represent standard deviation
obtained from the nine repeats for each sample. Cov means covalent.
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View OnlineHowever, the anti-HFA antibody immobilization density was
lower than that of the covalent-orientated immobilization
strategy. This might be because PrA molecules adsorbed in the
orientated format still have a tendency to undergo conforma-
tional changes and/or leaching off the surface. The higher anti-
body immobilization density of the covalent-orientated strategy
may be due to the fact that covalently bound PrA molecules
could resist leaching whilst maintaining their active conforma-
tion for binding.
The antibody immobilization density of the covalent strategy
was higher than that of covalent-orientated strategy and this may
be due to the fact that the total number of amino groups avail-
able for antibody crosslinking was significantly higher than the
binding sites available on covalently immobilized PrA molecules.
Therefore, there is a higher probability for an antibody to be
directly crosslinked to the amino groups on the surface in
comparison to binding in an orientated fashion to the covalently
bound PrA molecules.
On the other hand, the covalent-CM5-dextran immobilization
strategy had the highest anti-HFA antibody density, which may
be due to the fact that CM5-dextran has a long hydrophilic
polymer chain with a large number of available carboxyl groups
on the side chains. Moreover, apart from the increased effective
surface area provided by the CM5-dextran, electrostatic inter-
actions of the positively-charged amino groups on anti-HFA
antibody towards the negatively-charged carboxyl functional
groups on the surface of CM5 dextran can also occur.
Our results are very similar to the findings reported recently,24
where it was observed that a carboxymethyl dextran hydrogel-
based immobilization strategy had a very high antibody immo-
bilization density in comparison to random and orientated
immobilization strategies. Here the random immobilization
strategy was based on the passive immobilization of antibodies
on a self-assembled monolayer (SAM) formed by 11-mercap-
toundecanoic acid (MUA) whereas, the orientated immobiliza-
tion strategy employed the capture of antibodies on the layer of
covalently immobilized Protein G on the MUA SAM-function-
alized surface.Fig. 4 SPR-based immunoassay curves for HFA detection when various
antibody immobilization strategies were employed. Error bars represent
standard deviation obtained from nine assay repeats for each sample
type.Comparison of antibody immobilization strategies on basis of
HFA capture densities
Anti-HFA antibodies bound to SPR Au chips, prepared by
various antibody immobilization strategies, were employed for
the detection of different concentrations of HFA (0.6–20.0 ng/
mL), as shown in Fig. 3. The blank for the assay was the running
buffer i.e. 10 mMHBS, pH 7.4. The RU of the blank in each flow
cell was then subtracted from the RU value corresponding to the
detection of a particular concentration of HFA in that flow cell.
All immobilization strategies used were evaluated using an
HFA concentration of 5 ng/mL, which was the HFA concen-
tration just above the EC50 of the random immobilization
strategy. It was highest for the covalent-orientated strategy and
lowest for the random strategy. The mass densities of HFA
detected by the various antibody immobilization strategies were
in the decreasing order of covalent-orientated > covalent
>covalent-CM5-dextran > orientated > random. The EC50 of
covalent-oriented strategy based anti-HFA bound SPR chip for
HFA detection was also found to be the lowest (Table 1), whichThis journal is ª The Royal Society of Chemistry 2011indicates that it was the most sensitive immunoassay format. The
mass density of HFA detected while using the covalent-orien-
tated strategy was the highest of all the immobilization strategies
employed. Conversely, the covalent-orientated strategy, which
had a lower anti-HFA antibody mass density in comparison to
the covalent-CM5-dextran and covalent strategies, had the
highest response units for HFA capture and thus, the highest
mass density. This clearly demonstrates that the total amount of
antibody immobilized does not necessarily equate with
maximum antigen (HFA) capture. The antigen-detection ability
of adsorbed antibodies can be significantly compromised.19,25 We
previously demonstrated that covalently-bound antibodies
capture higher amount of antigen than adsorbed antibodies
under the same set of conditions.3 Therefore, the adsorption of
antibodies can introduce certain conformational changes that
may impact their antigen-recognition behaviour, thereby ulti-
mately resulting in reduced antigen detection. The results shown
in Fig. 4 demonstrate that the effectiveness of an immunoassay is
clearly dependent on the antibody immobilization strategies.
Our findings show that the covalent-orientated strategy, based
on the binding of PrA to the chip and the orientated immobili-
zation of capture antibodies, is ideal for the SPR-basedAnalyst, 2011, 136, 4431–4436 | 4435
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View Onlineimmunoassay for HFA. There was no evidence of biofouling
even after continuous HFA detection cycles or extended storage
at 4 C (Supplementary Fig. S2 and S3†).
Conclusions
Various antibody immobilization strategies, i.e. random, cova-
lent, orientated, covalent-orientated and covalent-CM5-dextran,
were employed to determine their effect on the analytical
performance of a SPR-based immunoassay for HFA. The
highest anti-HFA antibody immobilization density was obtained
with covalent-CM5-dextran, whereas the highest amount of
HFA was captured with the covalent-orientated strategy.
Therefore, the orientation of the antibody plays an important
role in the analytical performance of the SPR immunoassay. The
relative molar density of HFA detected, which corresponds to
the functional antibody immobilization density, is a more reli-
able indicator of analytical performance than the total antibody
immobilization density.
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